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Magnetic navigation in Percutaneous coronary and non-coronary 
interventions
There is no question that Percutaneous Coronary Intervention has revolutionized the way we 
manage coronary artery disease. Over the past two decades we have witnessed maturity in 
several techniques and equipment enabling the interventional cardiologist to manage lesions 
that have previously been entirely in the domain of the cardiac surgeon1. Despite these remark-
able achievements there still remain lesions that are complex enough to create a challenge 
in the most experienced hands2,3. The inherent tortuosity in complex vascular anatomies, 
branching segments and chronically occluded vessel have been all associated with lower 
procedural success and higher complication rates when compared to the “straight forward ves-
sels”4. The Magnetic Navigation System (MNS) is a novel and versatile technology that allows 
the re-orientation of a wire within the patient’s body. This unique ability means that the “trial 
and error” method of externally re-shaping the tip of the wire and re-engaging the vessel can 
be effectively eliminated. As such previously “unreachable areas” in the heart or within the 
vasculature can now be potentially reached5. 
The MNS is an established technique for cardiac electrophysiology procedures but as yet has 
not been proven in the field of percutaneous coronary interventions6. This aim of this Thesis 
is to critically evaluate the extension of the MNS in unselected patients and to identify the 
strengths and weaknesses of the current software and hardware. Chapter 1 introduces the 
reader to a general introduction to the MNS. It pays tribute to the early pioneers and gives an 
up-to-date analysis of what is currently possible with this technology and an insight into what 
the future holds, particularly with respect to chronic occluded arteries7 and cell transplanta-
tion8. Chapter 2 attempts to evaluate the performance of the MNS hardware and software in 
an experimental setting. Phantom models were chosen so as to provide a precisely control 
environment for testing and validation. Direct comparisons were made with the magnetic wire 
and standard conventional wires in a 2-dimensional branching tortuous phantom simulating 
angulated coronary vessels. Also since the MNS uses 3-dimensional reconstruction software 
to create a precise roadmap for the magnetic wire to follow, the precision and accuracy of this 
software was assessed with an alternative system using stenotic phantoms in porcine models.
Having evaluated both the software and hardware, the evaluation of the MNS in a clinical set-
ting was undertaken9. Attempts were made in Chapter 3 to identify the patient population 
that would be best suited to have a magnetically assisted procedure. Assumptions were made 
based on the length of time needed in crossing using conventional standard wire techniques. 
A scoring system was developed based on both vessel and lesion characteristics. This was 
then evaluated in patients admitted for treatment with the MNS to determine if the system 
had a role to play in vessels having anatomical complexities. Two complex lesions where the 
MNS was postulated to have an advantage were examined in the second part of this Thesis. In 
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Chapter 4, the ability of the system to reorient the wire’s tip to cross bifurcating vessels and the 
struts of stent covering the ostium following treatment were evaluated. In managing another 
complex lesion subset, the chronically total occluded (CTO) vessel, an alternative method for 
deriving a pathway based on Multislice Computer Tomography (MSCT) was examined. Chapter 
5 firstly assesses how the Navigant® software can facilitate magnetically assisted percutaneous 
interventions directly by co-integrating the MSCT scan. Then evaluates the possibility that in 
the future an entire intervention with stent positioning and deployment may be possible based 
entirely on the integration of 3D information without needing contrast agents. The techni-
cal aspects of the magnetic wire and the development of a dedicated wire for the CTO are 
discussed in Chapter 6. This chapter also examines the Thoraxcenter’s experience in using the 
various generations of magnetically enabled wires from the initially installation of the system to 
the present time. It critically assesses the key elements that are important to address if the MNS 
is to compete with the sophistication of the modern conventional CTO wires.
The final part of this Thesis, Chapter 7 examines the application of the MNS to two important 
non-coronary intervention areas. Its use in guiding left ventricular lead implantation base on 
virtual 3D reconstructed image of the coronary sinus and the possibility to use a magnetically 
enabled injection needle to facilitate precise stem cell implantation within the myocardium. 
Finally Chapter 8 describes a couple of cases to demonstrate the wider spectrum in the clinical 
application of the MNS.
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summary
Magnetic navigation is rapidly emerging as a useful technology in the field of interventional 
cardiology. Precise control of the direction of a guide wire or a device in three-dimensional 
space offers a means to access vessels and areas of the heart that are often challenging to 
access with conventional methods. In this comprehensive Review, we detail the development 
of magnetic navigation technology and how this tool has been adapted for use during percuta-
neous coronary intervention. We aim to provide an up-to-date analysis of what is currently pos-
sible with this technology and an insight into what the future holds, particularly with respect to 
chronic occluded arteries and cell transplantation.
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introduction
The growth of interventional cardiology has led to numerous technological developments:1 
the development of metallic and biodegradable stents that elute novel bioactive molecules;2 
specialized guidewires with subtle differences for accessing different types of lesion;3 and 
various new pharmacological agents.4 One area that has not seen substantial progress thus 
far is the technology used to precisely guide a wire across a lesion. In most instances, crossing 
a lesion still relies heavily on both the skills of the interventional cardiologist performing the 
procedure and the mechanical properties of the guidewire. The Niobe® Magnetic Navigation 
System (MNS; Stereotaxis Inc., St Louis, MO) is a novel technology that can precisely control 
the tip of a magnetically enabled wire or device in vivo.5 Preliminary data suggest that the MNS 
could be useful in tortuous vessels or in complex lesions such as bifurcations, in which the initial 
bend placed on the wire might not be ideal for crossing tandem lesions.6 Magnetic navigation 
also means the wire is less likely to deviate into side branches, therefore, reducing radiation 
exposure and the amount of contrast required.7 The combination of dedicated magnetically 
enabled devices with three-dimensional (3D) imaging methodologies such as multislice CT 
(MSCT) and the NOGA® mapping system (Cordis Corporation, Miami Lakes, FL), can increase the 
accuracy in targeting chronic total occlusions (CTOs) and stem-cell implantation.
To date, the transition of this technology into interventional cardiology has been slow. In 
many centers the MNS was first used in cardiac electrophysiological procedures, for which the 
benefits are well established; only now are centers extending the use of this technology to 
the interventional setting, despite the obvious advantages that the MNS offers. This somewhat 
cautionary approach stems from the fact that no randomized clinical trials have currently com-
pared the MNS with older, more-established techniques. This issue clearly needs addressing, 
with future developments in both the software and hardware designs being investigated in 
timely clinical trials. At present, the expenses incurred in setting up an MNS will also influence 
its popularity. This Review discusses some of the major technological developments in the 
context of interventional cardiology and provides an insight into what is currently possible and 
what might be possible with this novel technology in the future.
early developments
Vascular studies using magnetic navigation first began over 50 years ago when Llander,8 and 
later Tillander,9 used magnetic fields to guide an articulated steel-tip catheter in rabbit aorta. 
After these initial investigations, small external permanent magnets were used to stereot-
actically direct iron particles for thrombosis of intracranial aneurysms,10, 11, 12 later, rotating 
electromagnets were used, enabling better control.13 In 1991, Ram and Meyer performed 
the first magnetically guided angiography in a human. They successfully used a magnetized 
catheter controlled with external permanent magnets in a neonate with anatomically complex 
congenital heart disease.14 Despite initial success, further development was hampered by low 
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field strengths, the need for large magnets and the lack of precise 3D control.15, 16 In order for 
stereotactic localization and computer-controlled vector guidance to be possible, considerable 
advances in both medical physics and magnet design were required.17 Further advancements in 
these areas and the use of MRI coregistered with real-time fluoroscopy enabled the navigation 
of both a small object in a canine brain18 and magnetically enabled catheters in pig brains.19 
These experiments led to the MNS first being used in interventional radiology and cardiac 
electrophysiology, and now in interventional cardiology.20, 21, 22 Across these disciplines there 
are now more than 100 systems installed worldwide. It should be noted, however, that applying 
this technology in interventional cardiology presents a greater challenge than in more estab-
lished indications such as neurosurgery. Unlike the brain, the heart is a dynamic structure, and 
the patient’s chest moves with respiration.
the niobe® magnetic navigation system
navigation hardware
The Niobe® MNS (Figure 1a) has four key components: two permanent adjustable magnets 
mounted on mechanical frames situated at either side of the fluoroscopy table; navigation 
software (Navigant®, Stereotaxis, St Louis, MO) to control the magnets by creating a virtual 
roadmap and magnetic vectors after imaging data are gathered; a real-time fluoroscopy sys-
tem to display a virtual map of the live image; and finally, a sterile touch-screen monitor for 
controlling the system, ideally placed at the operating table. In the second-generation system, 
Niobe® II, the mechanical frames enabling the magnets to be positioned were adapted to allow 
the magnets to translate or tilt about their axes. This tilting action enabled more angiographic 
projections—the previous version of Niobe® had limited right anterior oblique and left anterior 
oblique views because of the bulkiness of the magnets. 
The majority of systems are integrated with a modified C-arm flat-panel detector fluoroscopic 
imaging suite (AXIOM Artis dFC; Siemens AG, Malvern, PA), but there are systems that can also 
incorporate biplane fluoroscopic imaging and rotational angiography. Biplane fluoroscopy 
has the advantage of reducing the amount of contrast used during image acquisition, but 
once the images are transferred into the Navigant® software the lateral C-arm must be stored 
in order for the magnets to be positioned. Rotational angiography, on the other hand, enables 
a 3D image to be generated directly from a single acquisition.When the patient is correctly 
positioned and isocentered, the magnets interact to produce a spherical magnetic field 15 
cm in diameter and uniformly of 0.08 Tesla—the ‘magnetic volume’. Within this volume any 
applied magnetic vector can precisely direct a 2–3 mm magnet mounted on the tip of a 
wire (Figure 1b) or steerable device so that a full 360° rotation can be achieved. Clinically 
approved devices include guidewire and electrophysiological ablation catheters; other 
devices currently in development include coronary and peripheral ablative radiofrequency 
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wires, multidirectional probing catheters, and catheters fitted with needles that are designed 
for cell implantation.
navigation software
Free-mode navigation
Magnetic navigation is performed by presetting a magnetic vector using the touch-screen 
monitor. Following programming, the vector is displayed as a dotted line on the live fluoros-
copy image, and the permanent magnets—illustrated by a solid vector line—move to align 
a magnetic field to this vector. Wire advancement is controlled manually to follow a desired 
incremental distance and is guided by either two-dimensional (2D) or 3D software features 
in Navigant®. The 2D navigational modes include the use of preset navigational vectors that 
are adapted to a particular coronary anatomy. This software also allows the user to create new 
presets if necessary, for example in patients who have vascular anomalies or to target coronary 
artery bypass grafts. Other approaches include the ‘bulls eye view’, which allows navigation 
around a central axis, and is, hence, a particularly useful technique for CTOs. The 3D Navisphere® 
program (Stereotaxis, Inc., St Louis, MO) is a spherical navigation object that contains regularly 
spaced polar lines (e.g. latitude and longitude lines). The aim of this program is to improve 
Figure 1 The Niobe® Magnetic Navigation System.
(a) A typical magnetic navigation system set-up showing the magnets, C-arm and the control room. 
(b) The Titan® magnetic navigation wire showing the 2 or 3 mm magnet located at its tip.
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recognition of the 3D structure of the coronary artery tree. Navigation is also feasible through 
the ‘clock face’ mode, which mimics the dial of a clock (Figure 2). This technique permits fast 
navigation relative to other techniques, but does require some understanding of the spatial 
coronary anatomy. Direct anatomical navigation is possible by directly introducing a fluoro-
scopic image in Navigant®; however, 2D image representation of a 3D structure has obvious 
limitations.
True-vessel navigation
True-vessel navigation uses an accurate 3D representation of the coronary artery. Navigant® 
software can create such a virtual map from two X-ray images provided that they are 30° apart. 
This program uses a feature called constellations to map identical points on both images, thus, 
generating a 3D navigational path or ‘centerline’ through the vessel lumen (Figure 3a). Alignment 
of the centerline with the live fluoroscopy image is required for navigation. A 3D representation 
of the coronary anatomy and centerline can also be created from two fluoroscopic images using 
the CardiOp®-B software (Paieon Inc., New York, NY; Figures 3 and 4). The advantage of using this 
program is that it can limit vascular foreshortening23 and improve the accuracy of quantitative 
coronary angiography measurements.24, 25 Using this software, navigational vectors can be 
Figure 2  The clockface navigational mode
By touching the perimeter the vector moves in that direction; controls for anterior and posterior movements are 
at the edges.
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directed through a virtual representation of the vessel lumen, so subtle changes in the vessel 
morphology can be accentuated (Figure 3c).26
A 3D road map can also be created from an MSCT dataset. The importance of MSCT in inter-
ventional cardiology stems from its ability to detect early-stage coronary artery disease,27, 28 
identify vascular anomalies and provide information on coronary plaques composition.29 Using 
Navigant®, the vessels can be isolated from the dataset and a 3D volume-rendered reconstructed 
MSCT image can be incorporated into the virtual roadmap for magnetic navigation (Figure 4b). 
The mapping of points along the vessel is used to create a virtual lumen and a centerline (Figure 
4d), which is coregistered and aligned to the fluoroscopic image for navigation. The ability of 
MSCT to ‘fill in’ the occluded vessel segments that are not seen angiographically means that it 
is a useful tool for navigating through CTOs (Figure 5a), with newer versions of Navigant® able 
to show both the endoluminal view and the multiplaner reconstructed cross-sections (Figure 
5b).
the Mns and intervention: what is currently possible?
Patent coronary arteries
Tortuous and severely angulated coronary arteries are associated with reduced procedural suc-
cess rates and a raised incidence of CABG surgery.30 A guidewire must be maneuvered without 
causing complications such as dissection or perforation. Several phantom studies in hepatic 
celiac arteries and the cerebral arteries have demonstrated higher procedural success using 
the MNS than with manual manipulation, and shown that the MNS is easier, more accurate 
and faster even when used by inexperienced operators.31, 32, 33 Studies in a coronary phantom, 
however, reported longer crossing times with the MNS than with a standard wire, although 
fluoroscopic times were significantly reduced.34 The longer crossing times could have been 
Figure 3.  True-vessel navigation using an accurate three-dimensional representation of the coronary artery 
(a) A constellation road map created from two-dimensional X-ray images; chosen points are depicted by 
squares along the navigational path. (B) Navigation using a three-dimensional reconstruction created 
with the CardiOp®-B software. (c) Navigation by means of the endoluminal view. Abbreviation: OM, 
obtuse marginal branch.
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related to the use of first generation Cronus® (Stereotaxis Inc., St Louis, MO) magnetic wires—
subsequent generations have been easier to track. Indeed, a recent 2D phantom study using 
five increasingly tortuous vessel models found that as vessel complexity increased the newer 
generation wires—Titan® and Pegasus® (Stereotaxis Inc., St Louis, MO) —were significantly 
better in reducing both the crossing and fluoroscopy times than were conventional wires.35 
Moreover, in some of the phantom models, prior experience of magnetic navigation was not 
a prerequisite for successful crossing. Overall wire usage was significantly reduced with the 
MNS.
A seminal paper by Atmakuri et al. showed the effectiveness of magnetic navigation during 
percutaneous coronary intervention (PCI) in native coronary arteries that would have been 
difficult to cross with conventional methods because of severe tortuousity.36 In this study of 
68 lesions in 59 patients, successful MNS crossings were achieved in 85% of cases. More impor-
tantly perhaps, magnetically guided intervention was successful in 9 (63%) of the 13 patients 
in whom PCI with a conventional wire had previously failed. The procedural success rates for 
magnetically guided intervention as the primary intervention and following failed conventional 
PCI (‘secondary’ intervention) were 84% and 62%, respectively, with longer median fluoroscopy 
and crossing times observed in secondary procedures. Similar success was reported in a study 
of 21 consecutive diseased coronary arteries, although guidewire navigation with the MNS was 
Figure 4 Three-dimensional representation of the coronary artery.
(A) A three-dimensional reconstruction of the artery using the CardiOp®-B software. (B) The same arteries 
extracted from a multislice CT data set (C and D), displayed as navigational centerlines with a directional 
vector on the live fluoroscopic images.
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found to be slower than manual navigation.37 The patients enrolled in this study did, however, 
have simple, straightforward lesions indicating that the MNS could be more suitable for use 
in complex coronary lesions and as a secondary procedure following failed conventional wire 
placement. This theory is exemplified further by the successful results seen when the MNS was 
used following an unsuccessful alcohol septal ablation that failed because of severe angulation 
(130°),38 and when used to cross a crushed stent of a bifurcation that was complicated by dis-
section.39 At present it is not clear how wide the applicability of magnetic-assisted navigation 
is likely to be in patent vessels. In order to evaluate this issue, our group has been assessing 
prolonged conventional crossing times to characterize the lesions and vessels that might be 
appropriate for magnetic navigation.
occluded coronary arteries
CTOs have been described as one of the last frontiers in interventional cardiology.40 Despite 
advances in technology and the development of specialized devices and dedicated wires, the 
rate of successful crossings is still unsatisfactory.41 An attractive strategy for treatment of CTOs 
was postulated by Serruys in 2006.1 The first stage of this strategy involves magnetic navigation 
to steer a guidewire through the occlusion. Second, optical coherence tomography, intravas-
cular ultrasonography or MSCT cross sections are employed to ‘look forward’ within the vessel 
to ensure that the wire is ideally positioned in the true lumen. Finally, ablative power at the 
tip of the wire is used to recanalize the CTO.42 The first successful study to demonstrate the 
feasibility of MSCT angiography and magnetic-enabled PCI used a system that ‘looked forward’ 
at the occlusion—the bull’s eye view—making the search pattern for microchannels through 
the occlusion more uniform by avoiding repetitions.43 Although mapping the occluded seg-
ments was easily accomplished, the bulky 2–3 mm magnetic tips used were a notable limita-
tion. Furthermore, the fact that navigation was performed using a fixed roadmap (centerline) 
Figure 5 Using the Navigant® system the multislice CT data set can be used to create: (A) a road map of a 
chronic total occlusion not seen angiographically and (B) cross-sections along the map.
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rather than a dynamic one gated to the electrocardiogram meant that there was discordance 
between the live fluoroscopy image and the centerline—another limitation. Ordinarily, when 
navigating through a patent vessel this discordance is not a problem as the wire is contained 
within the vessel’s lumen, so that when the heart moves with each beat the wire can still fol-
low the trajectory of the predetermined vectors. In CTOs, however, the lack of a patent lumen 
means that as the heart moves, the tip of the wire can be perpendicular to the vascular wall and 
when pushed can protrude. Hence, it is of paramount importance to develop technologies that 
allow dynamic road mapping (centerline) to be superimposed on the live fluoroscopy image, 
especially when considering magnetic-enabled radiofrequency ablation. Paieon Inc. is devel-
oping a dynamic road-mapping system based on their software that can recognize systolic 
and diastolic phases on fluoroscopic images. This system might have a role in patent vessels or 
those with subtotal occlusion, but not necessarily in CTOs because contrast media is needed to 
demarcate the vessel contours.
Much more appealing are methods aimed at electrocardiographic phase gating of the 
MSCT-derived centerline to the live fluoroscopic image following alignment to recognizable 
landmarks such as spinous processes and the catheter tip. This technique ensures that at a 
designated point in the cardiac cycle both the centerline and the live fluoroscopic image of 
the vessel are superimposed, enabling safe advancement of the ablating wire. Development of 
the magnetic-enabled wire with radiofrequency ablation functionality is nearing completion 
(Figure 6). This device is composed of a 0.014 inch wire with a small radiofrequency electrode 
Figure 6 A diagrammatic representation of the magnetically enabled radiofrequency ablating wire for chronic 
total occlusions.
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at its tip and three small magnets embedded proximally. An external generator supplies the 
radiofrequency energy needed for ablation. A safety and feasibility pilot study of this wire in 
‘within-stent’ CTOs is planned for early 2008 at the Thoraxcenter, Rotterdam, The Netherlands.
stem-cell injection
Intramyocardial injection of bone-marrow-derived stem cells is a novel technology that has the 
potential to induce myocardial regeneration and improvement in left ventricular function.44 
Currently, electromechanically guided injection is the preferred mode of delivery in patients 
with chronic myocardial ischemia.45 Indeed, clinical studies have shown that transendocardial 
injections of stem cells using the NOGA® mapping system are feasible and safe46 In this system, 
once the mapping electrode makes a good contact with the myocardium and the operator 
recognizes the appropriate electrical signal strengths, stem cells are injected through a needle 
linked to the device. One major drawback with this system is the difficulty of reaching remote 
areas of the left ventricle with manual manipulation of the catheter. This drawback can be 
addressed by using the magnetically enabled MNS-guided NOGA® electromechanical mapping 
catheter (Stereotaxis Inc.; Figure 7). 
The guiding can be performed remotely to reduce operator radiation exposure. Moreover, the 
magnetic momentum at the catheter tip precludes the need for shaft support, allowing the 
Figure 7 A diagrammatic representation of magnetically enabled cell injection catheter following an 
automatic map in the myocardium.
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use of a softer catheter that is less likely to penetrate the myocardium and cause a perfora-
tion. By using MSCT or MRI to identify the infarcted area, relevant data can be integrated into 
Navigant® to further augment the accuracy of target localization. A recent animal study showed 
the preclinical feasibility of Stereotaxis-compatible NOGASTAR mapping and MYOSTAR® injec-
tion catheters (Cordis Corporation, Miami Lakes, FL) both equipped with a small permanent 
magnet at the tip.47 Remote NOGA® mapping was possible with a computer-controlled catheter 
advancement system (Cardiodrive unit; Stereotaxis Inc., St Louis, MO). The introduction of the 
NOGA® map into Navigant® provided 3D vectors for the navigation of a magnetically enabled 
MYOSTAR® catheter. The combination of these technologies resulted in a 95.8% success rate 
of magnetic-guided injection of mesenchymal precursor cells into the myocardium. When 
labeled, cells were detected in all but one segment on histology.
What does the future hold?
Magnetic navigation is still in the developmental phase and as such will not revolutionize the 
way we currently perform PCI. By considering magnetic navigation as an adjunct technique to 
current practices, however, this technique could be used to beneficial effect in clinical situa-
tions that are technically difficult or associated with low procedural success. The development 
of both software and hardware is, therefore, in the context of adjunct therapy. More powerful 
magnetic fields (i.e. 0.1–0.12 Tesla, increased from the current 0.08) and software upgrades 
to further improve the precision of wire control are in development. In terms of CTOs, future 
developments include dynamic road mapping and appropriate gating of the MSCT images with 
real-time fluoroscopic images. In addition, alignment between angiographically determined 
3D reconstructed nonoccluded segments and the occluded sections obtained through MSCT 
will be more accurate. Moreover, as MSCT cross-section analysis provides important informa-
tion on plaque composition and can accurately identify the vessel’s border—a ‘true’ centerline 
can be reconstructed by ‘stacking’ the gated cross sections if the center of each cross section 
(Figure 5b) is determined precisely. Incorporation of this idea in future versions of the Navigant® 
software is being contemplated, so that a gated wire can be advanced in a frame-like fashion 
to ensure central wire transit. The unwarranted complexity of several MNS workstations, which 
can slow processing speed, will be reduced in the future by a new single-screen user interface 
(Odyssey™ Network Solutions, Stereotaxis, St Louis, MO) that links diagnostic information from 
several sources. To further improve the speed of navigation without compromising safety 
there will, however, need to be improvements in alignment of the centerline to the real-time 
fluoroscopy image, possibly through dynamic electrocardiographic gating. This improvement 
would allow the operator to drag the vector with confidence, instead of using 1–5 mm jumps 
along the centerline. With this development, the MNS could then compete with conventional 
wires in all lesions, not just complex cases.
INTRODUCTION AND OVERVIEW OF THIS THESIS 27
New advances in material science have permitted the development of several guidewires with 
variable degrees of support and flexibility, tailored to individual coronary lesions. The newest 
generation in wire design—the Pegasus®—is made from a nitinol–stainless steel composite 
for improved flexibility with minimal deformity. Future wire-related developments will include 
magnets that can change the stiffness of the wire to improve the delivery of a device, multi-
magnet configurations to enable smoother transition across the tip, and wires with the ability 
to feedback their position in space. The ability to accurately identify a wire’s position can be 
useful when combined with a robotic wire advancement system. To date, such systems have 
been successfully employed in electrophysiological procedures48, 49 but have not yet been 
extended to MNS-guided PCI. A stand-alone remote navigation system (CorPath®, Corindus Ltd, 
Haifa, Israel) for wire advancement and stent deployment using a joystick to control the wire’s 
axial (i.e. advance, retract) and rotational movements has been shown to be feasible,50 which 
opens the possibility of linking such a device to the MNS to achieve full automation.
Limitations
Even though the concept of directional wire guidance has been effectively realized, the areas in 
which the system offers a clear advantage over current approaches still need to be identified, 
which explains the slow market penetration in interventional cardiology. In addition, apart 
from a few institutional registries, there are limited data on this new technology. The lack of 
randomized, controlled trials makes comparisons with existing technologies purely specula-
tive. Furthermore, new operators experience a learning phase before achieving an adequate 
level of competence, irrespective of whether they are a physician or technical staff. Similarly, 
as the software develops, there is a need for continuing educational updates or seminars to 
ensure that operators are kept abreast of new developments.
At present, the main limitation with the software remains the alignment of the virtual image 
to the real-time image. There is also a need for dynamic road mapping of the vessel; at present 
operators navigate through a static image. The 3D-reconstruction packages used still have 
limitations with respect to accuracies in tracing the vascular contours from which the central 
path for navigation is ultimately derived. The physical limitations of magnets attached to the 
wire tip could hinder advancement in extremely tortuous vessels, highlighting the importance 
of the multimagnet design that offers a smoother transition. Ultimately, the success of 3D 
magnetic-enabled procedures still depends heavily on the time it takes to prepare the road 
map. The time taken can vary enormously depending on the vessel characteristics and must, 
therefore, be taken into account during procedural planning. The 2D navigation approach is 
quicker; however, the level of accuracy is compromised.
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conclusions
Magnetic navigation in coronary intervention is rapidly evolving. State-of-the-art magnetic 
devices are now competing with conventional nonmagnetically enabled wires and devices. 
These technological advances are creating new roles for stereotactic magnetic navigation, 
which in the future will include a wider range of invasive cardiac procedures.
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evaLuating the accuracy and 
PerForMance in PhantoM ModeLs
a randomised controlled study comparing 
conventional and Magnetic guidewires in a 
2-dimensional Branching tortuous Phantom 
simulating angulated coronary vessels
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abstract
objectives:
To directly compare the magnetic navigation system (MNS) guidewires with conventional 
guidewires in branching tortuous phantoms with operators of varying MNS and percutaneous 
coronary intervention experience.
Background:
Vessel tortuosity, angulation, and side branches remain limiting factors in coronary interven-
tions. The MNS addresses these limitations by precisely directing the tip of a magnetised 
guidewire in vivo aided by two permanent adjustable external magnets.
Methods:
Crossing and fluoroscopy times of six operators were evaluated in five tortuous Perspex® phan-
tom vessels in three consecutive attempts. Standard guidewire (SG) usage was unrestricted. 
Two 2nd generation magnetic guidewires (MG) were used. Failure was noted if the cross was 
unsuccessful within 5 min.
results:
The magnetic navigation was vastly superior to SG techniques with increasingly tortuous 
phantoms. It dramatically decreased both the crossing and fluoroscopy times with maximal 
reduction from 201.7 ± 111 to 36.4 ± 13 sec, P < 0.001 and 204.7 ± 24 to 47.2 ± 19 sec, P < 
0.001, respectively. The MNS had a 98.8% procedural success rate compared to 68% with SG 
techniques. Moreover it considerably limited the amount of wire usage from 5.5 to 1.3. Opera-
tors with prior MG experience performed significantly better than those without, except in the 
simplest phantom where the difference was nonsignificant (33.8 ± 13 sec vs. 41.7 ± 17 sec, P = 
0.2).
conclusion:
MNS significantly reduces both the crossing and fluoroscopy times in tortuous coronary phan-
tom models achieving excellent success rates with dramatic reductions in guidewire usage. 
Operators with prior MNS experience had an advantage over the inexperienced
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introduction
The tortuosity and side branches in a coronary tree can determine the procedural outcome of 
a percutaneous coronary intervention (PCI) [[1]]. An appropriate guidewire that manoeuvres 
easily through a tortuous segment or side branch can avoid complications such as a dissection 
or a perforation. The success in crossing a lesion depends both on the appropriate shape at the 
tip of the guidewire and the manual dexterity of the operator. As such the tip of a guidewire 
may require reshaping several times during an interventional procedure in a process of trial and 
error. Additionally, the frictional contact of a preshaped wire on the vascular wall can limit the 
amount of torque transmitted by the operator leading to wire prolapse. As complexity increases 
these standard coronary guidewire limitations can often lead to longer procedural and fluoros-
copy times together with the use of higher contrast loads [[2]]. The magnetic navigation system 
(MNS) with its steerable wire can potentially address some of the above limitations [[3]]. In a 
random set of patients who underwent PCI, both the procedural and fluoroscopy times were 
significantly reduced [[4]] and confirmed results obtained in a nontortuous coronary vessel 
phantom [[5]]. To address tortuosity, more complex and tortuous anatomy phantom models 
of the hepatic, coeliac arteries [[6]], and the cerebral arteries [[7]] have been previously used 
to compare MNS with standard techniques but thus far no comparison has been made with 
tortuous coronary phantoms by practicing interventional cardiologist.
In this randomised study we assessed the efficacy of the MNS guidewires with conventional 
guidewires in phantom vessels with varying degrees of angulation and reduction in vessel’s 
caliber so as to mimic a coronary trunk and its’ side branch. Our aims were to determine: (a) 
the crossing time to reach to a fixed point on the phantom using magnetic navigation in com-
parison to manual manipulation of the wire in the hands of interventional cardiologists with 
varying MNS experience, (b) to determine if there is a reduction in fluoroscopy time, (c) and to 
assess the procedural success and wire usage between the two different approaches for each 
of the phantom vessels evaluated.
Material and Methods
The Stereotaxis Niobe® II MNS (Stereotaxis, St. Louis, MO) has two permanent adjustable mag-
nets that can be rotated, translated, or tilted to produce a uniform magnetic field of 0.08 T. 
This field precisely directs a tiny magnet mounted on the tip of a guidewire by changing its’ 
magnetic moment and allows fine control of the orientation of the tip of the guidewire in space. 
The system is integrated with a modified C-arm flat-panel detector fluoroscopic imaging suite 
(AXIOM Artis dFC, Siemens Medical Solutions, Forchheim, Germany) for angiographic imaging. 
A three-dimensional (3D) virtual vessel roadmap can be created from two angiographic images 
provided that they are 30° apart by using reconstruction software (CardiOp-B, Paieon Medical, 
Rosh Ha’ayin, Israel). As our phantom models were two-dimensional (2D) we chose the alterna-
tive 2D mode displayed as a “clock face” on a touch screen monitor (Fig. 1). In this 2D navigation 
mode touching the screen at a particular point results in the Navigant software calculating a 
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vector that directs a magnetic field to align the wire tip in the desired direction. The advantage 
of this technology is that it allows a full 360° omni directional rotation of the tip of the wire at 
anytime during the procedure, in vivo, without the need for a preshaping wire’s tip.
the guidewires
The TitanTM Soft Support coronary guidewire (Stereotaxis, St. Louis, MO) is a 180 cm moderate 
support, hydrophilic coated wire with a diameter of 0.014 in./0.36 mm having a flexible 2-cm 
distal coiled tip that has a 2 or 3 mm gold cup neodynium magnet attached. The PegasusTM 
guidewire is similar to the Titan Soft Support coronary guidewire apart from its more hydro-
philic nitinol coating. The conventional wires used in the study were PT GraphixTM Intermediate, 
ChoiceTM PT Floppy (Boston Scientific, Miami, FL), Miracle brosTM3G (Abbott Vascular Devices, 
Redwood, CA) and high torque BMW (Guidant, Santa Clara CA).
the Phantom
The phantom is a Perspex® model with 3 and 2 mm channels simulating five different tortuous 
vessels with varying degrees of difficulty graded 1-5 due to increasing angulations and side 
branches (Fig. 2). In the least tortuous phantom A both the magnetic (MG) and standard (SG) 
guidewires were required to traverse a 120° turn followed by a right angle bend in a simulated 
vessel of 3 mm calibre. This was in contrast to the most challenging and tortuous simulated 
vessel (phantom E) where upon a 3 mm vessel gave rise to a 2 mm side branch at a right angle 
and then made a sharp 120° turning. To simulate tissue lubricity the phantoms were wetted 
with a mixture of soap and diluted contrast. 
Figure 1 The “clockface” navigation system
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the Procedure
The phantom model was fitted with a 6 French diagnostic catheter, filled with 20% contrast 
solution and placed in the magnetic field of the MNS. Six interventional cardiologists from our 
institution were divided into three groups depending on their level of experience with magnetic 
navigation and SG techniques. In the group 1, operators 1 and 2 had the most MNS experienced 
with each having performed more than 35 magnetic aided cases. Group 2 (operators 3 and 4) 
had moderate MNS experience with less than 35 cases and group 3 had MNS inexperienced 
operators (operators 5 and 6) and they were also the most junior of all the conventional inter-
ventionalists. The operators were randomly assigned to start with either a SG of their choice 
or one of the two 2nd-generation magnetically enabled wires. Operators had to manipulate 
their guidewire past a fixed point along the simulated phantom vessel (A-E). The crossing and 
fluoroscopy times were measured when the wire positioned at the tip of the catheter passed 
a predetermined fixed point on the phantom (Fig. 2). Recordings for both the MG and SG were 
triplicated for each simulated phantom vessel and an average crossing and fluoroscopy time 
was determined for each group of operators.
Figure 2 The phantom A-E with diagramatic representation of the level of difficulty. The angles and “vessel” 
caliber are as follows: (A) 3 mm, 120° turn into a 3 mm, 90° turn; (B) 3 mm, 120° turn into a 3 mm, 90° turn; (C) 
3 mm, 60° turn into a 3 mm, 120 turn and then into a 60° turn to a 2 mm vessel; (D) 3 mm, 90° into a 2 mm 
followed by a 90° turn; (E) 3 mm, 90° into a 2 mm followed by a 120° turn. The “arrow” indicates the starting 
point and the asterisk (*) show the end of each phantom run.
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To compensate for any deterioration in the guidewire’s tip or wire performance during the 
procedure the operators were allowed to exchange a damaged wire for a new or different 
guidewire as many times as deemed necessary so as to achieve a successful cross within 5 min. 
If the vessel was not crossed during this 5-min period then the attempt was classed as unsuc-
cessful due to a time failure. Each time failure was recorded as 300 sec for both the crossing and 
fluoroscopy times. However, it must be stressed, that this value was in fact an underestimation 
of the time it would have taken if the operator had eventually crossed the simulated vessel.
statistics
As the crossing times and fluoroscopic exposure times were continuous variables they are 
presented as means and standard deviation. T-test and one-way ANOVA (Bonferoni) were used 
to determine if there were significant differences in the procedural time and fluoroscopic times. 
Analyses were performed using SPSS 11.5 for Windows (SPSS, Chicago, IL). P value <0.05 was 
considered statistically significant.
Figure 3 (A) The average crossing times/sec obtained using SG and MG for all operators with phantoms A-E. 
(SG, standard guidewire; MG, magnetic guidewire). (B) The average fluoroscopy times/sec obtained using SG 
and MG for all operators with phantoms A-E. (SG, standard guidewire; MG, magnetic guidewire).
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results
Crossing and Fluoroscopy Times in Phantoms A-E
Overall, the MG was vastly superior to the SG in both the crossing and fluoroscopy times (Fig. 3). 
The SG was faster than the MG in phantom A (41.8 ± 26 sec vs. 47.9 ± 20 sec, P = 0.3) however 
the difference was not significant (Fig. 3A). In phantom B, the average MG crossing time was 
shorter than the SG (49.3 ± 23 sec vs. 76.5 ± 65 sec, P = 0.1) but was significantly less in the more 
tortuous phantoms C and D with dramatic reductions in crossing times from 201.7 ± 111 to 36.4 
± 13 sec, P < 0.001 and 204.7 ± 24 to 47.2 ± 19 sec, P < 0.001, respectively. Similar results were 
observed with the most angulated phantom E where it was greatly superior in manipulating 
through a 2 mm side branch (89.1 ± 65 sec vs. 247.3 ± 82 sec, P < 0.001). 
In the majority of cases the trend of fluoroscopy times (Fig. 3B) closely mimicked that 
observed in the crossing times. As such, phantom A had longer fluoroscopy times with the MG 
(47.7 ± 23 sec vs. 72.0 ± 58 sec, P = 0.1) and phantom B had longer fluoroscopy times with the 
SG (47.7 ± 23 sec vs. 72 ± 58 sec, P = 0.1). With increasing complexity (phantoms C-E) there were 
both significant and dramatic reductions in fluoroscopy times similar to that reported with the 
crossing times.
Sub-Group Analysis of Crossing Times in Phantoms A-E
On the subgroup analysis of the operator performances (Fig. 4), in the simplest phantom A the 
most MNS experienced operators (group 1) were significantly faster (28.5 ± 9 sec vs. 60.7 ± 18 
sec, P < 0.007) than those inexperienced (group 3). This was not surprising as the inexperienced 
group needed to get acquainted with the equipment. The overall decrease performance of the 
MG to the SG (41.8 ± 26 sec vs. 47.9 ± 20 sec, P = 0.3) was thus due to the longer times attained 
by groups 2 and 3 since group 1 was faster with the MG (28.5 sec vs. 32.8 sec). In phantom B, 
group 1 performances with the MG were also significantly faster than group 3 (26.2 ± 4 sec 
vs. 53.7 ± 13 sec, P = 0.025) but there was no significant difference observed between groups 
2 and 3 (68.0 ± 24 sec vs. 53.7 ± 13 sec, P = 0.4). Of note in this phantom, both groups 1 and 3 
times with the SG were more than twice that of MG (64.7 and 112.8 sec vs. 26.2 and 53.7 sec, 
respectively) with the intermediate experienced group 2 having no significant difference with 
either wire (MG, 68.0 sec and SG, 52.0 sec). 
As the tortuosity and branching increased (phantoms C-E) there was a dramatic difference 
between the MG and SG performances amongst all the groups (Fig. 4). In phantoms C there 
was no significant difference between all the MG users regardless of previous MNS experience 
and in phantom D only group 1 remained significantly faster than group 3 (39.5 ± 12 sec vs. 62.7 
± 21 sec, P = 0.008). With the conventional wire technique a similar trend was observed with no 
significant differences between the senior (groups 1 and 2) and the junior (group 3) operators 
in both phantoms C (190.8 ± 113 sec vs. 223.7 ± 112 sec, P = 0.6) and phantom D (205.9 ± 106 
Ch
ap
te
r 2
40
sec vs. 202.3 ± 109 sec, P = 0.9). This trend continued in phantom E were groups 1 and 3 had 
non-significant time differences (244.2 ± 99 sec vs. 271.5 ± 70 sec, P = 0.9) with the SG and 
group 1 still being significantly faster with the MG than group 3 (48.8 ± 12 sec vs. 141.5 ± 85 sec, 
P = 0.03). Overall, the operators with previous MNS experienced (groups 1 and 2) performed 
better (62.8 ± 31 sec vs. 141.5 ± 85 sec, P = 0.01) in this phantom.
Procedural Success and Wire Usage in Phantom A-E
There were 100% successful crossings in phantoms A and B with both the MG and SG (Fig. 
5A).  In phantom C and D, the procedural success with the SG was (10/18) 56% and (9/18) 50%, 
respectively as compared to a 100% success with the MG. The success of the SG in the most 
tortuous phantom E was only (8/18) 33% and the MG (17/18) 94%. The one failure with the MG 
was observed in an operator with no prior MNS experience.
Up to eight SG were used by operator 1 with a 60% overall success rate (9/15 successful cross-
ings), to manipulate through all the phantoms (Fig. 5B). In contrast, a maximum of two MG 
(operator 5) were used for the same task with a 93% success rate (14/15 successful crossings). 
The overall ratio of SG to MG usage was found to be 5.5 SG to 1.3 MG
Figure 4 The average crossing times/sec obtained using SG and MG for groups 1-3, operators with phantoms 
A-E. (SG. standard guidewire; MG, magnetic guidewire).
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Limitations
Our study was limited by the fact that 2D phantoms were not representative of the 3D charac-
teristics of ordinary coronary arteries. In addition, these 2D models were limited to “clockface“ 
navigation rather than the more precise 3D reconstruction software. The phantoms also 
employed static road mapping for wire progression rather than the transient dynamic road 
mapping used in patients.
conclusions
MNS is an emerging tool in interventional cardiology and has been successfully employed 
to cross lesions that failed with conventional techniques. In our phantom study we have 
unequivocally shown that a MG is vastly superior to a SG with dramatic reductions in cross-
ing and fluoroscopy times in phantom models that mimic coronary arteries with increasing 
tortuosity and side branches. As the complexity of the phantoms increased operators with prior 
MNS experience performed better than those with no previous MNS exposure. There was an 
outstanding procedural success with the MNS (98.8% vs. 68%) together with a clear reduction 
guidewire usage (5.5 vs. 1.3).
Figure 5 (A) The overall procedural success using SG and MG for phantoms A-E. (SG, standard guidewire; MG, 
magnetic guidewire). (B) The SG and MG usage in operators 1-6 for phantoms A-E. (SG, standard guidewire; 
MG, magnetic guidewire).
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abstract
objectives:
The in vivo comparison of the accuracy of two 3-dimensional quantitative coronary angiogra-
phy (QCA) systems
Methods:
Precision-drilled plexiglass phantoms with five different luminal diameters (0.5-1.9 mm) 
were percutaneously inserted into the coronary arteries of four Yorkshire pigs. Twenty-one 
angiographic images of these stenotic phantoms were acquired for in vivo validation testing. 
Quantitative assessments of the minimum, maximum, and mean luminal diameters together 
with the minimum luminal area were determined using two 3D QCA systems, the CardiOp-B® 
and CAAS 5
results:
The CardiOp-B system significantly underestimated the minimum luminal diameter MLD whilst 
both systems significantly overestimated the maximum luminal diameter at the minimal luminal 
area (MLA) over the phantom’s true value. The CAAS 5 system had a greater degree of accuracy/
mm (mean difference = 0.01 vs. 0.03) and precision/mm (SD = 0.09 vs. 0.23) than the CardiOp-B 
in assessing the minimal LD. An increased precision/mm (SD = 0.01 vs. 0.29) and accuracy/mm 
(mean difference = 0.03 vs. 0.11) in the mean LD was observed with the CAAS 5. In comparing 
the MLA/mm2 the CAAS 5 was more precise/mm2 (SD = 0.14 vs. 0.55) and accurate/mm2 (mean 
difference = 0.12 vs. 0.02) to the true phantom MLA compared to the CardiOp-B system.
conclusion:
In a 21 phantom study, the CAAS 5 3D QCA system had a greater degree of accuracy and preci-
sion in both the luminal and area measurements than the CardiOp-B 3D QCA system.
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introduction
In the percutaneous treatment of coronary artery disease the on-line two-dimensional quanti-
tative angiography (QCA) is often the chosen method to determine both the vessel length and 
size to guide stent implantation [[1]]. There are, however, several limitations with this technique 
as depending on the angiographic views the vessels can appear foreshortened or overlapped 
resulting in inaccurate measurements [[2]]. Moreover, in tortuous vessels this can lead to an 
underestimation of the appropriate length of stent required to cover the lesion [[3]]. Recently, 
a novel method, the three-dimensional (3D) reconstruction of standard coronary angiography 
using an algorithm integrating single-plane images has been validated [[4]]. This technology 
is aimed at providing a solution to many of the limitations inherent with 2D-QCA. In addition, 
the enhanced accuracy in determining the lesion length and luminal diameter the 3D recon-
structed image can be incorporated in a designated navigation software (Navigant® Stereotaxis, 
St Louis, MO) to enable magnetically aided guidewires to precisely transit through the vessel 
lumen [[5]]. The accuracy of the luminal diameter can be crucial for a successful wire transit 
to avoid vascular wall trauma or plaque disruption [[6]]. The potential benefits of this 3D-QCA 
technology has led two companies Paieon Medical, Rosh Ha’ayin, Israel and Pie Medical Imag-
ing, Maastricht, the Netherlands to develop the CardiOp-B and CAAS 5 systems, respectively. 
Both systems are similar in using two angiographic images to reconstruct a 3D image but in 
the current version of the CardiOp-B the calibration standard is performed manually whilst in 
the CAAS 5 system it is automated. The aim of this study was to compare the accuracy of the 
detection of a luminal stenosis using two 3D QCA systems in vivo using radiolucent cylindrical 
plexiglass or polyamide stenotic phantoms with precision-drilled eccentric lumens implanted 
in porcine coronary arteries [[7]].
Material and Methods
The ethics committee on animal experimentation at the Erasmus Medical Center, Rotterdam, 
NL approved the study that was conducted in accordance to the guidelines of the American 
Heart Association on animal use in research.
Preparation and Insertion of the Stenotic Phantoms
The stenotic phantoms (Fig. 1) were precisely engineered by the Department of Bioengineering 
at the Erasmus Medical Center. Radiolucent plexiglass (acrylate) and polyacrylamide cylinders 
of diameters 3.0 or 3.5 mm and length of 8.28, 7.96, 7.85, 8.01, and 7.38 mm were precision-
drilled to have circular lumens of 499 (aimed to be 0.5 mm), 707 (0.7 mm), 982 (1.0 mm), 1,367 
(1.4 mm), and 1,921 (1.9 mm) µm in diameter, respectively. This accuracy calibrated optically at 
40-fold magnification achieved a maximum tolerance of 0.003 mm. A second 1.3 mm diameter 
lumen was drilled parallel to the stenosis lumen to attach to the tip of 4-Fr Fogarty catheters 
(Vermed, Neuilly en Thelle, France) to facilitate the intracoronary insertion and positioning of the 
phantoms. Four Yorkshire pigs (average weight, 40-45 kg) were pretreated with intramuscular 
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ketamine (20 mg/kg) and intravenous etomidate (5 mg/kg). The animals were then intubated 
and ventilated with a mixture of oxygen and isoflurane. Anesthesia was maintained with a 
continuous intravenous infusion of pentobarbital (5-20 mg/kg/hr). A 12-Fr introducer sheath 
was inserted into both carotid arteries to allow the sequential insertion of the guiding catheter 
and the phantoms. Jugular access was used for the administration of medication and fluids. An 
intravenous bolus (10,000 IU/l) followed by a continuous infusion of heparin was given. Follow-
ing the experiments, the animals were humanely euthanized. 
In Vivo Image Acquisition of Stenosis Phantoms by Fluoroscopy
Biplane cine angiographic system (Axiom ArtisTM, Siemens, Forchheim, Germany) was used to 
create digital angiograms of matrix size of 1024 × 1024 pixels. Identical radiographic imaging 
settings were employed (kVp, mA, ms) in the two projections used to image each phantom to 
maintain consistency. Following intubation of the left or right coronary artery with a 6-Fr guid-
ing catheter (Mach 1TM, Bos0ton Scientific, Natick, MA) intracoronary isosorbide-dinitrate (1 mg) 
was administered and an angiogram was made to aid orientation of the phantom in the vessel. 
The phantoms were wedged in the coronary arteries and positioned in the X-ray isocenter using 
the tip of a metal wire marker placed on the Fogarty catheter. Coronary angiography was per-
formed by manual injection of contrast medium (VisipaqueTM 320 mg I/ml, Amersham Health 
B.V., Eindhoven, The Netherlands). The ventilator was disconnected transiently during contrast 
injection to minimize the effect of diaphragmatic movement on angiographic images.
Figure 1. The magnified tip of one of the Fogarty catheters view along its long (A) and short axis (B) with 
a transparent radiolucent cylinder (phantom) having a channel of 1.9 mm diameter (white arrow) and the 
catheter lumen used for insertion of removable metallic stylet (black arrow) to aid positioning.
EVALUATING THE ACCURACY AND PERFORMANCE IN PHANTOM MODELS 49
Three Dimensional QCA Analyses of In Vivo Phantom Images
In total, 21 readings were made in 21 different arteries; four arteries had phantoms of diameters 
1.9 mm, six arteries had phantoms of 1.4 mm, six arteries had 1 mm diameter phantoms, four 
arteries had 0.7 mm phantoms, and one artery had a 0.5 mm phantom. The in vivo analysis of 
each phantom was performed in end-diastole on the same number of the frame count and 
was ECG gated so that all of the analyses using both QCA systems were performed on identical 
images. Calibration of the CardiOp-B system was done manually using the conventional catheter 
calibration of the nontapering part of the tip of each 6-Fr guiding catheter filled with contrast. 
The CAAS 5 system performs an automatic calibration based on the DICOM information in the 
image. Once calibrated, the two orthogonal views (at least 30° apart) that were simultaneously 
acquired in the biplane system were then used to reconstruct the 3D vessel image (Fig. 2). This 
was achieved by marking three points in the CardiOp-B system: proximally, distally, and at the 
Figure 2. The 3D reconstruction of a phantom derived from two orthogonal views (frontal and lateral) using 
the CASS 5 system. The 3D color varies according to the severity of stenosis ranging from white (healthy vessel) 
to dark red (99% cross-sectional area stenosis). The yellow squares denote proximal reference point (P*), most 
stenotic point (S), and distal reference point (D) of the target lesion, respectively. The region of interest (ROI) 
for calculation of mean luminal diameter can be manually defined by moving the proximal (P*) and distal (D) 
points (Definition of ROI for mean LD; Graph view). 
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stenosis on the two angiographic images. In the CAAS 5, this was done by defining a common 
image point (a landmark common to both images), two points (distal and proximal) to the 
stenotic region [[8]]. The software then created automatic contour detection and if this was 
inaccurate then finer adjustments were made to the edge detection manually in the CardiOp-B 
system and the restriction option, an algorithm that excludes gross image artifacts such as the 
diagnostic catheter was applied in the CAAS 5 system. The restriction option is therefore not 
a manual edge correction but instead it offers users the possibility of excluding parts of the 
image of the detection by restricting the area of interest.
Following contour detection and corrections/restrictions if required, the 3D reconstruction 
of the artery was automatically created. The software determined the minimum luminal area 
(MLA) and the pixel size at each position in the 3D space. Based on the position of the MLA 
and the known pixel size, the minimum luminal diameter (MLD) for each of the angiographic 
images was automatically calculated. Assuming a noncircular shape at the MLA then there 
will be two MLD values (maximum and minimum LD) obtained, the smallest representing the 
absolute MLD. The mean luminal diameter was based on the values in between the borders of 
a predetermined segment in the phantom (Fig. 2). Along the centerline in between this seg-
ment, the diameter at each scanline was taken and divided by the total number of scanlines to 
automatically afford the mean LD. The following data was therefore compared, the minimum 
LD (MLD) and the maximum LD at the MLA, together with the minimum luminal area MLA and 
the mean LD over the region of interest (ROI) in each 3D QCA system to that of the phantom 
models. We purposely chose to perform only one measurement per phantom given the primary 
interest in the relative accuracy and precision of both techniques, instead of an assessment of 
the intra- and inter-observer variability of the QCA techniques. Expert users from both the Pie 
Medical and Paieon companies were used to perform the measurements.
statistical analysis  
Continuous variables are presented as mean ± standard deviation and compared using the 
Wilcoxon signed-rank test. Categorical variables are expressed as counts and percentages. The 
mean of the differences between measurements and phantom dimensions of both systems 
was computed and considered to be an index of the accuracy of the measurements, while 
the standard deviation of the differences was defined as an index of precision. Bland-Altman 
plots [[9]] were used to assess the agreement between both 3D QCA systems and the phantom 
models. Pearson’s correlation was used to determine the degree of correlation between the 
measurements. Statistical analyses were performed with SPSS 12.0.1 for Windows (SPSS, Chi-
cago, IL). A P value < 0.05 was considered statistically significant.
EVALUATING THE ACCURACY AND PERFORMANCE IN PHANTOM MODELS 51
results
Comparison of Minimum LD with Phantom “True” Values
In this study the CardiOp-B system had only one manual adjustment to correct the detected 
contour whilst six adjustments were used in the CAAS 5 system to restrict the contours to the 
region of interest. Overall, the comparison of both 3 D QCA systems with the true LD noted 
in the 21 phantom models revealed a closer association with the CAAS 5 system than in the 
CardiOp-B (Table I). The CardiOp-B system significantly underestimated the minimum LD (MLD) 
whilst both systems significantly overestimated the maximum LD at the MLA over the true 
value. In assessing the MLD, the CAAS 5 system had a greater degree of accuracy/mm (mean 
difference = 0.01 vs. 0.03) and precision/mm (SD = 0.09 vs. 0.23) compared with that observed 
with the CardiOp-B system. The Bland-Altman plots of the MLD (Fig. 3a and b) showed that both 
systems had one outlier reading beyond 2 SD. This value was, however, smaller in the CAAS 5 
system resulting in a better overall correlation to that of the phantom’s actual diameter (r = 0.99 
vs. 0.87) and influencing the degree of precision. Notably, in the CardiOp-B system 11/21 (52%) 
of the measurements laid outside ± 10% of the true phantom LD compared with 3/21 (14%) of 
the measurements derived using the CAAS 5 system. Table I and Fig. 3a and b compares min LD 
(MLD) in both systems. 
Comparison of Mean LD with Phantom ˝True” Values
There was no significant difference observed when the mean LD in either system was com-
pared with the luminal diameter of the phantoms (Table I). The Bland-Altman plots revealed 
two observations outside ± 2 SD range in the CardiOp-B analysis compared with only one 
Table 1 Comparison of the two 3-D QCA systems  (CardiOp-B® and CAAS 5) accuracy, precision and the 
correlation to the true luminal diameter of the 21 stenotic Phantoms. Accuracy = mean differences between 
recorded measurements and the phantom; Precision = standard deviation and p value is derived from the 
recorded measurements and the phantom
accuracy Precision correlation slope intercept P value
cardiop-B® vs. Phantoms
min LD (MLD) 0.03 0.23 0.87 0.87 0.15 0.03
max LD 0.24 0.40 0.78 0.86 0.23 0.001
mean LD 0.11 0.29 0.84 1.02 0.08 0.31
MLA 0.12 0.55 0.87 1.09 0.01 0.74
caas 5 vs. 
Phantoms
min LD (MLD) 0.01 0.09 0.99 0.92 0.06 0.26
max LD 0.06 0.11 0.97 1.12 0.10 0.015
mean LD 0.03 0.10 0.98 0.87 0.19 0.39
MLA 0.02 0.14 0.99 0.91 0.13 0.95
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observation noted in the CAAS 5 system (Fig. 4a and b). As observed with the minimum LD 
values there was an increased precision/mm (SD = 0.10 vs. 0.29) and accuracy/mm (mean differ-
ence = 0.03 vs. 0.11) with the CAAS 5 mean LD values with the latter having a closer correlation 
with the true value (r = 0.98 vs. 0.84). Figure 4a and b compares mean LD in both systems. 
Comparison of Minimal Luminal Area with Phantom “True“ Values
The Bland-Altman plots of the MLA further demonstrated higher precision/mm2 (SD = 0.14 
vs. 0.55) and accuracy/mm2 (mean difference = 0.02 vs. 0.12) with the CAAS 5 (Fig. 5a and b). 
Moreover, in the CardiOp-B system 14/21 (67%) of the measurements laid outside ± 10% of the 
true phantom MLA compared with 7/21 (33%) of the measurements derived using the CAAS 5 
system. Consequently, the Pearson coefficient demonstrated a closer correlation with the CAAS 
5 than the CardiOp-B system (r = 0.99 vs. 0.87). Figure 5a and b compares mean LD in both 
systems.
discussion 
3D QCA has been shown in phantom models [[10]] as well as in stented vessel segments [[11]], 
and complex lesions like bifurcations [[12]] to have a closer correlation to the true vessel’s 
dimensions than 2D QCA. Moreover in conventional angiography, overlapping vessel can 
impair the optimal visualization of a lesion and if the lesion is eccentric then it may be missed 
altogether [[13]]. In the formulation of a 3D QCA, the system uses a 3D computer-based model-
ling algorithm to integrate the 2D projections, identify key vessel features like bifurcations and 
the centreline, calculate and display the vessel’s cross-sectional contours that are subsequently 
“filled in” to create the virtual vessel. Both the CardiOp-B system and CAAS 5 systems adopts 
Figure 3. Bland-Altman plots of the minimal LD (a) CardiOp-B® with the phantoms (b) CAAS 5 with the 
phantoms.
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this system when generating the reconstructed vessel but there are subtle differences between 
the two program that may influence the degree of accuracy. The CardiOp-B system utilizes a 
manual guide catheter mode calibration method in contrast to the CAAS 5 system that uses an 
automatic calibration at the region of interest (ROI). With the manual method, the catheter size 
in French or mm has to be inputted for system recognition and calibration. This is an established 
method that has been shown to have greater precision than the equivalent 2D measurements 
with respect to the minimal lesion diameter (P < 0.005), minimal lesion area (P < 0.05), and lesion 
length (P < 0.01) [[4]]. However, it has been reported that because the catheter may not be in the 
same plane as the ROI that this method of calibration can give rise to differences in magnifica-
tion and measurements and influence the accuracy [[13]]. In addition, the way in which the 
contour is drawn on the 2D angiographic image also highlights an important difference that 
Figure 4. Bland-Altman plots of the MLD (a) CardiOp-B® with the phantoms (b) CAAS 5 with the phantoms.
Figure 5. Bland-Altman plots of the MLA (a) CardiOp-B® with the phantoms (b) CAAS 5 with the phantoms.
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may also influence the accuracy and precision between the two systems. Both the CardiOp-B 
and CAAS 5 systems have the ability to manually correct the generated contours if they are 
adjudged to be inaccurate. Although this is subjective, in this paired comparative study contour 
adjustment had to be performed on one of the 21 phantom models in the CardiOpB as the 
detected contour deviated significantly from the vessel’s edge. In the rest of the models, edge 
detection was adjudged satisfactory. No edge corrections were needed in the CAAS 5 but the 
catheter had to be excluded from the ROI on six occasions. Because the edge detection is used 
to deduce the measurement, the less manual correction needed then greater is the accuracy of 
the automated system.
The aim of this study was to evaluate the accuracy and precision of both the CAAS 5 and 
CardiOp-B 3D QCA system with respect to precisely engineered stenotic phantoms in vivo. The 
rational was that in addition to evaluating precision in measurements, the importance of the 
study stems from the demand to accurately determine the luminal diameter so that a precise 
endoluminal road map of a vessel can be achieved for magnetic navigation when the 3D 
reconstructed image is incorporated in the Navigant software [[14]]. The lack of accuracy may 
result in the guidewire exiting from the vessel lumen to cause a perforation. The results dem-
onstrated good overall correlation of the minimal LD and maximum LD at the MLA together 
with the mean LD and MLA in each system to the true values of the phantoms. However in the 
CardiOp-B system, the range of these correlations were slightly less (0.78-0.87) compared with 
the CAAS 5 system (0.97-0.99). In addition, systematic underestimation of luminal diameter 
measurements has been previously reported for the CardiOp-B system QCA system [[11]]. In 
assessing the minimum LD (MLD), greater precision and accuracy was observed with the CAAS 
5 arguably because of two observations in the CardiOp-B system varying markedly from the 
true value (Δ min LD 47% and 25%) in comparison to one observation (Δ min LD 34%) in the 
CAAS 5 system. However, what is important to note is that in terms of the accuracy is that 11/21 
(52%) of the measurements laid outside ± 10% of the true phantom LD using the CardiOp-B 
system compared with 3/21 (14%) of the measurements derived using the CAAS 5 system. This 
was also mirrored with the MLA measurements where two thirds of the values in the CardiOp-B 
system 14/21 laid outside ± 10% of the true phantom MLA compared with one third (7/21) 
with the CAAS 5 system. The result highlights the perceived superiority of automatic isocenter 
calibration together with improved edge detection [[15]].
Despite the variability in 3D QCA measurements in both systems, we should remain appre-
ciative of the fact that this novel technology creates a 3-dimensional coronary map and as 
such have widespread application to both scientific research and clinical practice. By doing 
so, it solves many of the limitations currently observed with 2D QCA and unlike other imag-
ing modalities like multislice computed tomography and magnetic resonance imaging it can 
provide absolute measurements of coronary luminal diameter and lengths in real time. It is 
therefore hopeful that the findings of our study will stimulate further research in this exciting 
new imaging field.
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Limitations
This study is the first direct comparison of two commercially available 3D QCA systems. The 
study was, however, limited by the relatively small sample size of 21 phantom models. This was 
due to difficulties in obtaining more animal models. The concentric phantoms used in this study 
do not represent natural coronary lesions, as they do not allow the assessment of asymmetry. 
It is better to use eccentric phantoms but precise and validated eccentric phantoms were not 
available. The validation tests with these cylindrical concentric phantoms were, however, used 
by our group recently to test 2D and 3D QCA systems [[10]].
conclusions
In a 21 phantom study, the CAAS 5 3-D QCA system had a greater degree of accuracy and preci-
sion in both the luminal and area measurements than the CardiOp-B 3D QCA system. Further 
development and validation studies are warranted in order for this novel technology to be 
increasingly adopted in routine clinical practice
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summary
Magnetic navigation is an emerging technology that has been effectively applied to neurologi-
cal and cardiac electrophysiological procedures and now is being extended to percutaneous 
coronary interventions. A dedicate software package, Navigant® is able to accurately control 
a 0.08 Tesla magnetic field generated by two large permanent external magnets to change 
the magnetic moments of a tiny magnet located at the tip of a guidewire/device. The applied 
magnetic field can be changed at any time to precisely redirect the wire tip in order to improve 
navigation through complex and tortuous anatomy within the coronary tree. The incorpora-
tion of three-dimensional information in the Navigant® enhances the steering accuracy of the 
system. The combination of improved navigation together and newer generation of magnetic 
guidewires may potentially improve time, contrast and material usage in crossing difficult 
coronary lesions. Future potential development is aimed at addressing chronically occluded 
vessels and improving intramyocardial stem cell delivery.
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introduction
The fundamental technique that bridges all percutaneous intervention is the ability to precisely 
track a guidewire or a catheter at or through a lesion. In some cases this remains the Achilles’ 
heel of the entire procedure as it determines success or failure. In order to increase success 
there is a repertoire of wires with varying weights, trackablity and torque that each cardiologist 
has in his or her ‘tool-box’. But there is often a tradeoff since wires that excel in one feature as 
for example the support achieved with a stiffer wire may lose in its ability to maneuver though 
the subtle changes in a tortuous vascular anatomy. This provides the rationale for developing 
systems offering precise distal tip control so as to redirect a wire in vivo within the coronary tree 
without the need to removing it from the patient and reshaping the tip(1). The magnetic naviga-
tion system (MNS) uses a magnetically enabled wire tip to have full 360o omni-rotation(2). This 
is achieved by using large external permanent magnets to precisely control magnetic vectors 
created through a dedicated software called Navigant® (Figure 1). This novel technology is now 
firmly established in cardiac electrophysiology and in addition has been favorably accepted in 
neurosurgery following early animal and human studies(3,4). But its extension into the com-
petitive world of interventional cardiology has had a cautionary start despite over 100 systems 
installed worldwide. This maybe because the technology still has to define areas where there 
are potential benefits over conventional percutaneous coronary interventions (PCI) in order 
to convince the skeptical interventional community(1). At present, the MNS is an expensive 
Figure 1. Magnetic navigation system is shown with the magnets in the tilt position on either side of the 
patient. Inserted at the bottom left hand panel is the touch screen monitor used to direct the navigation along 
the chosen vessel
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technology that requires a learning phase for both the software and the hardware. Moreover 
unlike neurosurgery, targeting a moving structure- the beating heart presents a challenge for 
the navigational roadmaps created from static images. Nevertheless it is postulated that the 
system may provide new options to manage challenging and tortuous anatomy, chronic total 
occlusions (CTOs), reducing crossing/fluoroscopy time, contrast and materials, targeted stem 
cell therapies and ultimately in the realization of remote control PCI(5).
history
The use of magnets to control an intravascular catheter was first reported in 1951(6). Exactly 
40years later Ram and Meyer described the first human magnetically guided heart catheteriza-
tion in a neonate(7). Several key technological developments were needed in order to meet 
the level of sophistication achieved with the current magnetic navigation system (MNS)(8). 
Initially the early magnet designs used large and cumbersome electromagnets to redirect 
relatively large magnetized wires which meant that navigation was only permitted in relatively 
large vessels. It was only with the current smaller permanent magnets that the system allowed 
tiny magnets (≤ 0.014”) to be deflected at the tip of the wires used for percutaneous coronary 
interventions. Following pre-clinical evaluation the Niobe® I system (Stereotaxis, St Louis, MO, 
USA) received regulatory approval for human clinical use in cardiac electrophysiology and 
interventional neuroradiology in 2000, and for interventional cardiology in 2003.
the Magnetic guidewires
The magnetic guidewire used together with the MNS has a nominal diameter of 0.014inch 
/0.36mm and a nominal length of 185cm or 300cm. The wire is configured with a 2 or 3mm 
embedded gold encapsulate neodynium iron boron magnet at the distal tip (Figure 2). The Cro-
nus™ was first generation hydrophilically coated magnetic guidewire available in both magnet 
tip dimensions. When subjected to a magnetic vector the tiny magnetic tip realigned in the 
direction of the applied field and steering of the tip is performed. Once achieved, the wire can 
Figure 2. The Magnetic Guidewire with the 2-3mm embedded gold encapsulate neodynium iron boron 
magnet at the distal tip
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be manually advanced until another change of direction is required. This basic principle of wire 
orientation/guidance is conserved with the newer generation wires that include the Titan™ 
and the Pegasus™ range. Although the basic principle of steering is similar to the Cronus™ the 
newer wires are superior in their ability to deliver a device because of the different materials 
used in their shafts. Three point deflection testing performed by supporting the wires at two 
points and measuring the force required to deflect the mid-point to 4mm showed that they 
stiffen quicker in order to improve device delivery. The Titan™ soft support wire has a stiffness 
profile similar to a Balance Medium Weight (BMW, Abbott Vascular Devices, Redwood, CA, 
USA) moderate support wire with the even stiffer Titan™ Assert wire able to deliver a tip load 
of similar characteristics to a Miracle 3 gram (Asahi Intecc, Nagoya, Japan). The tip load mea-
sures the force needed to buckle the guidewire when applied 1 cm from the tip. In the newest 
wires, the Pegasus™ the distal shaft is made of nitinol to allow greater shape retention and the 
proximal shaft of stainless steel to maintain pushability. As with other magnetic wires they are 
hydrophilically coated to facilitate a smooth wire transit. The three-point deflection test pattern 
shows that the Pegasus™ Moderate and Assert have similar support profiles. However, the very 
distal 2cm of the Assert is stiffer to transmit more force when crossing tight or total occlusions. 
the Mechanical forces exerted on the Magnetic Wire
Unlike standard non-magnetized guidewires used in conventional PCI procedures magnetic 
wires have different mechanical forces exerted at the tip of the wire(10). In standard guidewires 
there is only a push force that the operator uses to direct the wire transit across a lesion. In 
the magnetic guidewire however in addition to this push force there is also a deflection force. 
The deflection force is that applied through the permanent magnet to cause deflection of the 
magnetic guidewire in the direction of the magnetic field vector. The magnitude of this force 
can be calculated by combining the torque exerted at the tip of the wire to that acting in the 
opposite direction of the deflection. The torque (τ) exerted on the tip of the wire is equal to the 
product of the magnetization vector (M, measured in amperes per meter) of the magnet in the 
tip of the wire, cross-sectional area (A, measured in square meters) of the magnet in the tip of 
the wire, magnet length (L, measured in meters), external magnetic field vector (B, measured 
in teslas), and the sine of the angle between the field and magnetization vectors (θ): τ = MALB.
sin(θ) (1) The torque is also described by two identical forces (F, measured in grams) acting 
Table 1: Characteristics of the Stereotaxis Guidewire Family
Stereotaxis Guidewire Family Comparison
Guidewire Distal Core Proximal Core Magnet Tip Length
Hydrophilic distal 
coating
Cronus™ Nitinol Nitinol 2 & 3 mm  25 cm
Titan™ Stainless Steel Stainless Steel 2 & 3 mm 10-34 cm
Pegasus™ Nitinol Stainless Steel 2 & 3 mm 40 cm
Ch
ap
te
r 3
62
in opposite directions on two poles of the permanent magnet through the moment arm: τ = 
2(L/2)F. (2) Combining the equations (1) and (2) yields a description of the force exerted by the 
magnetic field on the distal end of the guidewire: F = MAB.sin(θ) (3). This force is maximal when 
the wire is perpendicular to the magnetic field (i.e., sin(θ) = 1) and zero when the wire is parallel 
to the magnetic field(11). 
navigation software 
The Navigant® software allows several possible modes to navigate through the coronary artery. 
Broadly speaking these can be divided into two main groups: the so called ‘free mode’ where 
navigational vectors are manually derived from the 2 dimensional X ray angiographic images 
and ‘true vessel’ navigation where vectors are derived automatically from a 3-dimensional 
image of the vessel (e.g. an Multislice Computer Tomography MSCT dataset) or through a dedi-
cated 3D reconstruction software package (3RDC). Regardless of the chosen mode to create the 
vector in all cases the operator can manually change a vector though a sterile interactive touch 
screen monitor located at arms’ length at the operation table. With this monitor the operator 
can also chose for the vector to be automatically updated at a desired incremental distance 
(1-9mm). The chosen vector is displayed as a dotted arrow on navigational pathline (centerline) 
Figure 3. The chosen vector is displayed as a dotted arrow on navigational path-line on the live fluoroscopy 
image. The bottom left panel shows what the operator sees on the touch screen monitor.
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on the live fluoroscopy image (Figure 3). As the vector is updated the dotted arrow moves along 
the navigational pathline and the permanent magnets rotate about their axes to create a new 
magnetic field in line with the trajectory of the new coordinate (illustrated by solid arrow on the 
live fluoroscopy image). The operator manually pushes the wire forward to follow the preset 
incremental distance imposed by the desired vector.
a) Free Mode Navigation
The ‘free mode’ 2-D navigational modes include the use of ‘preset navigational vectors’ that are 
adapted to particular coronary anatomies e.g. left anterior descending and circumflex arteries. 
Other anatomical vasculature can be added if required such as coronary artery bypass grafts 
and peripheral arteries. The presets allow relative fast navigation but it lacks accuracy as it is 
based on the assumption of standardized vasculature. Similarly, the ‘clock face’ navigational 
mode where the vectors can move in a chosen direction by touching the periphery of a circle 
mimicking the dial of a clock is equally simple to use but also lacks accuracy(12). Its effective-
ness depends on skill of the operator and his or her spatial understanding of coronary anatomy. 
In combination with a ‘Bulls Eye View’ where the tip of the wire can be made to move along the 
contours of a dartboard offers some degree of accuracy and this is particularly useful in locat-
ing microchannels within chronic total occlusions (CTO). Some spatial understanding of the 
coronary anatomy is required in the more complex ‘spherical navigational approach’ where the 
vessel or object is contained within the boundaries of a sphere having regularly spaced polar 
lines (e.g. latitude and longitude lines). In all the above navigational modes the vectors are 
generic, as they are not directly created from the anatomy of the vessel being treated. However, 
‘true’ anatomical navigation is possible on the vessel being treated by directly introducing two 
orthogonal fluoroscopic images of the vessel in Navigant® but such a 2-D image representation 
of a 3-D structure has obvious limitations(13). Much more accurate is the creation of a virtual 3D 
reconstructed vessel (3DRC) or using MSCT to accurately derive the vector coordinates.
b) ‘True’ Vessel Navigation 
‘True’ vessel navigation is an accurate representation of a 3D navigational roadmap of the 
coronary artery(14). Navigant® can create such a virtual map from two X-ray images provided 
that they are 30º apart. To do this identical points on both images in the same cardiac phase are 
simultaneously linked to generate the 3D navigational path or ‘centerline’ through the vessel 
lumen. This creates a static roadmap map that is co-registered with the live fluoroscopy image. 
It should be noted because the images are not gated it means that only in the phase where the 
images were taken will the navigational road map be perfectly aligned. But for the purposes of 
navigation the trajectory of the vector will be sufficiently good enough to permit the adequate 
wire transit. The 3-DRC centerline can also be created from two fluoroscopic images using 
dedicated software (CardiOpB®, Paieon Medical Inc., Rosh Ha’ayin, Israel) that has the added 
advantage to fine tune the direction of the vector by visualizing subtle changes in the vessel 
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through a virtual lumen - so called endoluminal view. A far more accurate 3D road map can 
be obtained by employing multislice computer tomography (MSCT) datasets (Figure 4). This 
imaging modality can also identifying vascular anomalies and provide information on coronary 
plaques composition(15,16). The vessels can be directly extracted from the MSCT dataset 
through post-processing software and be directly incorporated, co-registered and aligned to 
the fluoroscopic image in the Navigant®(17).
current status
It is not the intention of the MNS to revolutionize current practices in PCI but rather to facilitate 
in areas where conventional techniques may be met with difficulty. Potential areas are in the 
challenging anatomies associated with tortuosity, chronic total occlusions where the path of 
the vessel is not visible so the required tip direction is unclear and in improving the efficacy of 
myocardial stem cell implantation.
i) Challenging anatomy
Challenging anatomy often is associated with lower crossing success and higher rates for 
surgical referral. In a study comparing magnetic and conventional wires in phantoms models 
Figure 4. Top panels showing the tip of the catheters in fluoroscopy image co-registered with the extracted 
coronaries derived from the MSCT dataset.  These give the specific 3-D coordinates that allow integration of the 
2 modalities. Bottom panels showing the extracted coronaries with the centerline together with multiplaner 
reconstructed cross-section displayed in the Navigant® and the endoluminal views for MSCT based navigation.
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mimicking tortuous coronary arteries magnetic wires crossings were found to be superior in 
the more tortuous phantoms(18). More than 5 fold reduction in crossing times were recorded 
(201.7 ± 111sec to 36.4 ± 13sec, p<0.001) compared to standard guidewire techniques. More-
over the magnetic wires achieved a 98.8% crossing success compared to 68% with the standard 
guidewires with considerably fewer wires usage (1.3 vs. 5.5) as a result of wire tip damage. But 
much more interesting was the finding that in certain cases operators without prior MNS expe-
rience had equally good crossing successes with the magnetic wires as compared to senior 
operators. In the more difficult phantoms however, a learning curve was clearly demonstrable 
in those operators with limited MNS experience. 
In addition to this phantom study the ability to negotiate challenging anatomy has also been 
shown in several clinical scenarios where the procedural success was inherently dependent on 
the MNS. In a case of hypertrophic obstructive cardiomyopathy (HOCM) the origin of the major 
septal artery had an unusually extreme angulation (approximately 130 degrees) on coronary 
angiography that was impossible to access with a conventional guidewire approach(19). How-
ever by employing MNS guidewire the balloon catheter cannulation of the septal artery was 
possible to facilitate a successful transcatheter alcohol septal ablation procedure. MNS guided 
septal ablation has now been evaluated in a randomized study comprising 44 consecutive 
patients(20). In all cases the procedures were successful and the only complication, a vessel 
dissection occurring in the conventional group. Interestingly as observed in the phantom stud-
ies, the time required for guidewire cannulation of the septal branch decreased progressively 
with increasing experience (third tertile vs. first tertile (3 [1.25-4.75 vs. 10.5 [6-17] minutes, P = 
0.004) compared with the conventional group (6 [2-10.25] minutes, P = 0.075 vs. third tertile), 
suggesting a learning curve.
Early experience of the magnetic navigation in crossing coronary lesions showed relatively 
low success (88%) with the first generation Cronus™ wires. Although the majority of lesions 
were relatively straightforward four of the sixty-eight target lesions were complex and had 
previously failed with conventional wire techniques (21). When directly compared in crossing 
21 consecutive simple and straightforward lesions the magnetic wires had significantly longer 
crossing times compared to standard guidewires (median, 120 vs. 40 sec, P=0.001; 105 vs. 38 
sec, P=0.001, respectively)(22). In addition the contrast media usage and amount of radiation 
exposure were also higher with magnetic wires (median, 13 vs. 9 ml, P=0.018; 215 vs. 73 Gym2, 
P=0.002, respectively). Without a demonstrable advantage in simple lesions many groups have 
focused on vessels having various degrees of complexity or in cases that were previously met 
with failure using a conventional wire approach. One of the first study evaluated 59 patients 
grouped to attempt MNS guided PCI as a first option (“primary attempt”; n = 46) or following 
failure to pass a conventional guidewire (“secondary attempt”; n = 13)(23). It demonstrated that 
the target lesion was successfully crossed in 49 of 55 lesions (89%) and in 9 of 13 conventional 
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failed lesions (69%) the MNS was successful giving procedural successes of 84% and 62%, 
respectively. As expected the median crossing, fluoroscopy and contrast media usage was lon-
ger or higher among the secondary attempt group. Other reports where MNS was successful in 
cases that failed conventionally were in recrossing of a crush stent to facilitate kissing balloon 
post dilatation and in crossing a jump saphenous vein graft (SVG) having an acute angulation 
to a stenosis just before it anastomosed to an obtuse marginal branch (OM) and a right poste-
rior descending coronary artery(24,25). To try to identify other cases that are more likely to be 
crossed with the magnetic system a novel complexity scoring system is being evaluated. It uses 
3-D information of both the vessel and lesion characteristics in an attempt to address some of 
the notable limitations encountered with existing classification (26). Preliminary results have 
shown that there is a trend to support MNS in more complex vascular anatomies. In one of the 
largest prospective studies MNS was performed on 439 lesions in 350 consecutive PCI patients 
predominantly using the radial approach(27). Successful crossing was accomplished in 93% of 
the lesions with twenty-five of the 35 failures occurred in attempting chronic total occlusions. 
Lesion crossing time was 81 ± 168 sec (mean ± SD), and fluoroscopy time was 64 ± 123 sec. A 
clear learning curve was evident after the first 80 patients. In addition contrast agent usage was 
reduced when compared to a historical control group. Low success in crossing (sub) chronic 
total occlusions with magnetic wires was also reported in a study comparing guidewire steer-
ing by either 2D guidance or virtual 3DRC(28). In 30 patients with 36 coronary arteries lesions 
an overall crossing success of 86% (31/36 lesions) was recorded with the 5 failures occurring in 
patients having (sub) chronic total occlusions. The study did reveal that significantly less con-
trast medium was needed to position the magnetic guidewire by using the 3DRC (60 +/- 101 
ml vs. 14 +/- 15 ml.  p < 0.05). 
ii) Chronic total occlusions
Chronic total occlusion (CTO) often presents a challenge and its variable success rate (65 to 80%) 
is dependent on both the skill of the operator, the materials and the technique used(29). As a 
result a number of strategies have been suggested to facilitate the treatment of CTOs e.g. intra-
coronary thrombolytic infusion(30), tapered-tip, laser (31) and radiofrequency guidewires(32). 
A novel approach to manage a CTO is to integrate the MNS ability to steer a guidewire through 
the occlusion with a forward-looking technology such as MSCT cross-sections to ensure ideal 
positioning of the wire in the true lumen (Figure 4). Once the ideal position is accepted then 
ablative radiofrequency power can be delivered to the tip of the wire to recanalize the CTO (33). 
Early evaluation of MNS-MSCT approach to CTO used magnetic wires without ablative power 
and navigation was aided by the bull’s eye view to ‘looked forward’ at the occlusion –– to make 
the search pattern for micro-channels through the occlusion more uniform(34). Even though 
the success was limited by the bulkiness of the 2-3mm magnetic tips the feasibility of using a 
3-D map generated from an MSCT dataset to navigate was demonstrated. This is important 
because the lack of a fluoroscopic lumenogram in a CTO does not allow navigation using 3DRC 
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software. With MSCT both the distal vessel filled via collaterals and a tissue attenuation line 
(the scarred tissue of the original vessel lumen) can be identified. The navigational centerline 
is however fixed and as a result the mismatch with the moving artery in the live fluoroscopy 
image persists except in the phase in which the navigational path was constructed from the 
MSCT image. Ordinarily, when navigating through a patent vessel this is not a problem as the 
wire is contained within the vessel’s lumen so that when the heart moves with each beat the 
wire can still follow the trajectory of the predetermined vectors. In a CTO however, the lack 
of a patent lumen means that as the heart moves along its axis, the tip of the wire can be 
perpendicular to the vascular wall and when pushed can protrude. With magnetically enabled 
RF powered wires it is therefore crucial to have a dynamic road map (centerline) to superimpose 
on the live fluoroscopy image or to ECG phase gate a centerline derived from the MSCT to the 
fluoroscopic image following alignment to recognizable landmarks such as the spinal processes 
and the catheter’s tip. This would mean that at all points in the cardiac cycle the centerline will 
be superimposed on the live fluoroscopic image of the vessel and the advancement of the 
ablating wire can be safely undertaken. Stereotaxis is now in their final stages of developing a 
RF ablating magnetic enabled wire (Figure 5). This is a 0.018inch wire having a small RF electrode 
at its tip with three small magnets protected by a heat sleeve with the RF energy supplied by an 
external RF generator. The nitinol shaft is electrically insulated with asymmetrically coated PTFE 
(thinned distally) to provide adequate dielectric strength without affecting the wire’s flexibility. 
The composite metal alloys used in the RF electrode are encased in a polyurethane polymer 
jacket for smooth transitions between the different components. In vivo studies demonstrated 
good results in artificially created occlusions (5-8cm in length and aged 6-8 weeks) in porcine 
femoral arteries. The first in man (FIM) study assessing the safety and feasibility will firstly be 
done in caged coronary CTO ‘within stents’ and in peripheral vessels.
iii) Stem cell injection
An area in which magnetic navigation is postulated to have an advantage over conventional 
techniques is intramyocardial injection of stem cells(35). Current methods for delivery remain 
inexact despite using electromechanically guided injection. This uses NOGA electromechanical 
Figure 5: The magnetically enabled RF wire 
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mapping (EMM) of the myocardium to identify the infarction areas for treatment. Appropriate 
electrical signal strength recorded as the mapping electrode makes a good contact with the 
myocardium is used as a marker for intramyocardial injection(36). Although this approach is 
advantageous the mapping of remote areas in the heart can be difficult to access even with 
very experienced operators. But by using a magnetically enabled MNS-guided NOGA EMM 
catheter these remote areas can be effectively mapped. Moreover, the magnetic momentum at 
the catheter tip is supportive enough to allow the use of softer catheters that are less likely to 
perforate the myocardium. Preclinical studies on a Stereotaxis-compatible NogaStar mapping 
and MyoStar injection catheters (Biologics Delivery Systems, Cordis Corporation, Diamond Bar, 
CA) equipped with a small permanent magnet positioned at the tip have been encouraging 
with a 95.8% success rate for intramyocardial injection of mesenchymal precursor cells (MPC) 
(37). The NOGA mapping of the myocardium was performed remotely with a computer-
controlled catheter advancement system (Cardiodrive unit, Stereotaxis St Louis, MO)(38). This 
3-dimensional map was used in Navigant® to create the desired navigational vectors needed 
for the magnetically enabled MyoStar catheter to follow.
Limitations and Future developments
The ability of the MNS to precisely direct an in-vivo device externally makes it a powerful tool that 
has the potential to benefit several areas of interventional cardiology. At present it is expensive, 
technically demanding and has several drawbacks related to both the software and hardware. 
Both the operator and technician must overcome the learning curve before maximal gains can 
be achieved. In addition, current methods used to create the 3DRC are time consuming tak-
ing up to 30 minutes for the navigational pathway to be displayed on the fluoroscopy image. 
Moreover, this static image has inherent limitations with co-registration and with the accuracy 
in directing the vectors on static roadmaps. It therefore means for the full potential of the MNS 
to be realized there must be continuous improvements in both software and hardware design. 
Some of the major limitations are already being addressed with the next generation of wires/
devices. Current magnetic wires suffer from the lack of sophistication that has become widely 
accepted through the many generations of standard conventional wire designs. The crudeness 
of the 2-3mm magnet stuck on to the tip of the wire influences the wire’s ability to transit 
smoothly across a lesion. Planned future generation wires will have multi-magnet designs akin 
to the RF wire in order to address this particular limitation. Moreover, different alloy composite 
are being tested to retain the shape of the wire without compromising its ability to deliver 
a device. However a major limitation is the responsiveness of the hardware in executing the 
vector change demanded by the Navigant®. In the earlier versions of the software the vectors 
had to be manually updated by pressing an advancing icon on the touch screen monitor. This 
meant that the operator had a time delay prior to advancing the magnetic guidewire as the sys-
tem updated. In the latest version of the Navigant® 2.11 the vectors are automatically updated 
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at a preset rate – moving at incremental distance of 1-9mm over a chosen time in seconds. 
Although this is a desirable feature as it frees the operator from performing an additional task 
he or she still has to wait for the magnets to move to realign their field in the direction of the 
vector. This time delay makes the magnetic navigation system slower than conventional wire 
techniques and this may not be easily solved because of the mechanical limitations in moving 
large external magnets rapidly and accurately. It is also sometimes not fully appreciated that 
the operator is still required to manually advance the wire with his/her left hand and that the 
MNS is only steering the tip though the external field. By using a Cardiodrive® unit attached to 
the distal part of the wire automatic advancement is possible. This system has been extensively 
used in magnetic guided cardiac electrophysiological procedures and may provide a window 
for remote control intervention when amalgamated with technologies that can enable accu-
rate device positioning(39). Such technologies exist but require significant investment to make 
them magnetically field compatible. In the future the potential benefits of steering the tip of a 
guidewire in a desired direction, driving it externally and accurately knowing the position of a 
device on the wire will certainly have an impact on the current way of performing PCI (40). 
conclusion
The MNS is a promising technology that when integrated with 3-dimensional information can 
offer new possibilities in performing percutaneous intervention. Key developments are still 
however required in both hardware and software to provide a real challenge to conventional 
approaches. The versatility of the system however in its ability to redirect a device in vivo means 
that there maybe additional benefits in many important aspects of invasive cardiology and 
patient care.
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objectives:
To develop a clinical prediction rule based on 3D reconstruction of coronary arteries that would 
prospectively identify lesions that are difficult to cross and could benefit from magnetic naviga-
tion.
Material and results:
The coronary anatomy of a cohort of 120 lesions that had undergone percutaneous coronary 
intervention (derivation set) was analysed using 3D reconstruction for vessel and lesion 
characteristics. The crossing time was the total clock time to reach a satisfactory distal position 
after leaving the guiding catheter. Multivariable logistic regression and linear shrinkage with 
bootstrapping were used to develop a clinical prediction rule that dichotomised cases into easy 
or difficult (prolonged crossing time). A prolonged crossing time
(>120s) = 1*Vb + 1*(Vl=1) + 2*(Vl=2) + 2*Vc + (1*Lbb)+1*(Ll=1) + 2*(Ll=2). 
(N.B. abbreviations refer to morphological factors, see appendix 1)
A value of 6 was the best cut-off value. This clinical prediction rule was applied to a second 
independent cohort of patients (validation set) where crossing time was measured. The boot-
strapped c-statistic of the model was 0.82 indicating excellent discrimination.
conclusion:
3D reconstruction helped to develop a simple, accurate clinical prediction rule to identify dif-
ficult cases for conventional wires and in whom magnetic navigation may be preferable.
short abstract:
We describe the development of a clinical prediction rule, based on 3D reconstruction, to 
prospectively identify lesions in coronary arteries that are difficult to cross with a conventional 
angioplasty wire. This clinical prediction rule was developed in a cohort of consecutive patients 
undergoing angioplasty and validated in a second independent cohort and showed excellent 
discrimination between long (>120s) and short (<120s) crossing times. The use of these ana-
tomical vessel and lesion characteristics in the clinical prediction rule identifies difficult lesions 
that may benefit from the precise control given by magnetic navigation.
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introduction
Currently the majority of PCI procedures are performed satisfactorily with conventional wires. 
However, there is a proportion of PCI procedures where difficulty, or sometimes failure, occurs. 
As equipment improves and PCI extends into more difficult territories, e.g. smaller, more tortu-
ous, heavily calcified and more distal lesions, there will be an increasing challenge to manual 
dexterity. The recently introduced magnetic navigation system (MNS) from Stereotaxis uses a 
magnetic field to precisely steer the wire that utilises a 3D model of the vessel created from 
angiographic images, and may be of benefit in such problematic procedures. [1] Improved wire 
delivery may lead to reduced procedural time and complications. [2,3]
However, there is no specific method of identifying those cases where passing the lesion with 
a wire, or ‘crossing’, is difficult. The currently available range of lesion classification systems [4-8] 
is aimed at predicting complications and these have relatively modest accuracies. We have 
investigated a simple, specific, measurable and crucial part of the PCI procedure, the time to 
pass the wire from the guiding catheter to a position distal to the culprit lesion. Such prediction 
may have a number of major benefits. First, better guidance for operators in the assessment 
of the difficulty of a particular case may help better risk-benefit decision-making. Second, it 
may allow selection of patients who have difficult morphology for an alternate technique such 
as magnetic navigation. A clinical prediction rule (CPR) may be a useful method of ultimately 
comparing magnetic navigation or other navigation technologies to conventional wire 
manipulation. The aims of this study were two-fold. First, the development of a simple CPR to 
predict difficult lesions to cross with a conventional wire. Second, the validation of this CPR in 
lesions that had undergone angioplasty.
Methods
Patient selection
Derivation set
The crossing times of a cohort of 425 consecutive lesions that had elective and semi-urgent PCI 
performed with a conventional wire at a single centre were noted. Lesions that were excluded 
from analysis consisted of occluded vessels where a reconstruction could not be produced 
due to inadequate vessel flow (TIMI flow of 2 or less) such as primary PCI, ACS, and CTOs. ACS 
patients were generally not excluded. In addition, lesions where special techniques had been 
used, such as biplane angiography, or magnetic navigation, were excluded. After ranking the 
crossing times (Figure 1), a random sample of 40 lesions from each tertile was selected for inclu-
sion in the derivation set. The CPR was developed from this set.
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Validation set
The CPR was validated in a second cohort of 415 lesions, the validation set. The same exclu-
sion criteria were used as in the derivation set. 16 lesions were randomly selected from each 
tertile of the crossing times for further analysis. In order to blind the analysis, the analyst had no 
knowledge of the results of the crossing time.
Magnetic navigation system
The MNS (Navigant, Stereotaxis, St Louis, USA) has dedicated 3D reconstruction software 
(CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel) that produces a virtual model of the 
entire vessel. With the reconstruction package it is possible to take 2 angiographic views and 
identify the vessel edges. As the angles of the image intensifier and the position of the table 
are known, it is possible to triangulate the position of each point of the vessel and make a 3D 
reconstruction of the vessel that is volume-rendered (Figure 2). All measurements can be made 
from diagnostic angiography films of suitable quality. 
To produce as accurate and reproducible reconstructions as possible, the images were routinely 
taken in diastole (on or just before the QRS complex). The software has functions that allow 
measurement of length, diameter and area stenosis with respect to the calculated reference 
diameter at that point. The model can then be imported into the Navigant program where 
the angulation of each bend can be measured. The bends were assessed visually and then 
measured to see whether they fitted the following definition. A bend was considered to be an 
Figure 1. Graph showing distribution of the total population
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angulation of 45o within 10 vessel diameters (for the purpose of this analysis a standard vessel 
diameter was considered to be 3mm therefore a bend had to occur within 30mm).
Definition of crossing time
A prolonged crossing time was defined as the absolute time (in seconds) from the initial entry 
of the wire into the coronary system, out of the guiding catheter, until crossing and reaching 
a suitable position distal to the target culprit lesion in the coronary artery. The crossing time 
includes the time required for any and all procedural manoeuvres once the wire has initially 
left the tip of the guiding catheter, such as the time required to remove and re-shape the 
conventional wire, re-engagement of the catheter should prolapse occur, or to pass a balloon 
for support, and implies the placement of the wire in a satisfactory final position for device 
delivery.
This was a registry where no special techniques of passing a wire were used, and therefore 
the operators should have been performing normally. While a competitive element may have 
occurred within an operator’s mind, the data once collected was only available to one person. 
This data was not, and has never been, shown in a fashion that would compare one operator 
with another and while operators may well have tried to perform their best, this is felt to be an 
advantage with the ‘best’ crossing times recorded.
The relevant hypothesised anatomical factors encountered with conventional angioplasty 
guide-wires can be divided into vessel and lesion characteristics, see appendix 1.  We imposed 
an arbitrary maximum to each factor in order to prevent any specific factor from dominating 
the grading system.
Vessel characteristics
Number of bends before the lesion, (Vb), (Figure 3)
Figure 2. The left 2 panels show separate angiographic angulations with edges detected and the right panel 
shows a 2D image of the 3D reconstruction.
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Each bend causes deformation of the wire resulting in friction. A greater number of bends leads 
to increased friction resulting in more difficultly in manipulating the wire. The maximum score 
is 5.
The greater the cumulative angle, the more the wire is deformed along its course. This results 
in more friction and produces increased difficulty during manipulation. This has been dichoto-
mised to above and below 45o. The maximum score is 1.
End-to-end length from the ostium to the lesion, (Vl), (Figure 4)
The more distal the lesion is from the ostium, then the greater the chance of encountering 
problematic bends that impair manipulation, and also the longer the time required to physi-
cally pass the wire. This is divided into shorter than 50mm, between 50 and 100 mm and greater 
then 100mm. The maximum is 2.
Vessel calcification, (Vc).
Calcium may increase friction as the vessel becomes more rigid and less deformable and does 
not conform to the wire. The frictive effect of a specific angle will be accentuated if deformation 
cannot occur. The complete angiographic absence of calcium scores 0, mild calcification is 1 
and severe calcification is 2. The maximum is 2.
Figure 3. Identification of the bends in a vessel and measurement of each angle (possible in the Navigant 
program) The total angulation of the 5 worst bends, (Vta), (Figure 3)
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Visible sidebranches before lesion, (Vsb), (Figure 5)
Visible sidebranches result in a greater chance of taking a wrong bend. This is dichotomised to 
0 or 1.
Lesion factors
Luminal lesion characteristics such as complex and intricate 3D form or tight lesions with little 
space for manoeuvre affect how quickly and easily a wire can pass. Navigation through complex, 
intricate, and/or tight lesions may involve a variety of angles that cannot be easily be traversed 
by a conventional guide-wire with a fixed bend as it has a specific angle of approach.
Lesion characteristics
Sidebranches within 10mm, (Lbb) (Figure 5). 
Sidebranches within 10mm of the lesion increase difficultly because, on the approach to a 
lesion finer control is necessary, the fixed wire-tip angle needed for bends now may have more 
of a predisposition for sidebranches. This is dichotomised to 0 or 1.
Figure 4. The measurement of the length from the vessel ostium to the lesion in CardiOp-B (green square 
indicates proximal marking point and blue square indicates distal marking point)
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Sidebranches in lesion, (Lsb).
When the angulated wire tip has to pass through a stenosis, there is a greater chance that the 
tip will be pushed against the wall and this increases the chance of selecting sidebranches. This 
is dichotomised to 0 or 1.
Lesion angulation, (La).
The lesion angulation will affect the friction of the wire passing through the lesion.  This is 
dichotomised to 0 or 1.
Lesion calcification, (Lc).
Calcium makes the lesion rigid and reduces deformability, therefore producing more friction. 
This is dichotomised to 0 or 1.
Lesion length, (Ll), (Figure 6).
Longer lesions produce more friction on the wire. This factor has been divided into <10mm, 
between 10 and 20mm and greater then 20mm. The maximum is 2.
Length of severe (greater than 80% area) stenosis, (Lss), (Figure 6).
Tighter lesions have greater contact with the wire and this magnifies the effect of bends lead-
ing to a greater chance of the wire being forced against the wall. This is dichotomised to into 
<3mm and >3mm.
Figure 5. The left panel shows visible sidebranches (arrowed) greater then 1mm before the lesion with the right 
panel showing a branch just before the lesion (within 10mm).
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statistical analysis
 
The crossing time was dichotomised with an arbitrary cut-off value of 120 seconds based on 
the observed crossing times (Figure 1). By the design of the study, one-third of the lesions had 
the presence of a long crossing time and two-thirds had a normal crossing time. 
Statistical modelling
The association between each prognostic factor and the presence or absence of a long crossing 
time was studied by univariate logistic regression analysis. We applied a stepwise backward 
selection process (p=0.100) to select the predictors for the final model.
A key problem of regression modelling in small data sets is that the regression coefficients are 
overestimated for predictive purposes. We calculated a linear shrinkage factor for the regres-
sion coefficients with bootstrapping. [9] The difference between performance in the bootstrap 
samples and the original sample is an estimate of the optimism in the apparent performance 
(miscalibration). This difference is averaged to obtain a stable estimate of the optimism. ‘Shrunk’ 
Figure 6. The top panels show the measurement of the lesion length (green square indicates proximal marking 
point and blue square indicates distal marking point). The lower panel shows the segment greater than 80% 
measured in CardiOp-B (green square indicates proximal marking point and blue square indicates distal 
marking point).
Ch
ap
te
r 3
82
coefficients were calculated by multiplication of the standard coefficients with the shrinkage 
factor, which might take values between 0 and 1.
The final model was transformed into a CPR. Regression coefficients were rounded to the near-
est integer. A score was obtained for each individual lesion by assigning points for each variable 
and adding the results. 
Predictive performance
The prognostic ability of the model, i.e. the power to discriminate between subjects with and 
without a long crossing time, was estimated with c-statistic. The c-statistic, provides a quantita-
tive summary of the discriminative ability of a predictive model. A value of 0.5 indicates that the 
model does not have any discriminatory ability, and a value of 1.0 represents perfect discrimi-
nation. Calibration refers to whether prediction models agree with the observed probabilities 
and was assessed with the Hosmer-Lemeshow statistic.
Table 1. Patient characteristics for test and validation groups 
Baseline patient characteristics   
derivation 
(N=120)
Validation
(N=48) P value
Age-yr                                                                           65.9±10.6 65.5±10.4 0.8
Male sex-no.(%) 74.3 73.3 0.9
Diabetes mellitus-no.(%) 25.7 35.6 0.2
Hypertension-no.(%) 55.7 60.5 0.6
Hypercholesterolemia-no.(%) 94.8 94.8 0.9
History of smoking cigarettes-no.(%) 18.6 11.6 0.3
Previous PCI-no.(%) 32.4 42.2 0.3
Previous CABG-no.(%) 7.6 6.7 0.8
Previous myocardial infarction-no.(%) 38.8 46.7 0.4
Clinical presentation 0.05
  Stable angina pectoris 62.1 46.7
  Unstable angina pectoris 37.9 53.3
CCS class 1.0
  I 5.0 5.3
  II 38.3 36.8
  III 53.3 52.6
  IV 3.3 5.3
LVEF 0.6
  Good (>50%) 76.3 66.7
  Moderate (35-50) 15.8 27.8
  Poor (<35) 7.9 5.6
Vessel disease 0.5
  1VD 43.0 31.3
  2VD 30.8 35.5
  3VD 23.4 33.3
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Statistical analyses were performed with SPSS and S-plus software (MathSoft, Inc., Seattle WA, 
version 2000). The authors had full access to the data and take responsibility for its integrity. All 
authors have read and agree to the manuscript as written.
results
Mean age was 65 years and 74% were male. All baseline characteristics in the derivation set 
and the validation set were comparable (Table 1). There was a spread of values for the crossing 
times showing that 15% of lesions could still not be crossed at 5 minutes (310s) and 10% by 8 
min (480s) (Figure 1). 
The CPR was derived after applying logistic regression to the sample from the derivation group 
(results of univariate and multivariate analysis shown in Tables 2 and 3) to provide a relative 
estimate of crossing complexity: 
Procedure with a prolonged crossing time (>120s) = 1*Vb + 1*(Vl=1) + 2*(Vl=2) + 2*Vc + 
1*Lbb)+1*(Ll=1) + 2*(Ll=2) .  
(N.B. abbreviations refer to morphological factors, see appendix 1)
This dichotomises cases into easy and difficult (prolonged crossing time). A value of 6 was 
found to be the best cut-off value. The c-index of the standard model was 0.88 and 0.83 for 
Table 2. Results of univariate analysis.
Coefficient P value
vessel characteristics
Number of bends before lesion, (Vb) 0.73 <0.001
The total angulation of the 5 worst bends, (Vta) 0.58 0.177
End to end length from the ostium to the lesion, (Vl)
         50-100 1.18 0.009
         >100 1.55 0.045
Vessel calcification, (Vc) 2.03 <0.001
Visible sidebranches before lesion, (Vsb) 1.08 0.017
Lesion characteristics
Sidebranches within 10mm, (Lbb) 0.01 0.985
Sidebranches in lesion, (Lsb) 0.58 0.163
Lesion angulation, (La) 1.00 0.013
Lesion calcification, (Lc) 0.98 0.013
Lesion length, (Ll) 0.75 0.055
Length of severe (> 80% diameter) stenosis, (Lss) 1.01 0.013
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the shrunk model used for the CPR. Calibration with the Hosmer-Lemeshow test gave a non-
significant p-value. This CPR was then applied to the results from the validation cohort. The 
c statistic derived from this group was 0.82 showing good discrimination.
discussion
We have developed a clinical prediction rule (CPR) that examines the whole vessel that is under-
going PCI and is able to predict which vessels will require more time and contrast to cross. The 
CPR integrates the use of a 3D reconstruction developed from a combination of lesion and 
vessel characteristics to give a relative estimate of crossing complexity. It will allow an assess-
ment of the importance of physical factors on wire passage and whether difficult wire passage 
is related to increased complication rates. This is directly applicable to the decision process of 
selecting a patient for a magnetically navigated procedure.
This system is fundamentally different from previous classification systems that were developed 
for the prediction of procedural success and complications. The ACC/AHA guidelines for lesion 
grading were developed in 1988, [4] modified in 1990, [5] and use 11 simple angiographic 
factors to help take into account lesion complexity in the comparison of the outcomes of PCI. 
Further systems, such as the SCAI [6] or the Mayo Risk Score [7] or the SYNTAX score, [8] were 
subsequently developed in order to improve this predictive ability further. However, the dis-
criminatory power was lower than expected. [5,10] A number of possible reasons may help to 
explain this shortcoming. First, previous grading systems use a number of coronary factors that 
have generally been simple, angiographically-defined lesion characteristics. Use of such simple 
lesion characteristics may underestimate both the lesion complexity itself and also the impor-
tance of the rest of the vessel in successfully crossing with a wire. Second, while these factors 
have a great deal of merit in their simplicity, they are visual estimates from angiographic images 
and these are known to have poor inter-observer reproducibility. [11-13] Third, some systems 
include clinical factors, either as an endpoint or in their grading, that are frequently complex 
and multi-factorial. Difficulty in crossing an individual coronary lesion, that is so problematic 
Table 3. Multivariate predictors of the crossing times in the derivation set
ß coefficient Odds Ratio P-value
Bends to lesion, (Vb) 1.0278 5.06 (1.54-16.66) <0.001
(end to length from the ostium to lesion (VI)  
50-100mm
1.0495 0.44 (0.12-1.63) 0.119
      >100mm 2.7242 3.75 (0.38-37.13) 0.018
Vessel calcification (Vc) 2.9004 9.85 (2.52-38.42) <0.001
Sidebranches in lesion (Lbb) 1.0622 2.31 (0.78-6.89) 0.057
Lesion length (Ll) 10-20 0.8377 0.52 (0.15-1.76) 0.018
                            >20 2.0567 2.62 (0.68-10.01) 0.004
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as to result in a clinical complication, may only be indirectly related to a poor clinical state of 
an acutely sick patient or to the pre-existing clinical diseases.  Conversely, a poor clinical state 
or pre-existing disease may be more closely associated with a complication than the adverse 
coronary anatomy.  Therefore the use of clinical factors, either the pre-existing clinical diseases 
or the resultant clinical complication, may obscure a clear answer.
A number of factors have been investigated in previous studies. These indicate that increasing 
complexity of a lesion is associated with an increasing incidence of complications [6,14] and 
that some anatomical factors of the vessel, such as tortuosity, lesion length or angulation, are 
associated with decreased success of stent passage. [15-17] The introduction and use of new 
3D imaging technology enables a more complete anatomical analysis of the vessel and lesion 
in a new way. In order to give the clearest idea of factors that might influence passage of the 
wire we analysed the entire vessel as well as the target lesion. This approach has not been used 
before.
All the measurements required for the CPR can be obtained from adequate diagnostic angiog-
raphy films. The CPR can be applied in a matter of minutes and is therefore applicable in general 
practice. This system is completely independent of the clinical factors that, while important in 
the broad clinical outcome, are either only loosely related, or even irrelevant, to the passage 
of a wire through a coronary artery. The analysis aimed to reflect these factors by defining 
the anatomy of both the coronary vessel and lesion. There are a number of advantages of this 
system. First, it uses a 3D reconstruction to identify and measure specific vessel factors and 
to give hard numbers to predict a single, clearly definable endpoint. Second, it examines the 
anatomy of the entire vessel, a factor that is clearly crucial to the delivery of a wire. Third, it is 
independent of the clinical factors that obscure the importance of physical factors. Fourth, it 
has clear applicability in choosing patients who might benefit from a magnetically navigated 
procedure.
There are a number of limitations. Currently the reconstruction is time-consuming and can 
take up to 30 minutes to complete. The production of the reconstruction requires angiography 
of a suitable standard and is not always possible from standard views due to foreshortening 
or overlapping. The reconstruction that is produced is static and the impact of movement on 
the measured factors, such as angulation, is unknown. After analysis some factors were not 
incorporated into the CPR. There may be a variety of reasons for this.  Some factors occurred 
infrequently, such as the presence of a stent. The infrequent occurrence therefore may not 
reflect the unimportance of the factor but the effect of a small sample size e.g. few patients with 
stents. Another possible reason for a particular factor not showing significance is the variability 
of the factor itself. Sidebranches may be cannulated without intention during procedures but 
this may only occur with sidebranches that come off at a certain angle and not all as measured 
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in this analysis. Therefore, in general, these factors may play some role, but this may only occur 
in specific circumstances, or occasionally, and will need further investigation to identify any 
additional benefit. More generally, there was unselected use of wires and no selection of opera-
tors. The limitations of this model therefore also relate to individual operators, techniques and 
equipment. There were a number of operators and types of wires and this, together with no 
selection of the target vessel segment, may have led to heterogeneity. In addition, this study 
examines only one specific aspect of the PCI and deliberately does not address other necessary 
elements such as the passage and deployment of the balloon and stent. Lastly, this study was 
performed at a University specialist tertiary referral unit and the case mix might be different to 
that seen elsewhere.
Despite such limitations, the system could prove useful in application. The ability to predict 
difficult cases may allow consideration for alternative strategies.  In this context, the ability of 
the MNS to precisely direct the tip of a wire has a clear potential for improving the treatment 
of patients identified in this way. However the system could potentially be used in other ways. 
As the number of MNS in an institution is normally limited to one, reconstruction could be 
performed on selected subsets of patients. Identification of the patients who would most 
benefit would be not only beneficial for patients but would maximise efficiency. Alternately, an 
automated system would also allow all patients to be screened in addition to possibly improv-
ing reproducibility.
This CPR will be valuable in several ways. First, to identify which anatomical factors are pre-
dominant by prospectively identifying difficult cases. Second, this may be a crucial tool in 
deciding whether a patient should undergo a conventional procedure or rather will benefit 
from magnetic navigation. 
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appendix
grading factors
Vessel characteristics      range of values
Number of bends before lesion, (Vb)
  max 5       (0-5)
The total angulation of the 5 worst bends, (Vta)
  0:<45,1>45      (0-1)
End-to-end length from the ostium to the lesion, (Vl)
   0:<50mm, 1:50-100, 2:>10     (0-2)
Vessel calcification, (Vc)
  0:none, 1:yes      (0-1)
Visible sidebranches before lesion, (Vsb)
  0 or 1       (0-1)
Lesion characteristics
Sidebranches within 10mm, (Lbb)     
  0:no, 1:yes      (0-1)
Sidebranches in lesion, (Lsb)  
  0:no, 1:yes      (0-1)
Lesion angulation, (La)  
  0:<45,1:>45      (0-1)
Lesion calcification, (Lc) 
  0:no, 1:yes      (0-1)
Lesion length, (Ll)
  0:<10, 1:10-20, 2:>20     (0-2)
Length of severe (> 80% diameter) stenosis, (Lss)   
  0:<3mm, 1:>3mm      (0-1)

assessMent oF success in native coronaries
a randomised comparison of the Magnetic 
navigation system  versus conventional 
Percutaneous coronary intervention
Catheter Cardiovasc Interv  2008 (in press)
ramcharitar s, van Geuns RJ, Patterson MS, van der Ent M, 
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abstract
objectives: 
A randomised comparison of the Magnetic Navigation System (MNS) to conventional guidewire 
techniques in Percutaneous Coronary Interventions
Background: 
The MNS precisely directs a magnetised guidewire in vivo through two permanent external 
magnets.
Methods:
111 consecutive patients were enrolled. Crossing success, crossing/fluoroscopy times and con-
trast usage were directly compared. Lesions were classified according to the AHA/ACC criteria. 
Three tertiles of vessel/lesion complexity [low (<5), medium (6-10) and high (>10)] were defined 
using 3-D reconstructions and angiographic information.
results: 
The crossing success for magnetic and the conventional wires were 93.3% and 95.6% respec-
tively. Crossing and fluoroscopy times were longer with the magnetic wires (72.9 ± 50.3sec vs. 
58.1 ± 47.2sec, p<0.001 and 66.2 ± 44.1sec vs. 55.2 ± 44.4sec p=0.03 respectively). In vessels 
with low and medium complexity the magnetic wires had significantly longer times (p<0.001) 
but for those with high scores (>10) a trend towards shorter times was observed. The MNS 
resulted in a small but significant reduction in contrast usage (2.3 ± 3.5ml vs. 4.5 ± 4.4ml p 
< 0.001). Moreover by superimposing a virtual roadmap of the vessel on the live fluoroscopy 
image 48% of the lesions were crossed without requiring contrast agents with the MNS
conclusion: 
The MNS has comparable crossing success to conventional PCI. It is relatively slower but there is 
a trend to support a potential advantage in more complex vessels. By simultaneously employ-
ing a virtual roadmap there is a small but significant reduction in contrast usage.
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introduction
Magnetic navigation is an innovative technology that can accurately control the positioning 
of a guidewire or a catheter in vivo (1). To accomplish this, a small (2-3mm) magnet embed-
ded at the tip of the wire or catheter is reoriented by a predetermined and rapidly updated 
external magnetic field. The field is generated by two permanent external (0.08 Tesla) magnets 
that can rotate, tilt or translate on movable positioners (2). Within this field a magnetic vector 
is created through computer driven software to direct the tip of the device (the magnetically 
enabled wire or catheter). The advantage of in vivo control has been previously demonstrated 
in cardiac electrophysiological procedures whereby inaccessible pathways can be effectively 
targeted, even remotely (3). In percutaneous coronary intervention (PCI) the initial bend placed 
on the wire to engage the target vessel might not be ideally suited to cross the target lesion. 
As such, preliminary studies in patients with complex lesions and tortuous vessels have shown 
an advantage with magnetic assisted intervention (MAI) in cases that failed with conventional 
PCI (4). However, to date the only randomised direct comparison of the magnetic navigation 
system (MNS) to conventional approaches was performed in increasingly tortuous phantom 
models where it was suggested that the MNS might be advantageous (5). In order to further 
assess the implication of this novel technology to PCI, it is necessary to include randomised 
comparisons in native coronary lesions. Areas that warrant investigation include evaluating 
procedural success, crossing/fluoroscopy times together with contrast media usage. It is 
perceived that for some of these parameters the MNS may be advantageous as reorienting 
the wire in situ and the navigational road map created from a 3-dimensional reconstructed 
image - superimposed on real-time fluoroscopy - may indirectly influence the procedure (6). To 
assess the performance of the MNS we performed the first direct randomised comparison with 
conventional wire technique in patients presenting with stable and unstable angina.  
Material and Methods
Patient Selection and Definitions
In a 12-month period commencing September 2006, 111 consecutive patients admitted with 
stable and unstable angina were single blinded randomised to cross the culprit lesion twice, 
either using a conventional or a magnetically enabled guidewire. All patients were appropri-
ately informed about the procedure and gave their consent. Angina was defined according 
to the Canadian Cardiovascular Society and Braunwald classification respectively (7,8). 
Patients were excluded if they were haemo-dynamically unstable or had contraindications for 
magnetic-assisted intervention (MAI) such as a pacemaker. The objectives of the study were the 
direct evaluation of the crossing success, crossing/fluoroscopy times and contrast usage. This 
was assessed by measuring the time (sec) and contrast media (ml) required to cross the lesion 
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having firstly placed the guidewire at the tip of a guiding catheter engaged at the ostium and 
following the wire passage distal to the lesion. The wire was then withdrawn and the compara-
tive wire was then used to coincide with the start and end position of the first wire. Lesions not 
crossed within 6 minutes with either wire were labelled as wire failures as previously defined by 
our published phantom studies (5). Included within the 6 minutes was the time taken for wires 
to be removed from the catheter and reshaped in order to achieve a successful crossing. Wires 
that were damaged in crossing could be exchanged for a similar or different conventional or 
magnetically enabled wire if necessary. The operators (4 in total) had unrestricted access to the 
choice of either magnetic or conventional guidewires and were interventional cardiologists 
who were also trained in MAI procedures. The crossing success of each wire was defined as 
the amount/percentage of successful crossings within 6 minutes. The procedural success was 
defined as successful crossings without time restrictions using the complementary technique 
having failed with the first wire technique to cross within 6 minutes.
the Magnetic navigation system
The Niobe® II Magnetic Navigation System (MNS) (Stereotaxis, St. Louis, M. USA) integrated with 
a modified C-arm flat-panel detector-fluoroscopic imaging suite (AXIOM Artis dFC, Siemens 
Medical Solutions, Forchheim, Germany) for angiographic imaging was used throughout this 
study. The system allows two different modes for navigation by using either 2-Dimensional 
(2D) such as in the “clockface” method (Figure 1A) or 3-Dimensional (3D) maps of the coronary 
artery(1). In this study navigation was performed using a 3-dimensional reconstructed (3DRC) 
virtual vessel roadmap generated from two angiographic images 30° apart (CardiOp-B, Paieon 
Medical Inc., Rosh Ha’ayin, Israel) (Figure 1B). The 3DRC was first co-registered with the fluoro-
scopic image (Figure 1C) and a navigational pathway created through the lumen of the 3DRC 
(Figure 1D). This pathway was then displayed as a fixed centreline on the real-time fluoroscopic 
image. The operator was then able to manually advance the navigational vectors associated 
with this centreline at a predetermined distance (1-9mm) by pressing the advance/go button 
on the touch screen monitor.  In cases of complex 3DRC the navigation was performed using 
the 2-D “clock face” model. In this model navigational vectors are displayed in a circle that 
looks like the face of a 12hour clock on the touch screen monitor. By pressing points around 
the perimeter of the circle/clock, the software (Navigant®) calculates vectors to redirect the 
magnetic field and realign the wire tip to the chosen direction (Figure 1A). In both the 2D and 
3D navigational modes the operator manually advances the guidewire once the vector reaches 
the desired position. As training with the magnetic system requires both an understanding of 
the software and the hardware on average a novice needs at least 12 hours of practical training 
to be fully acquainted with all the techniques and tools. In our department, which is a leading 
center that evaluates the MNS to PCI we feel that after 35 magnetic cases the operator can be 
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called an experienced user. In addition, one trained technician is required to operate the system 
from a control viewing room in the catheterization laboratory.
The Guidewires
The conventional wires used in the study were PT Graphix™ Intermediate, Choice™ PT Floppy 
(Boston Scientific Corp. Miami Fl, USA), Whisper (Abbott Vascular Devices, Redwood CA, USA) 
and high torque BMW (Guidant Corp, Santa Clara CA, USA). The magnetic guidewires used were 
all 180cm long Titan™ Soft Support wires with a 2mm angled and 2mm or 3mm straight mag-
netic tips attached to a 0.014in/0.36mm stainless steel core (Stereotaxis, St. Louis, M. USA).
Lesions and Vessel Characterisations
Lesions were defined as type A, B1, B2, and C in accordance with the American College of Car-
diology/American Heart Association ACC/AHA classifications(9). Type A lesions were generally 
discrete (<10mm length), concentric, readily accessible non-angulated lesions with little or no 
calcification and did not involve the ostium or major side branches. Type B1-lesions were longer 
Figure 1. The clockface navigational mode showing a vector depicted by an arrow that can be repositioned by 
selecting points around the perimeter of the clock; B) a 3-dimensional reconstruction of a coronary bypass graft 
to the native left anterior decending artery and C) the registration with the fluoroscopic image; D) navigating 
at the bifurcation of the virtual reconstructed graft showing a navigational pathway through the lumen
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(10-20mm), or eccentric, or with moderate tortuosity and angulation (45-90°). These lesions 
might have moderate to heavy calcification and could involve the ostium or a bifurcation. 
Lesions classed as type B2 had more than one B1 criteria. Type C lesions were diffusely diseased 
(>2cm in length) with extreme tortuosity and angulations (>90°). When involving a complex 
bifurcation there is a potential risk of losing the side branch.
Given the limitations of the AHA/ACC classification, namely in not considering the vessel 
characteristics which may influence the ability to get a wire across our group has developed 
a simple score system for predicting prolonged crossing times to select patients who would 
benefit from MAI (10). The score takes into consideration the angulation of the proximal seg-
ment, the number of bends to reach the lesion, total vessel angulation, length, calcification, 
number of side-branches and if there is a stent proximal to the lesion. It also incorporates the 
following lesion characteristics: side-branch in the lesion or within 10mm of the lesion, lesion 
angulation and calcification, the lesion length and the length of lesion more than 80% diameter 
stenosis and also if the lesion is due to instent restenosis (Table 1)(11). The vessel angulations 
and turns defined as a change in angulation of > 45º were determined using the virtual 3DRC 
Figure 2: Relationship of A) Crossing and B) Fluoroscopy times of both the conventional and magnetic wires to 
the lesion subtypes
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images created in the CardiOp-B® and integrated in the Navigant®.  This scoring system was 
used to define three tertiles of vessels taking into account the lesion characteristics: - low (<5), 
medium (6-10) and high (>10) so that the performances of the wires in relation to the vascular 
anatomy could be evaluated.
statistical analysis
Continuous variables are presented as mean ± standard deviation. Student T-test was used 
to determine if there were significant differences between the parameters assessed using the 
two techniques. Spearman non-parametric correlation was used to define a trend between 
the crossing/fluoroscopy times, contrast media usage and lesion/vessel type. Analyses were 
performed using SPSS 11.5 for Windows (SPSS, Chicago, IL). P value < 0.05 was considered 
statistically significant. Scatter plot distribution was examined correlating complexity score 
with crossing/fluoroscopy times and contrast media usage for both the magnetic and the 
conventional wires.
results
In 93% of the cases magnetic navigation was performed with a 3-dimensional reconstructed 
(3DRC) virtual vessel roadmap superimposed on the real time fluoroscopy image. The ‘clock 
face’ technique was used for the remaining cases. In the 111 patients having 165 lesions there 
were 7 magnetic wire and 3 conventional wire failures corresponding to a crossing success 
within 6 minutes of 93.3% and 95.6% respectively. In addition, in another 4 cases (4 lesions) 
both wires failed in the same patient within 6 minutes. In 3 of these, the lesions were eventually 
crossed successfully (1 magnetically and 2 conventionally). In one case where both wires failed, 
the patient proceeded to coronary arterial bypass surgery. The overall procedural success in 
this study was 99.3% with 91.5% of the lesions crossed within 6 minutes. The direct comparison 
of successful crossing in the same vessel was performed in 151 lesions (151vessels) correspond-
ing to103 patients.
The patient characteristics are shown in Table 2. The average age of the patients was 64.4 years 
with three quarters being male. Over one fifth were diabetic, with 3.9% on insulin and almost 
two-thirds were hyperlipidaemic. Three quarters of the patients presented with stable angina. 
Nearly, one third of the patients had previous PCI with 6.8% having prior surgery. There was a 
similar distribution of single and multi-vessel disease within the total population. In 9.7% of the 
patients a creatinine >100µmol/l was observed. Lesions classified according to the AHA/ACC 
criteria were 15 Type A (10%), 30 Type B1 (20%), 95 Type B2 (63%) and 11 Type C (7%). The LAD 
was targeted in 60 patients (40%), followed by the RCA (N=29, 19%), then the diagonal (N=26, 
17%), the LCx (N=25, 16%), marginalis (N=9, 6%) and the ramus intermediate (N=2, 1%).
Ch
ap
te
r 3
98
Table 1: A scoring system based on vessel and lesion characteristics
vessel characteristics Score ( )
1st turn (Aorta-Prox vessel angulation)
Turns (number) before lesion 
5 worst angulations 
End to end length ostium-lesion/mm 
Visible calcification
Visible side branch before lesion
Stent before lesion 
(0):<90°, (1):90°-135°, (2)>135°
1 turn = 1, 2 turns = 2 etc, max (5)
(0)<45°, (1):45-90°, (2):90-135°, (3):135-180°, (4)>180°
(0)<50mm (1):50-100mm, (2):>100mm
(0):none, (1):mild, (2):severe
max (2)
(0):no, (1):yes
Lesion characteristics
Side branch within 10mm
Side branch in lesion
Lesion angulation
Lesion calcified
Lesion length/mm
Length/mm of >80% stenosis
Through a stent
Specific morphological abnormality
Eg. aneurysms, fistula etc.
(0):no, (1):yes
(0):no, (1):yes, (2):yes 
(0)<45°, (1):45-90°, (2):90-135°, (3):135-180°, (4)>180°
(0):no, (1):yes
(0):<10mm, (1):10-20mm, (2)>20mm
(0):<1mm, (1):1-3mm, (2):3-10mm, (3)>10mm
(0):no, (1):yes (1stent), (2):yes (through struts)
(0):no, (1):yes for each (max 6)
Table 2: Patient characteristics
Patient characteristics (N): Patients       %
Age/years
Sex 
Non/Unknown Smoker
Ex-smoker
Current Smoker
Diabetes
Insulin 
Hyperlipidaemia
Hypertension
Family History 
64.4              (45-90)†
(male)              74.2%            
(N=68)  66.0%
(N=28)  27.2%
(N=7)  6.8%
(N=23)  22.3%
(N=4)  3.9%
(N=65)  63.1%
(N=49)  47.6%
(N=47)  45.6%
indication
Stable Angina 
Unstable Angina
Previous PCI
CABG
diseased vessel
1 Vessel Disease
2 Vessel Disease
3 Vessel Disease 
renal dysfunction (Creatinine > 100µmol/l)
(N=78)  75.7%
(N=25)  24.3%
(N=30)  29.1% 
(N=7)  6.8%
(N=49)  47.6%
(N=43)  41.7%
(N=11)  10.7%
(N=10)  9.7%
† Range
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Crossing and Fluoroscopy Times
Overall the crossing times (sec) with the magnetically enabled wires were longer than the 
conventional standard wire approach (72.9 ± 50.3sec vs. 58.1 ± 47.2sec, p<0.001) especially in 
AHA/ACC B2 lesions (p=0.01) (Table 3).  The crossing times proportionally increased with the 
lesion complexity (Figure 2A). Simpler type A and B1 lesions were quicker to cross with either 
wire than the more complex B2 and C lesions, But sub-analyses of the crossing times revealed 
that the magnetic wires were significantly slower than the conventional wire in both groups. 
In the group consisting of type A and B1 lesions the times for magnetic wires compared to the 
conventional wires were (62.3 ± 42.8sec vs. 50.0 ± 31.9sec, p= 0.02) and in the group containing 
the lesions B2 and C the times were (77.4 ± 52.9sec vs. 61.5 ± 52.0sec, p= 0.002 respectively). 
In a comparative assessment of the fluoroscopy times, the conventional approach with the 
standard wires were overall superior to the magnetic wires although the difference was less 
(66.2 ± 44.1vs. 55.2 ± 44.4sec, p=0.03) compared to the crossing times (Table 3 and Figure 2B).
The relationship of the Crossing and Fluoroscopy Times to the Complexity score
Scatter plots and correlation of the complexity scores were performed for both the crossing 
and fluoroscopy times with the standard conventional and magnetic wires. Although there 
were no obvious correlation a lower slope and R2 was observed with the magnetic. This may 
suggests that the magnetic wire had less of an influence on both the crossing and fluoroscopy 
times in vessels/lesion having high complexity scores – (standard conventional wire’s slope 
and correlation coefficient of the crossing times/sec with complexity score was 7.5 and 0.2 
respectively; magnetic wire’s slope and correlation coefficient of the crossing times/sec with 
complexity score was 4.3 and 0.06 respectively; similarly, standard conventional wire’s slope 
and correlation coefficient of the fluoroscopy times/sec with complexity score was 7.2 and 0.21 
respectively; magnetic wire’s slope and correlation coefficient of the fluoroscopy times/sec with 
complexity score was 4.0 and 0.07 respectively). When the complexity scores were sub-grouped 
into tertiles of less than 5 and from 6 to 10 the crossing and fluoroscopy times were significantly 
prolonged (p<0.001) with the magnetic wires compared to the conventional standard wires 
(Figure 3). Interestingly, for the tertile greater than 10 both the crossing and fluoroscopy times 
with the magnetic wire were shorter than that observed with conventional wires although they 
were not significant (p values of 0.24 and 0.21 respectively).
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Crossing times and the Minimum Luminal Diameters 
Regardless of the studied vessel’s minimum luminal diameters (MLD) the magnetic wire was 
slower. In vessels with a MLD > 2mm the magnetic wire crossing times/sec compared to the 
standard conventional wires were 52.8 ± 42.9sec vs. 34.2 ± 20.2sec, p<0.03. Similarly, in ves-
sels having MLDs of 1-2mm and < 1mm the crossing times/sec were 74.1 ± 52.7sec vs. 56.9 ± 
46.1sec, p<0.004 and 75.8 ± 49.6sec vs. 63.7 ± 51.1sec, p<0.05 respective to that of the standard 
conventional wires.
Figure 3: Relationship of the Crossing and Fluoroscopy Times to the Complexity score per tertile (FT = 
fluoroscopy time; CT = crossing time)
Figure 4 Comparative contrast usage based on lesion type
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Contrast Media Usage
The Spearman non-parametric correlation test demonstrated a positive trend between con-
trast media usage and lesion complexity with the conventional wire technique (p=0.025). This 
increase in contrast media usage was eliminated when the MNS was employed (p=0.63) with 
the Spearman non-parametric correlation for trend. Type A lesions showed no significant dif-
ference in contrast usage (ml) in crossing with either the magnetic or conventional wire (1.5 ± 
1.8 vs. 1.9 ± 2.3 p = 0.59 respectively) (Figure 4). As lesion complexity increased significantly less 
contrast (ml) was needed with the MNS:- Type B1 (2.5 ± 3.2 vs. 4.0 ± 2.6 p = 0.01); Type B2 (2.3 ± 
3.8 vs. 4.9 ± 4.9 p < 0.001); Type C (2.9 ± 3.4 vs. 5.9 ± 4.9 p = 0.03).
Overall the MNS gave a small but significant reduction in contrast usage (2.3 ± 3.5 vs. 4.5 ± 
4.4 p < 0.001) relative to the conventional technique. Interestingly, no contrast was required 
when crossing in 72 lesions (48%) with the MNS and in 31 lesions (21%) with the conventional 
approach (Table 4). Moreover, regardless of the vessel crossed, the MNS required less contrast 
than the conventional wire and this was also observed with increasing complexity scores (Figure 
Table 4 The lesions crossed using zero contrast
Lesion type Number of lesions crossed without contrast
Magnetic Wire
72
Conventional Wire
31
Type A
Type B1
Type B2
Type C
8
14
47
3
7
3
19
2
Figure 5 Comparative contrast usage based on vessel type and complexity score
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4). Vessels with scores >10 complex vessels had the largest reduction 7.0mls vs. 2.6mls. Vessels 
with scores 6-10 had almost a two-fold reduction (2.7mls vs. 4.9mls) and those with scores of 
less than 5 had a limited reduction of 1.0ml. As observed with the crossing and fluoroscopy 
times a lower slope was recorded with the magnetic wire when the complexity scores were 
correlated with contrast usage Figure 6.
discussion
The application of the Magnetic Navigation System to percutaneous coronary intervention is a 
promising technology(12). There are now over 100 systems installed in catheterisation labora-
tories worldwide. The system has advantages over traditional PCI techniques with its ability to 
redirect a magnetised guidewire in-situ. This has been shown to be useful in situations where 
the ability to cross a lesion with a standard wire failed and in coronary phantom models with 
increasing tortuosity (5). Even though there is clearly an advantage in precisely controlling 
the tip of a guidewire, the interventional community has been slow to adopt MNS. There are 
several reasons why there maybe reservations: a) the presence of a rigid 2-3mm long magnet 
at the tip of the wire can compromise the performance achievable with conventional wires, b) 
many conventional wires have achieved a level of sophistication having evolved over several 
generations to enhance both their trackability and device deliverability c) the ‘ocular-hand 
coordination’ seems currently unbeatable because of the delay in responsiveness in the MNS 
hardware – the speed in moving the large external magnets to align to the desired vectors, d) 
there is a steep learning curve that must be reached by both the interventionalist and skilled 
technical staff (6,13), e) together with the additional financial costings for both the MNS and 
staff training, f ) moreover, any gain in crossing time might be compromised by the preparation 
of the MNS case although in some clinical scenarios this may prove to be beneficial long term 
eg. MSCT co-integration for CTO, g) but more importantly, there is little randomised data to 
support the use of the MNS to PCI. Some of these limitations are currently being addressed with 
Figure 6 The scatter plot relationship between contrast and all the complexity scores
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newer generations of wire design together with software updates that can offer automated 
navigational vector advancement - but many of them are yet to be resolved (14). 
In this first randomised study directly comparing the performance of the MNS to conventional 
PCI techniques we exclusively assessed one system (technique) versus the other. In some stud-
ies a ‘hybrid’ approach can be contemplated whereby the magnetic wire is used initially as a 
conventional wire technique until a problem of crossing is encountered at which point the 
external magnets are engaged and then the MNS utilised to facilitate the crossing of the wire 
through the lesion/vessel (13). This approach was discussed but not acted upon in order to keep 
the data independent and ‘clean’ for both techniques. Overall the crossing success of the mag-
netic wires was comparable to that of the standard guidewires (93.3%vs. 95.6%). Analysis of the 
four cases that failed to cross with both wires within 6 minutes was in two of the cases subtotal 
occlusions that failed with the magnetic wires and was eventually crossed with conventional 
wires. The case that failed with the conventional wire and was crossed with the magnetic wire 
was in a vessel with an acute angulation. The only case where both wires failed after numerous 
attempts the patient had an aneurysmal swelling that led into a pinpoint occlusion. 
It was not surprising that overall the crossing and fluoroscopy times were longer with the 
magnetic wire. This is partly because of limitations with the software available at the time of the 
study that required manual updates of the navigational vectors. This had to be performed by 
pressing an advancing icon on the touch screen monitor. It meant that the operator had a time 
delay prior to advancing the magnetic guidewire as the system updated. Newer versions of the 
software are being developed to address this limitation. But despite this limitation the only 
significant difference was seen in AHA/ACC B2 lesions as in these cases the operators generally 
chose smaller incremental distances for the vector to follow. Larger incremental distances were 
often used in type A and B1 lesions so the differences between the two techniques were less 
apparent. In type C lesions, the magnetic wire was not significantly slower due to observed 
limitations with conventional wire techniques in these lesion sub-types (15). In general, the 
fluoroscopy times were less than the crossing times because manipulations such as reshaping 
the conventional wire did not require fluoroscopy but was still being timed. Consequently, no 
significant differences in fluoroscopy times observed between the two systems.
The ACC/AHA criteria was however developed almost 20years ago using 11 simple angio-
graphic factors to define a lesion complexity in the comparison of the outcomes of PCI (16). It 
is based solely on the lesion and does not take into account the complexity of the vessel as a 
whole, which can sometimes influence the procedural outcome. In an attempt to circumvent 
this several other grading systems exist but they are generally based on simple angiographic 
features and hence fail to take into account the 3-dimensional (3-D) nature of the coronary tree 
(17,18). Moreover, visual estimates from angiographic images are known to have poor inter-
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observer reproducibility (19). By employing dedicated 3-D software more detailed information 
can be used to define a complexity scoring systems based on both the vessel and lesion char-
acteristics(11). Using this approach and dividing the scores in tertiles of low (5 or less), medium 
(between 6 and 10) and high complexity (greater than 10) a positive trend for the magnetic 
wire was observed for crossing and fluoroscopy times in the high complexity group. Both the 
magnetic wire crossing and fluoroscopy times significantly increased over the conventional 
methods used in vessels with low and medium complexity scores. But with high complex 
scores lower times were recorded with the magnetic wire (78.0 vs.93.7sec and 74.2 vs. 90.5sec 
respectively). This trend does however support anecdotal clinical reports that in selected cases 
with increased complexity the MNS can be advantageous (20,21). Attempts however to further 
subcategorise the population with the high complexity scores were unsuccessful because of 
the size of the study.
To assess measurable differences between the two techniques we quantitatively recorded the 
amount of contrast media used to cross the lesion. We appreciated the fact that this volume is 
relatively small in comparison to the total amounts traditionally used in an entire procedure. 
Nevertheless when assessed as a measurable difference between the two techniques the 
MNS did reduce the amount of contrast used to cross a lesion primarily because it integrates a 
3-dimensional roadmap to provide a visual clue to the position of the wire on the fluoroscopic 
image. As a result the significant difference between contrast and lesion complexity observed 
with the conventional wire was effectively eliminated with the MNS. In vessels with complexity 
scores > 10, there was almost a three fold reduction in amount of contrast used. Moreover 
48% of the lesions were crossed without the need of contrast as a direct effect of following a 
superimposed road map on the live fluoroscopy image. This is an important finding in support 
of developing technologies aimed at reducing contrast usage that can ultimately affect clinical 
consequence such as contrast-induced nephropathy (CIN). Already the use of an overlay created 
from an MSCT co-integration with the MNS can aid the visualisation of CTOs, which may limit 
the need for retrograde contrast media injection (14). Contrast usage have also been reduced 
by using 3D reconstruction (3DRC) software to correctly define the optimum angiographic 
projections needed for stent deployment (22,23). In addition some technologies can accurately 
localise a wire/device – global positioning - within the coronary artery (24). If these technologies 
were amalgamated with more sophisticated magnetic wires such as Stereotaxis’s multi-magnet 
design having 3 smaller 1mm interspaced magnets at the tip and furthermore is integrated 
with a system for automatic wire advancement then an entirely new approach to conventional 
PCI and contrast usage would be effectively realised (1,25). But for every emerging technology 
there is a limited period for it to be adopted so it is important that the current limitations and 
reservations be addressed if the MNS is to succeed in the competitive area of PCI.
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Limitations
The 3DRC used in this study was time-consuming and took up to 30 minutes to complete. The 
production of the reconstruction required angiography of a suitable standard and this was not 
always possible from standard views due to foreshortening or overlapping. A static road map 
created from the 3DRC image was superimposed on a dynamic real-time image for magnetic 
navigation. Only patent vessels were included, as the re-crossing of totally occluded vessels 
by the comparative wire was avoided because of inherent clinical risk. There were a number of 
operators and types of wires and this, together with no selection of the target vessel segment, 
may have led to heterogeneity. The lesion score was also not externally validated. In addition, 
this study examines only one specific aspect of the PCI related to crossing of lesions and does 
not address other necessary elements such as the passage and deployment of the balloon and 
stent. Lastly, this study was performed at a University specialist tertiary referral unit and the 
case mix might be different to that seen elsewhere.
conclusions
The Magnetic Navigation System has a comparably crossing success to conventional PCI 
techniques in crossing lesions as defined by the ACC/AHA criteria. The longer crossing and 
fluoroscopy times reflect limitations in manually updating the navigational vectors on the 
roadmap displayed on the live fluoroscopic image. In defining the vessel complexity taking into 
account the full 3 dimensional characteristics a positive trend was found in support of using 
MNS in more complex vascular lesions/anatomies.  Moreover the incorporation of the 3DRC 
navigational pathway with the MNS offered a small but significant reduction in the amount 
of contrast needed to cross a target lesion when compared to a conventional wire approach. 
Nearly half of the cases required no contrast agent to guide the magnetic wire transit within 
the vessel.
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Chapter 4
Magnetic navigation in the treatMent 
oF BiFurcating Lesions
Magnetic navigation system used successfully 
to cross a crushed stent in a bifurcation 
that failed with conventional wires
Catheter Cardiovasc Interv 2007 May 1; 69(6):852-5.
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abstract
Bifurcation lesions can be technically demanding to manage, and even in the era of drug eluting 
stents, their procedural success is variable. The use of the crush technique followed by “kissing” 
balloon postdilatation has been shown to improve the overall outcome. However, crossing 
the crushed stent is essential to allow performance of a final dilatation with “kissing” balloons 
and is regarded as the main Achilles’ heel of this technique. In this report, we describe the first 
reported, planned procedure to use a magnetic navigation system to steer a wire through the 
crushed stent to use “kissing” balloons that had previously failed with conventional wires. 
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introduction
Coronary bifurcation lesions are a challenging and frequent problem encountered in patients 
undergoing percutaneous coronary interventions [[1]]. Their overall long-term success rate is 
variable but has improved since the introduction of drug eluting stents (DES). A number of 
stenting techniques are employed in the management of these lesions and they include T-, V-, 
Y-stenting, the “culotte” and the “crush” technique [[2]]. The latter is a technique that ensures 
complete coverage of the side branch ostium so as to ensure drug delivery to minimize rest-
enosis at this site [[3]]. This involves wiring both the main vessel and side branch. The proximal 
part of the stent that is deployed in the side branch protrudes into the main vessel and is 
crushed with another stent that is deployed in the main vessel [[4]]. Crucial to the success of 
this technique is the use of “kissing” balloons to ensure complete apposition of both DES to the 
vessel wall [[5]]. To do this a wire must cross the crushed stent overlying the ostium of the side 
branch [[6]]. In certain cases this can be difficult and may result in a prolonged procedure with 
possible complications such as contrast nephropathy and increased radiation exposure. The 
magnetic navigation system (MNS) can be utilized to steer a wire through the stents’ struts to 
address this limitation of the “crush” technique [[7]]. The MNS has previously been successfully 
used in chronic total occlusions and in vessels with tortuous anatomy but has not so far been 
reported as an aid to bifurcation stenting [[8-10]].
We report a planned procedure to use magnetic navigation with an appropriate wire to cross 
a crushed stent where previous attempts with conventional wires had failed in the emergency 
setting. This was followed by “kissing” balloon dilatation and led to procedural success in a 
patient with a bifurcation lesion.
the Magnetic navigation system
The MNS has been shown to be effective in neurosurgical and cardiac electrophysiological pro
cedures [[11][12]]. In percutaneous coronary intervention it is a platform that offers a powerful 
tool to aid navigation of a guidewire through complex coronary anatomy [[13]]. The Stereotaxis 
Niobe® MNS has two permanent magnets that can be moved (rotated, translated, or tilted) to 
produce a uniform magnetic field of 0.08 Tesla within the patient’s chest. This field is used to 
precisely direct a tiny magnet mounted on the tip of a guidewire by changing its magnetic 
moment. This allows fine control of the orientation of the tip of the guidewire in space. The 
TitanTM Soft Support coronary guidewire used in this case is a 180-cm moderate support, 
hydrophilic coated wire with a diameter of 0.014 in./0.36 mm and has a flexible 2 cm distal 
coiled tip at the end of which is a gold cup attached to a neodynium 2- or 3-mm magnet.
A three-dimensional virtual vessel roadmap is created from the angiographic images using 
reconstruction software (CardiOp-B, Paieon Medical, Rosh Ha’ayin, Israel). The system computes 
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a navigation plan from the reconstructed virtual path that supplies all the vectors required to 
navigate through the coronary artery. By touching a point of interest on this virtual map that 
is displayed on a touch screen monitor, the Navigant software calculates the best vector and 
directs the magnetic field to align the wire tip with that direction. This can be performed at 
anytime during the procedure, in vivo, and without the need for a preshaped wire tip angle.
case report
The patient was a 58-year-old man who presented with an anterior ST elevation MI. His risk 
factors included being a noninsulin-dependent diabetic and being on treatment for hyperten-
sion. 
The Primary PCI
Angiography revealed an occluded LAD that, once open, showed a bifurcation lesion at LAD/
D1. This was managed by placing PT Graphix wires into each vessel. A Taxus Liberte 3.0 × 16 mm 
stent in the LAD was used to crush the proximal end of a Taxus Liberte 2.5 × 12 mm stent in the 
diagonal. Both stents were deployed without predilatation of the lesion at 16 atmospheres. To 
perform the “kissing” balloon technique it was necessary to cross the crushed stents’ struts to 
gain entry into the diagonal. This was unsuccessful despite the various techniques employed, 
Figure 1. (A) The results of crushing the proximal end of the stent in D1 with a stent in the LAD and a dissection 
of D1 (arrowed) created iatrogenically by inflating a balloon between the D1 stent and the vessel wall. (B) An 
IVUS image of the deployed crushed stent showing the dissection (arrowed)
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such as an over the wire balloon (OTW), to support the wire or by changing the angle of the 
wire tip manually.
When a stiffer wire (PT Graphix Super Support) was used, it did not enter the true lumen but 
went subintimally. This was apparent after dilatation with a Maverick 1.5 × 15 mm OTW balloon 
as it resulted in a dissection at the proximal end of the deployed stent in the diagonal (Fig. 1A 
and B). Consequently, it was even more imperative to use “kissing” balloons in this case to fully 
appose the diagonal stent against the dissected vessel so as to improve the overall outcome. 
Attempts were made to finish the procedure and, having tried to cross the stent struts for almost 
an hour, and in the presence of TIMI 3 flow down both the LAD and D1, the operator elected to 
leave the sheath in situ and use magnetic navigation in the morning. 
The Magnetic Navigation Assisted PCI
The left coronary artery was cannulated with a Mach 1 CLS 3.5 6F guide catheter. The first 
attempt was with another PT Graphix intermediate wire but this again preferentially chose to 
follow the tract of dissection, outside the stent before re-entering the true lumen. Therefore, a 
three-dimensional virtual vessel roadmap was created from the angiographic images by using 
reconstruction software (Fig. 2A). A vector was then created that navigated a TitanTM Soft Sup-
port angled magnetic tip wire between the crushed stents’ struts and avoid the false lumen (Fig. 
2C). Subsequent use of “kissing” balloons, Maverick 2.5 × 15 mm in the diagonal and Maverick 
3.0 × 15 mm in the LAD at 16 atmospheres (Fig. 3A), resulted in full apposition of the diagonal 
stent (Fig. 3B). The patient tolerated the procedure well and his cardiovascular status was stable 
as monitored via an arterial line.
Figure 2. The 3D reconstruction (A) and the endoluminal view of the LAD/diagonal bifurcation (B). The 
magnetically guided TitanTM Soft Support wire (arrowed) successfully crosses the stent strut into the true 
lumen and the Graphix Intermediate wire preferentially chose the false lumen of the dissection (C).
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discussion
Magnetic navigation is a novel technique that was successfully used to cross a crushed stent 
where traditional methods had failed. The tip of the steerable wire employed can rotate in 
three-dimensions depending on the programmable vector created by the magnetic field. This 
has the advantage that it can be performed within the coronary artery itself and is aided by a 
digitally reconstructed image of the coronary vessel. This technique was crucial to the success 
of this case as it was necessary to fully appose the crushed stent against the dissection using 
the “kissing” balloons technique.
conclusions
This is the first report of the use of the MNS to successfully cross a crushed stent in the 
management of a bifurcation lesion. The advantage of this technology is that it produces a 
three-dimensional digitally constructed visual map and can precisely direct a guide wire along 
a chosen path. This can potentially reduce the time of the procedure, the amount of contrast 
needed, and radiation exposure.
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Figure 3. (A) The postdilatation with “kissing” balloons using a Maverick 2.5 × 15 mm in the diagonal and a 
Maverick 3.0 × 15 mm in the LAD at 16 atmospheres. (B) The final angiographic result of the crush.
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abstract
objectives:
A randomised comparison of the Magnetic Navigation System (MNS) to standard guidewire 
techniques in the treatment of bifurcations
Background:
Optimal treatment of bifurcations requires kissing balloon post-dilatation. By precisely direct-
ing a magnetised guidewire in vivo the MNS may facilitate the recrossing of stents struts.
Methods:
31 consecutive patients with bifurcating lesions were randomised to cross the bifurcating ves-
sels prior to treatment and subsequently the struts of deployed stents with either magnetic or 
standard guidewires. All bifurcations were categorised according to the Medina classification. 
Crossing success, crossing/fluoroscopy times and contrast usage were directly compared. 
results:
The majority of bifurcations were in LAD/diagonal (80.6%). The side branch was involved in 
87% and was treated with the crush (54.8%), provisional (22.6%) or culotte technique (22.6%). 
The magnet wires had a greater crossing success (96.8% vs. 90.0%) and salvaged two cases as a 
direct result of false lumen formation with standard wires. Crossing times were longer with the 
magnetic wires in crossing untreated vessels (75.2 ± 53.4sec vs. 62.1 ± 56.1sec, p=0.03) and those 
covered with a single layer of struts (78.6 ± 63.6sec vs. 64.1 ± 45.8sec p=0.03) but was shorter in 
crossing double layers as in the ‘crush’ technique (132.9 ± 106.4sec vs. 137.1 ± 135.5sec p=0.45). 
There was no significant difference between the wires in reducing fluoroscopy time. A small but 
a significant reduction in contrast usage was noted with the magnetic wires.
conclusion: 
In routine bifurcation the MNS had greater crossing success despite being slower and was use-
ful in managing failed standard wire cases.
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introduction
Treatment of coronary bifurcation lesions represents a challenging area in interventional cardi-
ology1. They have lower procedural success rate, higher procedural costs and longer hospital-
ization with higher clinical and angiographic restenosis rates compared to their non-bifurcating 
counterparts. The introduction of drug eluting stents has radically changed the management of 
these lesions by limiting the restenotic rates of complex stenting at the bifurcation carina2. But 
to ensure adequate apposition of the stent to the wall or to improve the blood flow in the side 
branch kissing balloon post-dilatation of the stent(s) is desirable3. This means that if the “crush” 
bifurcation technique is employed 2 layers of the stent must be crossed in order to gain access 
to the side branch whilst in others (T-stent, provisional or culotte) recrossing a single layer is 
required. Gaining access to the side branch can be the Achilles heel of the entire procedure and 
has resulted in the development of dedicated stents designed to protect abrupt side branch 
closure4. We first reported that the magnetic navigation system (MNS) could be used to steer a 
wire through the layers of crushed stent into a side branch that had previously failed to access 
with standard wires5. This was possible because of the system’s ability to precisely control the 
wire tip externally so as to avoid the wire entering a false lumen in a dissected vessel. It was 
therefore speculated that the MNS may be advantageous in the recrossing of stents struts by 
negotiating through the overlapping layer(s) or vessel dissections that may result through 
standard guidewire manipulations. To evaluate this hypothesis we performed a randomised 
comparative assessment of the MNS to conventional percutaneous intervention (PCI) with 
standard wires in the management of routine bifurcating lesions. 
Material and Methods
Patient selection and definitions
In a 12 months period 31 consecutive patients diagnosed with having coronary disease involv-
ing a bifurcating vessel were managed with the Stereotaxis MNS (Stereotaxis, St. Louis, M. USA). 
They presented with either stable or unstable angina defined according to the Canadian Car-
diovascular Society and Braunwald classification respectively. The bifurcations were classified 
according to the Medina classification6. All patients were single blinded- randomised to cross 
both limbs of the bifurcation twice, either using a standard/conventional or a magnetically 
enabled guidewire. Firstly, following a treatment strategy for the bifurcation determined by 
the operator the layer of stent(s) covering the ostium of a vessel had to be recrossed so that 
kissing balloon dilatation could be performed. The crossing of the overlaying stent struts were 
randomised to be crossed twice either using a standard/conventional or a magnetically enabled 
guidewire first. The crossing success, crossing/fluoroscopy times and contrast usage for both 
techniques was determined and compared. The times (sec) and contrast media (ml) required to 
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cross was measured from the transit of the guidewire at the tip of a guiding catheter engaged 
at the ostium to a pre-defined point in a distal vessel. Inability to cross within 6 minutes with 
either wire was defined as a failure in accordance to previously published phantom studies7. 
Included within the 6 minutes was the time taken for wires to be removed from the catheter 
and reshaped in order to achieve a successful crossing. Wires that were damaged in crossing 
could be exchanged for a similar or different standard/conventional or magnetically enabled 
wire if necessary. The operators had unrestricted access to the choice of either magnetic or 
conventional guidewires and were all interventional cardiologists who were also trained with 
the MNS. The study was locally approved; all patients were appropriately informed about the 
procedure and gave their written consent. Patients were excluded if they were haemodynami-
cally unstable or had contraindications for magnetic-assisted intervention (MAI) such as having 
a pacemaker.
the Magnetic navigation system
The Niobe® II Magnetic Navigation System (MNS) (Stereotaxis, St. Louis, M. USA) is an innovative 
technology that can accurately steer a guidewire or a catheter in vivo 8. To accomplish this, a 
small (2-3mm long) magnet embedded at the tip of the guidewire or catheter is reoriented by 
a predetermined and rapidly updated external magnetic field. The field (0.08Tesla) is generated 
and focused by tilting and rotating two permanent magnets and is directed by means of navi-
gational vector created through computer driven software (Navigant®) (Figure 1). To do this the 
Navigant® can directly incorporate 2-dimensional angiographic films to create a navigational 
pathway. But a more accurate roadmap depicted as a centreline through a virtual vessel can 
be created by employing dedicated 3-Dimensional Reconstruction (3-DRC) software (Figure 
2A). This can allow precise wire steering through a virtually created lumen (Figure 2B) once 
co-registered with the fluoroscopic image (Figure 2C). As a visual aid the vectors together with 
a virtual navigational centerline is displayed on the live fluoroscopic image on the radiographic 
X-ray monitor (Figure 2D).. The vectors along the centreline can be automatically updated or 
manually controlled by a touch sensitive monitor situated at arm’s length from the operating 
table. 
In this study the navigation was performed using a 3DRC virtual vessel roadmap generated 
from two angiographic images 30° apart (CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel) 
and displayed as a fixed centreline on the real-time fluoroscopic image. The operator had the 
choice to manually advance or to use the automatic updates of the navigational vectors when 
deemed advantageous to facilitate the crossings. 
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the guidewires
The standard/conventional wires used in the study were PT Graphix™ Intermediate, Choice™ 
PT Floppy (Boston Scientific Corp. Miami Fl, USA), Whisper, Pilot 50 and high torque BMW 
(Abbott Vascular Devices, Redwood CA, USA). The magnetic guidewires used were all 180cm 
long Titan™ Soft Support wires with a 2mm angled or 3mm straight magnetic tips attached to 
a 0.014in/0.36mm stainless steel core (Stereotaxis, St. Louis, M. USA
Bifurcation classification and treatment strategies
In the Medina classification diseased vessels that comprise the bifurcation are given the numeri-
cally identified as 1 and those free of disease 06. The nomenclature is designated further by 
labelling the proximal main vessel followed by the distal main vessel and then the side branch. 
The treatment strategies employed were based on established techniques- the crush, T-stent, 
culotte, provisional and the Tryton™ Side Branch Stent4. The crush, T-stent, culotte and the Try-
ton™ uses two stents to refashion the bifurcation9. In the crush technique the side branch stent 
in allowed to protrude into the main vessel and In the crush technique the side branch stent is 
allowed to protrude into the main vessel and is crushed against the vessel wall with the main 
Figure 1. A) A virtually reconstructed bifurcation using the Paeion software displaying a directional vector 
created in the Navigant; B) The endoluminal view of the virtual carina at the bifurcation showing the 
navigational path in one of the branches; C) Co-registration of the virtual vessel to the angiographic image; D) 
The navigational vectors and centrelines displayed on the live fluoroscopic image.
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vessel stent. This results in two layers of struts covering the side branch ostium. The provisional 
technique is a single stent approach and as with the T-stent, culotte and the Tryton™ only one 
layer of stent’s struts is required to be crossed for kissing balloon optimisation.
statistical analysis
Continuous variables are presented as mean ± standard deviation. Student T-test was used to 
determine if there were significant differences between the parameters assessed using the two 
techniques. Non-continuous variables are presented as median, 25-75% interquartile ranges 
(IQR). Analyses were performed using SPSS 11.5 for Windows (SPSS, Chicago, IL). P value < 0.05 
was considered statistically significant. 
results
Of the 31 patients the percentage of stable and unstable angina was 81% and 19% respectively. 
The majority were males (68%) and 23% had a previous PCI procedure. The highest risk factor 
was smoking (ex or current) 45% and one fifth were diabetic. Over a third was on medication 
to control either hypertension or cholesterol. Bifurcating lesions were found to involve the 
left anterior decending (LAD)/diagonal (D) branches in 25 cases (81%), the left circumflexus 
(LCX)/obtuse marginal (OM) arteries in 5 cases (16%) and the right coronary (RCA) /posterior 
decending artery (PDA) in one case (3%). Based on the Medina classification the bifurcation 
were characterised as 13 cases of (1,1,1), 8 cases of (0,1,1), 6 cases of (1,1,0) and 4 cases of (1,0,1). 
This translated into disease involving 74% (23 cases) of the proximal main vessel, 87% (27 cases) 
the distal main vessel and 81% (25 cases) the side branch. Drug eluting stents (DES) were used 
in all the treatment strategies that comprised of 17 cases (54.8%) the crush, 2 cases (6.5%) each 
for the culotte and T-stent technique together with 5 cases (16.1%) each for the provisional and 
Tryton™ stenting approach. The majority of stents used in the crush technique were Taxus™ 
(41%) and Xience™ V (47%). Only Taxus™ was used for culotte and the T-stenting methods. In 
addition to these stents Cypher™ and Biometrix™ stents were used for the provisional approach 
and in combination with the Tryton™ Side Branch stent.
Analysis of the crossing profiles revealed that in all cases both wire successfully crossed both 
branches of the (non stented) bifurcation within 6 minutes. However the magnetic wire was 
significantly slower in crossing compared to the standard/conventional wires (Table 1). The 
comparative crossing and fluoroscopic times of the magnetic wires to that of the standard/
conventional wires were 75.2 ± 53.4sec vs. 62.1 ± 56.1sec (p=0.03) and 68.9 ± 48.1sec vs. 57.5 
± 48.0sec (p=0.04) respectively. Contrast media usage in crossing both limbs of the bifurcation 
was significantly better with the magnetic wires [median, 25-75% IQR, 2ml, 0 - 5mls vs. 4.5ml, 
0 -7mls (p<0.001)] respectively (Table 2). In the recrossing of the stents overlying the carina 
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the magnetic wires were more successful achieving 96.8% vs. 90% success over the standard/
conventional wires. Failure to recross within the 6 minutes was observed in only 4 cases (1 mag-
netic and 3 standard/conventional) but interestingly they all occurred only in cases involving 
the crush stent technique and all employed Taxus™ stents in reconstructing the carina. In the 
single magnetic wire failure the bifurcation in the LCX/OM had a Medina classification of 1,1,1 
and was treated with a Taxus™ 3.0x12mm in the main branch and a Taxus™ 2.75x28mm in the 
side branch. The 3mm long magnetic tip wire took over 6minutes to recross as the tip caught 
between in the struts resulted in the wire ‘buckling’ and unable to penetrate the two layers of 
struts. Recrossing was eventually successful by using the software to increase the gain of the 
angle at the wires’ tip so that it was able to negotiate through an alternative set of overlying 
stent cells. A similar situation was encountered with one of the failed standard/conventional 
wire cases. Here the bifurcation involved the LAD/D and was also classified as Medina 1,1,1. Two 
Taxus™ stents (3.0x24mm and 2.25x12mm) were employed in the crush. The Pilot 50 guidewire 
(Abbott Vascular Devices) used in crossing was caught between the struts and could not be 
Table 1 Comparative assessment of crossing/fluoroscopy times with the magnetic and standard/conventional 
wires in different bifurcation stenting strategies
crossing time/sec
Mean  ±  sd
Fluoroscopy time/sec
Mean  ±  sd 
Magnet wire standard wire Magnet wire standard wire
Native untreated 
bifurcation
N = 31
75.2 ± 53.4 62.1 ± 56.1 68.9 ± 48.1 57.5 ± 48.0
p = 0.03 p = 0.04
Culotte and Tryton  
N= 7
(22.6%)
57.0 ± 38.3 57.0 ± 36.6 52.3 ± 36.9 51.4 ± 38.5
p = 0.5 p = 0.44
T-stent and 
Provisional N= 7
(22.6%)
100.1 ± 78.8 71.1 ± 55.6 95.6 ± 73.3 67.9 ± 51.6
p = 0.02 p = 0.02
Crush/three layers of 
struts N= 17
(54.8%)
132.9 ± 106.4 137.1 ± 135.5 121.9 ± 95.0 130.3 ± 127.1
p = 0.45 p = 0.38
One layer of
struts
N = 14
78.6 ± 63.6 64.1 ± 45.8 73.9 ± 60.1 59.6 ± 44.6
p = 0.03 p = 0.45
Overall treated
bifurcation
N= 31
108.4 ± 92.5 104.1 ± 109.9 100.2 ± 83.5 98.4 ± 103.7
p = 0.4 p = 0.45
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advance distally. When the damaged wire was exchanged for another guidewire with a different 
angulated bend created manually at the tip so that an alternative cell could be engaged then 
the crossing and subsequent kissing balloon dilatation was successful. In the other two failed 
standard/conventional wire cases kissing balloon dilatations were only salvageable because of 
the magnetic wire. Both cases involved the LAD/D with diseased side branches, Medina 1,0,1 
and 0,1,1 respectively. Stents used were Taxus™ (3.5x24mm and 2.25x16mm) and Taxus™ stents 
(3.0x16mm and 2.5x12mm) respectively. In both cases a false lumen was created by the wire 
dissecting between the layers of the vessel and the underlying stent and thus prevented the 
standard/conventional wires from entering the true ostium (Figure 3). Only by using the mag-
netic wires to circumnavigate away from the dissected false lumen was the wire successfully 
tracked within the true lumen. 
Comparative assessment of the times taken in recrossing the stent overlying the carina revealed 
that overall the magnetic wires were slower than the standard/conventional wires. The differ-
ences was however non-significant with averages of 108.4 ± 92.5sec vs. 104.1 ± 109.9sec p= 
0.4 for the crossing times and 100.2 ± 83.5sec vs. 98.4 ± 103sec p=0.45 for the fluoroscopy 
times (Table 1). Grouped together by virtue of being technically similar the culotte and the 
Tryton™ Side Branch stent together had nearly identical times with either wire. This was unlike 
the group comprising of provisional and T-stent techniques where shorter times were observed 
with the standard/conventional wires (Table 1). When further categorised into the recrossing 
of single versus double layers of struts a significant difference in times was only observed with 
the crossing of the former. Both the crossing and fluoroscopy times were longer in recrossing 
a single layer of struts with the magnetic wire when compared to the standard/conventional 
wire (78.6 ± 63.6sec vs. 64.1 ± 45.8sec p=0.03 and 73.9 ± 60.1sec vs. 59.6 ± 44.6sec p=0.02 
respectively) (Table 1). In recrossing two layers of stent struts (crush technique) there was no 
significant difference (132.9 ± 106.4sec vs. 137.1 ± 135.5sec p=0.45 and 121.9 ± 95.0sec vs. 
Table 2 The assessment of contrast used in crossing the native vessels, all stents overlying the carina and one 
versus three layers of struts. Values are given as median, 25-75% interquartile range (IQR
Native untreated 
bifurcation
N = 31
Overall treated
bifurcation
N= 31
One layer of
struts
N = 14
Crush/three layers of 
struts N= 17
(54.8%)
median, 25-75% IQR median, 25-75% IQR median, 25-75% IQR median, 25-75% IQR
Contrast/ml used 
with magnet wire
2ml, 0 – 5ml 0ml, 0 – 5ml 0ml, 0 – 3ml 2ml, 0 – 5ml
Contrast/ml used 
with standard 
wire
4.5ml, 0 -7ml 5ml, 0 – 9ml 4.5ml, 0 - 6.8ml 5ml, 0 – 15ml
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130.3 ± 127.1sec p=0.38 respectively) although the magnetic wire was slightly faster. Contrast 
media usage was significantly reduced with the magnetic wire regardless of the layers of stent 
crossed (Table 2).
 
discussion 
The Magnetic Navigation System offers an innovative way of steering a device/guidewire which 
has already been adopted in cardiac electrophysiological procedures whereby inaccessible 
pathways can be effectively targeted, even remotely10. In percutaneous coronary interventions 
such ability to precisely redirect a guidewire within the coronary tree can potentially have a 
major advancement over traditional techniques11. This is because in the initial bend placed 
on the wire to engage the target vessel might not be ideally suited to cross the target lesion. 
Indeed early studies demonstrated that patients having complex lesions and tortuous vessels 
the MNS was successful in crossing lesions that had failed conventionally 12,13. However, to date 
the only published randomised direct comparison of the MNS to conventional approaches was 
performed in increasingly tortuous phantom models where it was suggested that the MNS 
might be advantageous 7. In addition, technical limitations with the current system curtail its 
potential advantage over conventional wires approaches in all rather than selective PCI proce-
dure 8. One major limitation is the rigid 2-3mm magnetic tip wires, which restrict the degree 
of flexibility when compared with the smoother transition of the tip with the shaft, found in 
the more sophisticated standard conventional wires. Moreover the ‘ocular-hand coordination’ 
of the ‘seasoned’ conventional PCI operator seems currently unbeatable since time is loss in 
Figure 2: The two cases (A and B) where the MNS successfully entered the true lumen of dissections created 
conventional/standard wires in crossing stents used in the crush technique.
Noninvasive cardiac computed tomography: an interventional cardiologist’s perspective
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moving the large external magnets to realign with the desired vectors 14. It is also an expensive 
technology that has a learning curve for both the operator and the technical staff.  
The complexity of bifurcating lesions means that there remain technical issues on the best treat-
ment approach to achieve optimal procedural outcomes and, more importantly, long-term suc-
cess with low restenosis rates and MACE rates15. The adoption of a simple strategy of stenting 
only the main vessel with provisional stenting of the side branch or a more complex strategy of 
stenting both vessels are still fiercely debated16. The “crush” technique was developed to improve 
ostial side branch coverage without compromising access to the side branch3. However several 
investigators have shown higher overall restenosis rate (main and side branch) although this 
can be dramatically reduced from 37.9% to 11.1% in the side branch with a final kissing balloon 
dilatation17. But even with a final kiss, the crushed portion of the stent is often not fully apposed 
thus increasing the risk of stent thromboses. In addition, the minimum residual stenosis within 
in the main branch is nearly always at the site of the crush18. It is therefore not surprising that 
several studies have failed to demonstrate an advantage of more complex double-vessel two-
stenting strategies over a simple one stent or provisional stenting strategy. Further progress 
in this lesion subset will depend on developing effective bifurcation-specific stent platforms. 
Currently in development or in trials are side branch access systems, which allow continued 
access with modest ostial branch scaffolding, devices that allow for continued access and 1–2 
mm of side branch scaffolding at the ostium and self-expanding modular systems19. But until 
these dedicated bifurcating stents have shown a definitive advantage recrossing the struts to 
perform final kissing balloon especially in the crush technique is essential to limit restenosis 
and stent thrombosis. Moreover even with a simple single stent strategy almost one third of all 
angiographically significant side branch lesions are hemodynamically significant by fractional 
flow reserve analysis and importantly flow can be improved following provisionally opening 
the overlying strut at the ostium20.
In this randomised study directly comparing the performance of magnetic and standard con-
ventional wires in routine bifurcation lesion treatment the MNS had a greater overall procedural 
success. More importantly it permitted the safe crossing into the side branch by avoiding enter-
ing the false lumen of dissected vessels in selected failed standard wire. But to rationale the use 
of the MNS to treat all bifurcations based on these limited success cannot be currently justified 
when the whole PCI procedure is taken into account. In the crossing of the branches of the pre-
treated bifurcating vessel the magnetic wires were significantly slower than the conventional 
wires. This is partly because of limitations with the software available at the time of the study 
that required manual updates of the navigational vectors on the touch screen monitor. It meant 
therefore that the operator had a time delay prior to advancing the magnetic guidewire as the 
system updated. Despite the slowness of vector updates the software had a direct effect on the 
contrast through the displayed navigational centerline on the live fluoroscopic image (Figure 
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2). Following the various stenting strategies there was no significant difference in the overall 
crossing and fluoroscopic times with either wire. Understandably for the same reasons as in the 
untreated vessels the magnetic wire was also significantly slower in crossing a single layer of 
stents. With no recrossing failures and only minor benefits with contrast media reduction the 
magnetic wires offer no additional advantage over the conventional wires in this subgroup. A 
better performance was observed with the magnetic wires compared to the standard wire in 
recrossing the two layers of stents in the crush technique although it did not achieve statistical 
significance. The failure of the magnetic wire could have been due to the lack of pushability 
to force a trapped magnetic tip between the overlapping cells. But the fact that the wire was 
retracted and the tip direction changed within the proximity of the carina to allow the wire to 
engage an alternative set of cells led to a safe recrossing without causing vessel trauma. This 
was the reason why the standard wire failed in two cases involving crushed stents as the opera-
tor unknowingly forced the wire between the struts and the vascular wall to form a false lumen. 
With a better-designed magnetic wire having a more gentle transition of the magnetic tip with 
the shaft such as the proposed multi-magnet where smaller magnets are beaded together in 
manufacturing the tip the current problems encountered in crossing the stents struts might be 
reduced. Moreover it may allow better targeting of selective stents cells such as those closest to 
the carina due to smaller curves to optimize some bifurcation stenting techniques21.  
Limitations
The study was limited by the small number of patients with bifurcating lesions admitted into 
the magnetic room over the study period. The 3D-reconstruction required angiography of a 
suitable standard and this was not always possible from standard views due to foreshortening 
or overlapping. The 3DRC used in this study was time-consuming taking upto 30 minutes to 
complete. The static road map created from the 3DRC image was superimposed on a dynamic 
real-time image for magnetic navigation and this meant that only in one phase the wire tip 
was perfectly aligned. There were a number of operators and types of wires and this, together 
with no selection of the target vessel segment, may have led to heterogeneity. This study was 
performed at a University specialist tertiary referral unit and the case mix might be different to 
that seen elsewhere.
conclusions
In this randomised study the Magnetic Navigation System had greater crossing success to 
conventional PCI techniques in managing bifurcations. It is relatively slower in crossing a single 
layer of stent struts and there is no real difference in the crossing or fluoroscopy times in cross-
ing two layers of stents. But importantly, in selected failed standard wire cases of the crush 
technique the system can permit safe crossings to complete final kissing balloon dilatation. 
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Furthermore, by employing a navigational road map superimposed on the live fluoroscopic 
image the system offers a small but significant reduction in the amount of contrast media 
usage.
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introduction
The in-vivo assessment of the coronary arteries was feasible by the end of the 1950s and 
quickly revolutionized the practice of cardiology.1 Forty years later a noninvasive alternative 
in the form of computed tomography coronary angiography (CTCA) became available.2,3 
The high diagnostic accuracy of CTCA for the detection and exclusion of significant (> 50% 
stenosis) coronary artery disease has repeatedly been demonstrated. Important upgrades in 
scanning technology have resulted in the current generation of 64-slice CT scanners ability 
to accurately assess clinically relevant segments of the coronary tree (vessels with a diameter 
of 1.5 mm or greater) within 10 seconds, a time comfortable to most patients. Even though 
there are limitations and it does not provide yet the same spatial and temporal resolution as 
its invasive counterpart. Also the 3-dimensional nature offers a hitherto underappreciated and 
added value in determining both the lesion and vessel characteristics that is vastly superior to 
conventional 2-D angiography. 
 
 In many countries, a patient that qualifies for coronary revascularisation usually undergoes a 
2-step imaging procedure, consisting of diagnosis and therapy. In the initial diagnostic phase an 
accurate assessment of all segments of the coronary arterial tree is performed.  The patient that 
harbors significant coronary artery disease that is deemed appropriate for revascularisation, 
ideally undergoes an ad hoc percutaneous coronary intervention (PCI), but more often due 
to logistical reasons will be scheduled for an elective PCI or coronary bypass surgery (CABG) 
at another day. Aside from the inherent risks that arise when cannulating the peripheral arte-
rial system and manipulating the catheter alongside the aorta, the intubation of the coronary 
arteries itself can be time-consuming and is not entirely devoid from complications. (Figure 
1) Furthermore, it requires a meticulous operator to provide the interventional cardiologist or 
cardiac surgeon with precise information regarding the lesion site and its relation with side 
branches. Not infrequently however, additional projections are needed at the moment of the 
planned PCI. Moreover in some instances the cardiac surgeon asks for a repeat catheterization 
because of suboptimal projections at the initial diagnostic angiogram. 
The purpose of this article is to discuss the inherent limitations of conventional coronary 
angiography (CCA) and highlight the advantages of cardiac CT in this regard. Furthermore, the 
information as provided with CTCA might prove to be essential in certain circumstances before 
attempting coronary revascularization or percutaneous valvular procedures.
diagnostic coronary imaging
CCA plays a central role in the management of patients with coronary artery disease and is 
regarded as the gold standard for confirming or excluding the presence of coronary obstructive 
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disease. Due to its invasive nature, this procedure should ideally be confined to patients in 
whom the likelihood of proceeding to coronary revascularization is high. Current guidelines 
recommend the use of noninvasive stress testing as a first-line test before proceeding to a 
catheter-based assessment of the coronary anatomy.4 In daily practice however our approach to 
patients with suspected or proven coronary artery disease is different. The majority of patients 
that undergo coronary revascularization do not have objective proof of ischemia.5 Recent sur-
veys demonstrate that normal CAs account for up to 20% of all coronary angiograms.6 Also, the 
proportion of patients that proceed to a coronary intervention is only one third of the number 
of patients catheterized.7 These data confirm that even today CA is still widely performed for 
excluding the presence of coronary atherosclerosis, as was concluded by Mason Sones 35 
years ago, and not as a prelude to coronary revascularization.8 It is not surprising therefore that 
diagnostic uncertainties that often persist when faced with a normal noninvasive stress test in a 
patient with unexplained chest pain.9 Furthermore, the favorable prognostic value of a normal 
nuclear scan or dobutamine stress echocardiogram (DSE) often is not sufficient to confidently 
finalize the diagnostic work-up and to reliably exclude the presence of coronary artery disease 
This is because standard SPECT and PET imaging rely on normalization of acquired data to the 
region of the myocardium with maximal perfusion, even if this area of perfusion may be abnor-
mal. As a result, this method may underestimate the extent of disease, particularly in patients 
with significant three-vessel or left main disease. 10,11 Stress echocardiography has limited 
sensitivity for the detection of single-vessel disease, which explains the good prognostic value 
of a normal DSE but at the same time its inaccuracy for clarifying the possible ischemic origin 
of a patient’s symptoms.12 
Figure 1. Invasive coronary angiogram of the right coronary artery. (a) Normal appearance of the vessel at 
initial catheterization. (b) In order to perform an intravascular ultrasound of the vessel, the artery was 
intubated  again 2 weeks later, which resulted in a proximal dissection of the vessel. The dissection flap is clearly 
visible (arrowheads).     
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Current 64-slice CT scanners are particularly useful for excluding the presence of significant 
coronary artery disease with a a normal scan result having a favorable prognosis.13,14 As a result, 
a CT-based approach seems most useful in patients with a low to intermediate likelihood of 
coronary artery disease, in whom it is deemed necessary to evaluate the coronary anatomy.15 
Most clinicians would advocate catheter-based CA as the preferred strategy in patients with 
a high pre-test likelihood of CAD primarily because of the option to perform an ad hoc thera-
peutic intervention. Nevertheless, such an ad-hoc approach has several disadvantages when 
compared to a stepwise approach: the latter strategy allows time to inform the patient about 
risks, benefits, and possible therapeutic alternatives and allows optimally preparation of the 
patient before before the procedure by ensuring adequate pre-hydration if necessary and pre-
treatment with oral anti-platelet agents. 16 These issues are now vitally important in the current 
climate of late stent thrombosis with drug eluting stents.17 In addition, an ad-hoc approach 
does not allow general discussion between the general cardiologist, interventional cardiolo-
gist, and cardiac surgeon to reach consensus about the most optimal treatment strategy. 
 
Importantly, only when adequately performed and interpreted can CCA reveal the exact loca-
tion and relative severity of obstructive lesions in branches of the coronary tree. Contrary to the 
general belief, CCA may not always prove to be the gold standard technique for the visualization 
of the coronary anatomy even in very experienced hands. Indeed, the intrinsic limitations of a 
Figure 2. (a) Invasive coronary angiogram of the right coronary artery (RCA). The diagnostic catheter (arrow) is 
obscuring the ostium of the vessel. The distal segment shows 2 consecutive significant stenoses (arrowheads). 
(b) Invasive coronary angiogram of the left coronary artery. The initial angiogram only revealed a significant 
narrowing in the proximal left anterior descending coronary artery (arrowhead). The distal part of the left main 
coronary artery (arrow) appears unaffected. A straight anteroposterior view (inset), which was performed 
when the patient was scheduled for a percutaneous coronary intervention, clearly shows a severe stenosis at 
this level (arrowhead).
Ch
ap
te
r 5
136
2-dimensional projectional imaging technique may sometimes be difficult to appreciate in the 
presence of a coronary narrowing especially in cases of complex anatomy18 (Figures 2 and 3). 
The lack of adequate contrast media opacification within the vessel can lead to inaccuracies in 
determining the true diameter stenosis at the minimal luminal diameter that may result in inap-
propriate management. Moreover, limitations due to vessel overlapping and foreshortening 
can have an impact on stent usage when compared to computer generated virtual 3-D vessel 
reconstructions.19 It should be borne in mind that CTCA is not a virtual 3-D reconstructed (3DRC) 
image but an accurate representation of the heart in different views. Furthermore unlike a 3DRC 
image and conventional 2-D luminography it allows the direct visualization of the atherosclerotic 
disease process. It may therefore have and important role in the future in indentify the so-called 
‘high risk’ plaques. 20
Figure 3.  Corresponding CT coronary angiogram (a) Curved multiplanar reconstruction of the right coronary 
artery confirming the 2 consecutive stenoses in the distal segment (arrows). The ostium (inset) also shows a 
high-grade stenosis (arrowheads), which initially was not visualized by the invasive coronary angiogram. (b) 
Multiplanar reconstruction of the proximal segments of the left coronary artery, clearly showing significant 
stenoses in the distal part of the left main coronary artery (large arrow), the proximal left anterior descending 
coronary artery (small arrows) and the large intermediate branch (arrowheads). Ao, indicates ascending aorta.  
THE INTEGRATION OF MULTISLICE COMPUTER TOMOGRAPHY WITH MAGNETIC NAVIGATION 137
Complex anatomy
Failure to visualize or to understand the course of a coronary artery has become a frequent 
reason to refer a patient for an alternative imaging technique. Coronary anomalies are the 
prototype example where the cardiac catheterization findings often are inconclusive or result 
in a prolonged procedure with excessive use of contrast material. (Figure 4)  In this regard, 
cardiac CT is becoming the investigation of choice to demarcate complex 3D coronary artery 
anatomies and the relationship to the surrounding structures.21,22 The favorable experience 
when assessing anomalous coronary arteries with cardiac CT, can be extended to other difficult 
coronary anatomy, such as ostial lesions, lesions at bifurcations or within the left main artery, 
and chronic total occlusions. Cardiac CT can provide important information in all the above 
complex anatomical lesion subsets in order to target the most appropriate modality for treat-
ment.
Ostial lesions
Catheter-based imaging of coronary ostial disease can be technically challenging because 
of difficulties in obtaining adequate contrast media opacification through non-selectively 
Figure 4. Anomalous origin of the right coronary artery (RCA). (a) An aortogram was performed to localize the 
origin of the RCA, whose contours are faintly visible (arrowheads). (b) Non-selective injection confirms its origin 
(arrowheads) out of the left coronary cusp. (c, d, e) CT coronary angiogram clearly showing the anomalous 
origin (arrowheads) and course of the RCA
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engaging the catheter outside the ostium and in the coronary cusp. By virtue of the technique 
itself CA poorly assessed ostium especially so if the catheter is deeply intubated. (Figure 5) 
Misinterpretation with possible inappropriate therapeutic handling can be a possible conse-
quence of failure to recognize catheter-induced spasm, a condition that typically affects the 
right coronary artery. (Figure 6) These caveats are effectively avoided by using cardiac CT which 
in our experience is the preferred imaging tool in re-assessing patients with suspected coronary 
ostial disease in whom the initial CA was inconclusive.
Figure 5. Patient with a true ostial stenosis of the right coronary artery (a) Initial invasive coronary angiogram 
showing the stenosis (arrow). (b) These findings are confirmed (arrow) when the patient was rescheduled to 
undergo a percutaneous coronary intervention. The contrast injection this time was non-selective, as is obvious 
from the appearance of contrast in the right coronary cusp (arrowheads), to minimize the chances of catheter-
induced spasm. (c) Corresponding CT coronary angiogram clearly showing the ostial involvement (arrow). (d, e, 
f, g) Cross-sectional intravascular ultrasound (d and f) and CT (e and g) images, clearly showing the significant 
narrowing of the lumen (d and e). The extent of disease (e, arrows) in the vessel wall is quite obvious on CT, the 
residual lumen area (arrowheads) is very small. (f, g) Corresponding cross-sections at the reference site (panel c, 
arrowhead), distal to the stenosis.
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Bifurcations 
Coronary atherosclerosis exhibits a predilection for areas of low shear stress, typically at bifurca-
tion sites. Plaque build-up usually is already extensive in these areas before becoming angio-
graphically visible. In today’s practice, percutaneous coronary intervention (PCI) for bifurcation 
pathology entails up to 20% of attempted lesion subsets.23 PCI of bifurcation lesions remains 
quite challenging and the most effective treatment strategy remains as yet undefined. Impor-
tant determinants of the chosen approach are the distribution of plaque in main vessel and side 
branch, as well as the degree of angulation between both branches. Coronary bifurcations are 
notoriously difficult to examine completely by CCA despite multiple angiographic projections, 
due to factors such as vessel overlap and foreshortening. Cardiac CT offers accurate three-
dimensional information and is not subject to the limitations of conventional angiography. 
(Figure 7) CTCA reliably assesses the plaque distribution across the bifurcation and in contrast 
Figure 6.  Patient who was referred to undergo a percutaneous coronary intervention for an ostial stenosis 
of the right coronary artery. (a) Initial angiographic image showing the coronary narrowing (arrowhead). (b, 
with inset) On cardiac CT the vessel had a normal appearance. (c) A repeat coronary angiogram confirmed the 
CT findings. (d) On intravascular ultrasound the ostium was indeed widely patent with only minimal intimal 
thickening (arrowheads).
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to CCA allows a more precise assessment of coronary bifurcation angles.24,25 These advantages 
might be of benefit for deciding on an adequate treatment strategy.  
Left main coronary artery
The left main (LM) coronary artery combines the difficulties that arise when assessing ostial and 
bifurcational disease. Indeed, ostial lesions of the left anterior descending or circumflex artery 
frequently involve the distal LM bifurcation. Despite its clinical significance, LM disease may not 
be accurately evaluated by CCA alone.26,27 CTCA overcomes the limitations of CCA and can be a 
clinically useful, adjunctive method to evaluate LM coronary artery disease. (Figure 8)
Figure 7. (a) Invasive coronary angiogram showing a significant bifurcation lesion (large arrow) of the 
left anterior descending coronary artery with the first diagonal branch (D1). Also note the limited contrast 
enhancement (small arrows) in what looks like a small side branch. (b) Three-dimensional reconstruction of 
the heart with CT showing the bifurcation lesion. The dense spot within the lesion (arrowhead) corresponds 
to calcification. The branch that was faintly visible angiographically, can now be clearly recognized without 
interference of overlapping vessels as the intermediate branch (arrows). (c) 3-mm thick maximum intensity 
projection clearly showing the calcified (arrowhead) and non-calcified plaque components causing the lumen 
narrowing. (d) After wiring the intermediate branch its true dimension can be well appreciated (arrows).
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Chronic total occlusions
Coronary chronic total occlusions (CTOs) are found in up to 50% of patients with significant 
coronary artery disease, but PCI is attempted in only a fraction of these lesions.28 The relatively 
low procedural success rate compared to PCI of non-occluded coronary arteries and the higher 
risk of procedural-related complications in case of failed recanalization, explain the rather 
low referral rates for PCI.29 Several angiographic features have been identified as predictors 
for successful recanalization, and the presence or absence of these can influence the deci-
sion regarding whether PCI is attempted or the patient is referred for coronary artery bypass 
surgery.30 CTCA not only assesses the luminal impact of atherosclerosis, but also visualizes 
the disease process in the coronary artery wall and by consequence in occluded parts of the 
coronary arteries. (Figure 9) Independent predictors of PCI failure for CTOs, are the length of the 
Figure 8. (a) Diagnostic coronary angiogram of the left coronary artery in a female patient with atypical 
chest pain who presented with ventricular fibrillation during a bicycle stress test. Although not visible there 
was a suspicion of ostial left main disease because of the absence of contrast back flow in the coronary 
sinus. (b and c) The CT coronary angiogram clearly shows a severe ostial narrowing (arrowheads). (d) A 
non-selective repeated invasive coronary angiogram confirms the CT findings (arrowhead). (e and f) A 
percutaneous coronary intervention was performed: shown are the positioning and deployment of the stent. 
(g) Postprocedural coronary angiogram.
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occlusion and the presence of heavy calcifications within the occluded segment: both variables 
are more precisely defined by CTCA as compared to CCA.31 Preprocedural evaluation of CTOs 
by means of CTCA is becoming routine in several institutions as it provides the interventional 
cardiologist a roadmap that appears to be helpful in the selection of the devices to facilitate a 
successful crossing of the occlusion.32,33 Moreover differentiating the nature of the occluding 
plaque whether it is soft (lipid-rich) or hard (fibrocalcific), can influence thedevice selection 
and clinical outcome. 34 Retrograde or contralateral cannulation can often be avoided since the 
3-dimensional visualization of the course of the occluded vessel oprovides visual landmarks for 
Figure 9. Patient with recurrent angina after previous coronary bypass graft surgery, including a venous graft 
to the right coronary artery (RCA) and left internal mammary artery (LIMA) to the left anterior descending 
coronary artery. At initial invasive catheterization the origin of the left coronary artery appeared occluded. 
(a) Cardiac CT scan, coronal view, indeed showing a short occlusion (arrowheads) of the left main stem. (b) 
Three-dimensional reconstruction of the heart showing the patent LIMA (arrow) and venous graft to the 
RCA (arrowheads). (c) Contrast injection after wiring of the LIMA (arrow) results in opacification of the native 
coronary artery up to the distal part of the left main stem. (d) Six-month angiographic result after successful 
PCI (inset) of the left main stem.
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the interventional cardiologist to steer the guidewire towards the direction of the distal vessel 
beyond the occlusion.
Plaque imaging
CTCA confirms what surgeons and pathologists have emphasized in the past- that angiography 
underestimates the extent of atherosclerotic disease in general and can be greatly misleading 
in predicting the distribution of plaque in any given portion of the vessel wall. The fundamental 
difference between CCA and CTCA is the basic image format: while CCA provides high-resolution 
imaging, it is limited to the luminal surface. CTCA overcomes the limitations of silhouette imag-
ing and reveals details of the distribution and composition of atheroma within the vessel wall. 
(Figure 10)  It could be of considerable value to be able to identify lipid-rich plaques and, ideally, 
identify morphological factors influencing the likelihood of plaque rupture. Visualization and 
characterization of coronary plaques with CTCA is feasible and provides us new dimensions of 
information on the coronary atherosclerotic disease process. However, data are not available 
yet that show a patient benefit when using CTCA as a tool for risk stratification of asymptomatic 
individuals.
therapeutic use of cardiac ct imaging
Guidance during complex percutaneous coronary interventions
In addition to its diagnostic value, cardiac CT images might also facilitate the actual process of 
PCI. This is currently being realised by integration of the CTCA with the Stereotaxis Niobe®  Mag-
netic Navigation System (St Louis, MO, USA). 35 In this novel technology two permanent external 
magnets situated at either side of the patient can  be rotated, translated or tilted to produce 
a uniform magnetic field of 0.08 Tesla within the patient’s chest. This field is used to precisely 
direct a tiny magnet mounted on the tip of a guidewire by changing its magnetic moments. 
Figure 10. (a) Invasive coronary angiogram showing “wall irregularities” (arrowheads) and thus indirect 
signs of atherosclerosis distal to the origin of the first septal branch  (arrow). (b) Corresponding CT coronary 
angiogram, maximum intensity projection, showing atherosclerosis (arrowheads) in its earlier stages, 
i.e.outward remodeling of the vessel without lumen impairment, proximal to the take-off of the first septal 
branch (arrow). (c) Intravascular ultrasound of the left main stem clearly showing plaque build-up in the 
intimal layer (arrowheads).
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This allows fine control of the orientation of the tip of the guidewire in space achieving a full 
360ºomni rotation. This unique ability to manipulate a guidewire in vivo facilitates easier wire 
transit across otherwise difficult lesions and tortuous vessels. 36,37 Moreover it can potentially 
reduce vessel trauma in addition to reducing radiation exposure and contrast usage. In pre-
liminary assessment it is feasible to perform coronary intervention without contrast media in 
patients having prior CTCA when the dataset is co-integrated in the Navigant® software and the 
derived roadmap is co-registered with the tip of the guiding catheter in the coronary sinus. 
In addition, the integration of CTCA and MNS may provide a novel route to improving the suc-
cess rate in treating CTOs. By co-registering the occluded coronary segment of the volume 
rendered image in the Navigant® software to the fluoroscopy live image an accurate virtual 
Figure 11.  (a) Invasive coronary angiogram, showing a chronic total occlusion (arrow) of the circumflex artery 
(CX). Only the very distal part of the vessel is visible through collaterals (arrowheads) (b) Corresponding CT 
image (curved multiplanar reconstruction): compared to the angiographic information the occlusion appears 
much shorter and consists of non calcified tissue. (c) The CT dataset has been uploaded in the navigation 
software; the course of the CX, including the path of the occlusion, is marked by a green line overlay. (d) The 
course of the CX has been marked as a yellow line. The rectangular which is present in panel c and d marks the 
location of the wire tip in the vessel. The inset in panel d represents the perpendicular cross-sectional view of 
the vessel to allow the steering of the guidewire in the desired direction.
THE INTEGRATION OF MULTISLICE COMPUTER TOMOGRAPHY WITH MAGNETIC NAVIGATION 145
road map through the vessel lumen can be achieved. (Figure 11) This can be used to guide a 
magnetically aided radio-frequency ablating wire through the occlusion.
Percutaneous therapies for valvular heart disease
In addition to the investigation of the coronary arteries, cardiac CT is well suited to assess 
valvular anatomy and disease of the large extra-cardiac arteries. Percutaneous aortic valve 
replacement (PAVR) is an emerging technology in the management of patients with severe 
aortic stenosis unsuitable for surgical management. 38,39 These percutaneous heart valves are 
routinely implanted via a transfemoral arterial access using large diameter sheaths (18 to 24 
French). Limited experience with this technology means that there is restricted knowledge of 
how these percutaneous devices impact on the often challenging cardiac anatomy and general 
Figure 12.  Eighty-three year-old woman with symptomatic severe aortic valve stenosis who was considered 
a candidate for percutaneous aortic valve replacement. (a) The thoraco-abdominal CT scan revealed severe 
calcifications (arrows) of the abdominal aorta and iliac arteries. (b) CT image, coronal view, showing the 
severe calcifications of the aortic valve (arrowheads). (c) Because of the expected difficult femoral access, the 
valve replacement was successfully performed through the left subclavian artery. The arrows are showing 
the borders of the freshly implanted aortic valve, which consists of a equine pericardial valve mounted on a 
stainless steel bioprosthesis.     
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haemodynamics post implantation. In the few centres that offer this therapeutic option, CT 
scans are routinely used to evaluate the size of the aortic annulus and iliac arteries to ensure 
adequate patient selection and feasibility of passage of a 18-to-24 French system. (Figure 12). 
In the future, cardiac surgeons and interventional cardiologists will increasingly rely on this 
noninvasive imaging modality to plan the specific intervention and to assess the results on 
follow-up
Limitations of ctca: a word of caution
Subsequent improvements in CT scan technology have brought this cardiac imaging tool to 
the stage where accurate and noninvasive evaluation of the coronary anatomy is feasible. As 
is true for any new technology that is being considered for clinical use, the final hurdle to take 
is to determine the incremental information offered by this new test in comparison to existing 
standard assessments. Continuing rises in the costs of health care and the increasing use of 
cardiac imaging tests in particular, underscribe the need for a test to be cost-effective before 
changing existing diagnostic pathways. 40,41Awaiting further scientific evidence, several societ-
ies have issued guidelines describing the optimal use of cardiac CT in an appropriate clinical 
context. 15,42 In general, cardiac CT proves most valuable for clinical situations where one seeks 
to confidently establish the absence of coronary artery disease. Initial studies have highlighted 
the potential of CTCA to be cost-effective in this regard.43 Determination of the right clinical 
scenario is just one of the determinants of a succesful cardiac CT program. Other factors, such 
as adequate heart rate control, body mass index of the patient and amount of coronary artery 
calcification, are equally important and contribute to the “ readability” of a scan.44,45 A cardiac 
CT scan is not entirely limited to the heart, but also includes the adjacent thoracic structures. 
Non-cardiac findings requiring clinical or radiological follow-up are reported in up to 25% 
of patients undergoing cardiac CT and are a good reason to liaise with other specialists, in 
particular the radiology department.46 The potential increase in cancer risk due to CT-related 
ionizing radiation is an important limiting factor and is spurring the search towards dose-
saving algorithms and new scanning protocols that allow to bring down the patient’s effective 
radiation dose in the range of that of ICA.47-49 Finally, state-of-the-art cardiac CT imaging and 
interpretation requires adequate training in cardiovascular diseases and radiology imaging and 
ideally requires a sufficiently long interaction period of at least 6 months within a cardiology 
and radiology department of a dedicated teaching hospital.50,51
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conclusion
Cardiac CT holds great promise for cardiovascular imaging. This relatively new technology 
alters the way in which we diagnose CAD and provides diagnostic opportunities that may 
potentially be beneficial for many individuals with known or suspected cardiovascular disease. 
As a diagnostic test the use of CTCA is considered appropriate for clinical scenarios where 
one seeks to confidently exclude the presence of CAD. By substituting more costly diagnostic 
imaging modalities, in particular invasive coronary angiography and nuclear imaging studies, 
it is expected that CTCA will result in substantial cost savings for the health care system. The 
cost-effectiveness of cardiac CT is currently being evaluated in large clinical trials. 
 
Invasive coronary angiography remains the preferred test for the patient with typical angina 
as it provides the option for immediate intervention. As illustrated in this review, improved 
coronary imaging using CTCA might be of value in certain circumstances to complement the 
invasively obtained angiographic data and thus might improve the safety and efficacy of the 
subsequent therapeutic action taken. This complementary role of cardiac CT imaging already 
results in so-called “reverse referrals”, i.e. patients initially referred for an invasive CCA are sub-
sequently sent for a cardiac CT to detect significant features of vascular pathology that are 
inaccessible by conventional angiography.
  
More and more, cardiac CT is finding its place as a diagnostic tool in clinical cardiology. To prove 
valuable in the long-run a high professional standard needs to be maintained by providing 
adequate training in cardiac CT and through strict adherence to guidelines issued by profes-
sional societies.
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description
Multi-slice computed tomography (MSCT) is a rapidly evolving technology in the field of coro-
nary artery imaging(1). Current 64-slice MSCT allows the delineation of coronary lumen and 
the visualization of the plaque burden through the attenuation of soft-tissue contrast and its 
high sensitivity for vessel calcification(2). At present, this technology is utilized for its diagnostic 
potential. However, it is now possible to couple a MSCT scan with the Niobe® Magnetic Naviga-
tion System (MNS) through its dedicated software Navigant® (Stereotaxis, St Louis, MO, USA) 
and to use it for performing percutaneous coronary intervention (PCI)(3).
history
Magnetic navigation is a technology that allows the accurate guidance of a magnetically 
enabled guidewire through the use of external magnets that generate a precisely directed 
magnetic field. The coupling of this technology with MSCT was initially introduced in the Navi-
gant® 2.10 software as an innovative approach to manage chronic total occlusions (CTOs)(4). It 
allowed the user to segment out the 3D rendered MSCT volume and to identify the diseased 
vessel by manually marking points on the vessel surface. This generated a pathway used as a 
baseline to produce directional magnetic vectors, tangent to the pathway at the point where 
the guide-wire magnetic tip is placed.
With the recent upgrade to Navigant® 2.11, a segmented MSCT volume that only shows the 
coronary tree (Siemens Medical Solutions, Forchheim, Germany) can be imported into the soft-
ware. The pathway of the diseased coronary arteries can automatically be traced, even through 
CTOs. The interventional cardiologist can hence request magnetic vectors that truly correspond 
to the patient anatomy. In addition, the operator has access to the endoluminal view (5) that 
simulates looking through the vessel lumen and simultaneously to the corresponding Multi-
Planar Reconstruction (MPR) slice, as well as an automated update of the magnetic vector as 
the wire is advanced. In this technical report we have illustrated the first use of this innovation 
- in a complex patient with triple-vessel disease.
technical specifications 
 
Pathway Planning and Crossing
This is done in three steps:
1. Extraction of the coronary tree from the raw MSCT DICOM dataset (Siemens)
2. Automatic vessel centerline computation (Stereotaxis)
3. Sequenced magnetic guidewire navigation (Stereotaxis)
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Coronary Tree Extraction
The Siemens Circulation™ (Circulation, version syngo CT 2007A, Siemens, Forchheim, Erlangen, 
Germany) allows the identification of the coronary tree from an MSCT angiogram (Figure 1). The 
package then performs a semi-automatic segmentation of the coronary tree based on a single 
seed point. This post-processing of the DICOM dataset can be imported into the Navigant® 2.11 
software. 
Pathway Planning
Once the coronary tree is imported into Navigant® 2.11, the user assesses the diseased vessels 
and asks the software to compute their centerlines: the trajectory in the middle of each vessel. 
This results in a pathway based on which the magnetic field – critical for directing the guide-
wire tip – will be generated. The magnetic vector will be tangent to the point in the vessel 
Figure 1 Volume-rendered MSCT image with coronary segmentation is displayed in blue with vessel 
calcification shown in bottom right image
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where the operator has chosen to navigate. It therefore defines the instantaneous advance-
ment direction (Figure 2). In addition to this, Navigant® 2.11 uses the data from the MSCT to 
generate an endoluminal view and an MPR slice. Hence, the interventionalist is provided with a 
forward-looking representation of the inside walls of the diseased coronaries. At the same time, 
the Hounsfield map of the transversal MPR slice is shown.
Magnetic navigation
The navigation is performed after co-registration of the MSCT to two Xray images that are at 
least 30º apart and aligning the centerline/navigational path to the live fluoroscopy image. At 
each position along the navigational path all three corresponding magnetic vector, endolumi-
nal view and MPR slice can be shown on a touch screen monitor. A novel feature that is unique 
to Navigant® 2.11 is that after registering a magnetic wire the physician is able to choose a 
step size (1 to 9mm) and a so-called sequencing rate (1 to 60sec) for the vector to automati-
cally update along the vessel. This means that the operator can fully concentrate on the wire 
advancement guided by the moving vectors on the live fluoroscopy image (Figure 3). As the 
vector is sequentially updated so too are the MPR slices together with the endoluminal views. 
Figure 2 Coronary tree with the automatically computed pathway and the tangent magnetic vector
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This automated sequencing can however be temporarily stopped at any desired time (Figure 
4)
clinical experience
the case
A 56-year old diabetic woman presented unstable angina. Angiography performed at her refer-
ring hospital revealed significant three-vessel disease (Figure 5 a-c). Lesions were identified in 
the proximal segments of both the right coronary artery (RCA) and the left anterior descent 
(LAD) as well as diffuse disease in the obtuse marginal (MO). Percutaneous Coronary Inter-
vention was planned following a clinical consultation with our surgical colleagues. Standard 
six French catheters (4.0 Judkins Right and 3.5 CLS) were used to facilitate the MSCT guided 
Magnetic Assisted Intervention (MAI). The procedure of integrating the MSCT in Navigant® 2.11 
(Pathway Planning) and crossing the lesion is detailed above.
Figure 3 Navigation and tools for the operator
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clinical outcome
Using the approach of automated wire advancement, the proximal lesion in the RCA was 
crossed with a Titan 3mm straight tip magnetic wire in 30 seconds with minimal contrast (8ml). 
The lesion was predilated with a Voyager 2.5x20mm balloon at 8 atmospheres following which 
a Xience™ V stent (2.5x20mm) was implanted at 20 atmospheres. A similar magnetic wire was 
used to cross the lesions in the MO (20sec, 2ml contrast) and in the LAD (20sec, 2ml contrast) 
to permit the direct implantation of Xience™ V stents (2.5x15mm and 3.5x15mm) respectively. 
There was TIMI 3 flow in all three coronary arteries on angiography (Figure 5d-e) and she was 
discharged home after an uncomplicated 48h stay in hospital. She is requested to continue 
dual anti-platelet medication for one year. 
discussion
The MNS allows a full omni directional (360º) movement of a 2-3mm Neodymium magnet 
attached to the tip of a 0.014mm guide wire. Magnetic vectors created in Navigant® precisely 
control this movement so as to follow a 3-dimensional navigational path or road map of the 
coronary artery. The use of MSCT to create such a road map not only gives useful information 
about the plaque composition and eccentricity but more importantly it enables the direct 
visualization of occluded segments in a CTO. It is reported that the success in treating CTO 
can depend not only on the length of the occlusion but also on the amount of calcium within 
the occlusion. As such, the ability to directly visualize the MPR slices whilst simultaneously 
being aligned to the position of the vector that guides the wire is an extremely useful tool. This 
paper describes the first ever PCI where an interventionalist can visualize exactly what is being 
Figure 4 Automated vessel sequencing MPR slices upper left quadrant
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encountered ahead of a guidewire. The link with MNS gives the wire the ability to steer around 
eccentric plaque as highlighted in this case or to channel microvessels within an occlusion. It is 
worth pointing out that the endoluminal view is a display tool and the vectors generated are 
the same with or without this additional feature. However, by manually adjusting the vector 
to take into account subtle changes in the vascular anatomy while looking in the endoluminal 
view can offer a higher degree of navigational accuracy. The overall complexity of the case 
demonstrates that MAI is safe and feasible in patients with multi-vessel disease.
conclusion
The incorporation of MSCT extracted coronary arteries in Navigant® 2.11 provide an innova-
tive approach to facilitate PCI with its potential advantages of visualizing the MPR slice, the 
endoluminal view and automated segmental vector advancement. 
Figure 5 Angiographic views of the three diseased vessels pre- (a-c) and post (d-f) treatment
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abstract
introduction:
We investigated invasive percutaneous coronary investigations and interventions based 
directly on multislice computer tomography coronary angiography (CTCA) integration into the 
magnetic navigation system (MNS) to avoid using contrast agents during the procedure.
 
Methods: 
Fifteen patients scheduled for invasive investigation with an intention to treat were included. 
Based on diagnostic non-invasive workup CTCA centerlines of the target vessels were created, 
co-registered and overlaid on real-time fluoroscopic images. Using a guidewire with a magnetic 
tip the vessels were manually wired with the assistance of variable local magnetic fields. The 
severity of the lesion was determined by fractional flow reserve (FFR) or intravascular ultra-
sound (IVUS) with stent sizing determined by IVUS measurements. Locations of IVUS catheter 
along the lesion were incorporated in software to facilitate stenting without contrast agents.
results:
Using magnetically enabled wires the lesions were crossed in 105.3±35.5sec with an average 
fluoroscopic time of 83.4±38.6sec. In 11 of the 15 patients no contrast agents were used in 
crossing the target vessel. In all cases FFR or IVUS measurements were successfully used to 
identify the culprit lesion. Out of 10 patients in whom an IVUS was performed only in one patient 
was any contrast agent needed. In 4 patients the complete percutaneous intervention (lesion 
crossing, stent sizing, positioning and deployment) was performed following subsequent co-
registration of the IVUS probe position in the MNS.
conclusion:
The integration of pre-procedural CTCA within the MNS allowed percutaneous coronary inves-
tigations and interventions (stenting) without using contrast agents.
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introduction
The number of percutaneous coronary artery interventions (PCI) has steadily increased ever 
since Gruentzig performed the first angioplasty in 19751. Improved interventional devices 
supported by novel pharmacological agents together with an understanding of the patho-
genesis of atherosclerosis have established both the safety and efficacy of PCI in numerous 
clinical settings. This has resulted in widespread adoption with more than 2 million procedures 
performed annually worldwide2. But despite these major advances the general method of per-
forming a PCI has remained unchanged for over a quarter of a century, relying primarily on the 
manual dexterity of the operator and the use of radiographic X-rays with selective injections 
of potentially harmful contrast agents into the coronary arteries to visualize the anatomy and 
guide appropriate stent placement. But there are several limitations with such an approach 
since representing 3-dimensional (3-D) information with a 2-D X-ray lumenogram leads to inac-
curacies in lesion evaluation and subsequent stent sizing. This is because vessel foreshortening 
and overlap can hinder the full lesion characterization while plaque eccentricity can lead to 
inaccurate luminal measurements.
For diagnostic purposes contrast enhanced multislice computer tomography coronary angiog-
raphy (CTCA) has achieved a quality standard nearly comparable to invasive selective coronary 
angiography (CAG) for initial lesion evaluation provided that the amount of calcium in the arte-
rial wall is low3. This has led to a sharp increase in the number of CTCA performed within the 
last few years primarily as a screening tool to rule out significant coronary artery disease (CAD)4. 
Therefore we feel that in the not too distant future most elective PCI patients will have a CTCA 
at some point in their diagnostic work-up. This is because, in addition to being non-invasive, 
CTCA provides important information on the extent of the atherosclerotic plaque and provides 
unique 3-D information of the nature of coronary arterial tree, which can serve as a tentative 
roadmap to guide a PCI procedure. Moreover, recent technological advancements has allowed 
a visible static 3-D road map (a centerline) of the CTCA dataset to be superimposed on the live 
fluoroscopic. This can be used to precisely direct magnetically enabled guidewires in the coro-
nary artery when incorporated within the Magnetic Navigation System (MNS)5. The system has 
the ability to change the direction of tip of the wire without the need for externally reshaping6. 
By integrating both systems it means therefore, that a further contrast filled lumenogram at 
the start of the procedure can be effectively skipped so reduce the amount of contrast needed 
for the procedure. Furthermore, the notable inaccuracies of 2-D lumenography can be avoided 
by functionally characterizing the lesion with fractional flow reserve (FFR) and by using intra-
vascular ultrasound (IVUS) measurements to choose the appropriate stent length7. Our aim 
therefore was to demonstrate that following such a strategy - PCI without contrast media could 
be feasible provided that CTCA and IVUS information could be effectively integrated within the 
MNS (Figure 1). 
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Methods
Patients
To investigate the feasibility of this concept, CTCA was initially performed on 5 patients with 
single vessel disease diagnosed on coronary angiograms undertaken at referring hospitals. 
Following this initial evaluation phase, 10 additional patients with more complex multivessel 
disease where recruited in whom a CTCA was performed in accordance with local clinical pro-
tocols. All 15 patients included in the study were subsequently scheduled for Magnetic Assisted 
Intervention (MAI) using the Niobe® II magnetic navigation system (Stereotaxis, St. Louis, M. 
USA). During the PCI procedure indeterminate lesions seen on CTCA were further characterized 
by IVUS or FFR measurements8. Patients were excluded if they were haemodynamically unstable, 
presented with an acute infarction or an acute coronary syndrome or had contraindications for 
a MAI such as a pacemaker or Intracardiac Defibrillator (ICD). Other exclusion criteria were left 
main or ostial right coronary artery disease, significant amount of calcium on CTCA or if the 
patient had other medical condition preventing a prolonged PCI procedure. The institutional 
review board approved the study. All patients were consented to undergo the CTCA studies 
prior to conventional coronary angiography. 
Computer Tomography Coronary Angiography Acquisition 
CTCA was performed using the newest generation dual source 64-slice CT scanner (Somatom 
Sensation 64 Cardiac Configuration Siemens, Erlangen, Germany). Images were reconstructed 
Figure 1 The Concept of performing a non-contrast PCI from a pre-procedural CTCA
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by using a monosegmental electrocardiographically gated reconstruction algorithm9. One 
experienced observer interpreted the lesion on the CTCA in accordance to the conventional 
coronary angiogram algorithm used in the 17-segment modified American Heart Association 
classification model10. This was performed off-line (Leonardo VB30A; Siemens) with the images 
visually classified for the presence of significant stenosis using both the multiplanar reconstruc-
tion and curved multiplanar reconstruction. Blood vessels with diameters of 2 mm or larger 
were considered significant because of their clinical relevance and because they are amenable 
to revascularization.
Magnetic Guidewire Navigation using CTCA co-integration
Magnetic navigation was achieved through two permanent external magnet situated at either 
side of the operating table capable of generating a 0.08 Tesla magnetic field to accurately redi-
rect a tiny 2 or 3mm long magnet at the tip of the guidewire (Titan™, Stereotaxis, St. Louis, M. 
USA). In our laboratory, the Niobe® II the system is integrated with a modified C-arm flat-panel 
detector-fluoroscopic imaging suite (AXIOM Artis dFC, Siemens Medical Solutions, Forchheim, 
Germany) for angiographic imaging. Before the start of a procedure the CTCA - DICOM images 
were uploaded into a MNS dedicated guidance software called Navigant®. These images were 
create using the Leonardo Circulation post-processing software (Siemens Medical Solutions, 
Forchheim, Germany) Figure 2A. A minimal cost algorithm was used to create a navigational 
pathway through the extracted vessels Figure 2B which was co-registered to the live fluoro-
scopic image. This was achieved by firstly recording two orthogonal non-contrast filled images 
of the guiding catheter tip during suspended breathing after engaging the ostium of either the 
left or right coronary artery. On these images the tip of the catheter in end diastole was identi-
fied as a registration point in the three dimensional space. Using this point and software that 
prompts the identical point on the extracted CTCA coronary arteries the dataset were aligned 
and co-registered to the actual position of the patient Figure 2C. From this moment onwards 
the centerlines/navigational pathway from the CTCA could be overlaid on every live fluoro-
scopic image in any desired orientation. Along the entire length of this centreline/navigational 
pathway Navigant® created navigational vectors to instruct the two large external permanent 
magnets to rotate, tilt and translate about their axes to redirect a 0.08Tesla external magnetic 
field Figure 2D. The navigational vectors associated with this centreline were automatically 
updated at a predetermined distance (1-9mm) every second and when correctly positioned 
the operator manually advanced the guidewire. By continuously repeating this process of wire 
steering through automated vector updates and manual wire advancement the magnetically 
enabled guidewire was allowed to cross the lesion and be advanced distally along the vessel 
using minimal or no contrast agents.
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Fractional Flow Reserve Analysis
Fractional flow reserve (FFR) was measured with a sensor-tipped 0.014-inch angioplasty guide-
wire (WaveWire/WaveMap, Volcano Therapeutics, Inc, Rancho Cordova, CA or PressureWire, Radi 
Medical Systems, Uppsala, Sweden). After crossing the target lesion a two lumen multifunctional 
probing catheter (Boston Scientific, Corporation, Santa Clara, CA) was used to replace the mag-
netic wire with the pressure wire. Hyperaemia was induced by intravenously infusing 120μg/
min adenosine (Adrecar, Sanofi, Munich, Germany). The maximum pressure gradient was used 
to calculate the FFR, which was defined as the ratio of the mean post-stenotic pressure to the 
Figure 2 A) Extracted coronaries arteries from the CTCA dataset to be introduced directly into the MNS; B) slice 
through a navigational pathway (depicted by yellow line) simultaneously showing the corresponding MPR 
cross-section at that position; C and D) Co-registration of the navigational pathway to the guiding catheter in 
two orthogonal planes; E) the navigational pathway with a directional vector and F) it being displayed on the 
live fluoroscopic image 
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mean aortic pressure, measured by the guiding catheter, during maximal hyperaemia. A FFR of 
≥0.75 was considered functionally not significant.
Intravascular Ultrasound Analysis
IVUS was performed using CVIS AtlantisTM SR Pro 2.5F 40-MHz catheter (Boston Scientific 
Corporation, Santa Clara, CA) with an automated pullback device (0.5 mm/sec) after the lesion 
was crossed with the magnetically enabled wire. All measurements were made off-line at end 
Figure 3 A and B) Radiographic recordings of two orthogonal images IVUS probe positioned in the middle of 
the lesion and C and D) these two points co-registered as a new reference point (green circle) in the 3D space 
of Navigant®; E) the overlay of the location of this point  (open white circle) on the live fluoroscopic was used 
to position the stent on the middle of the lesion; F) The stent being deployed following a single “safety check” 
angiogram.
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diastole following intracoronary administration of isosorbide dinitrate. These measurements 
included the minimum luminal and proximal reference diameters. Reference vessel measure-
ments were made before a major branch in the least diseased section. Stent apposition was 
visually assessed with incomplete apposition defined as at least one stent strut not apposed to 
the vessel wall, with clear blood flow behind it.
Performing an entire PCI procedure without contrast
This was achieved following appropriate stent sizing. The IVUS catheter was re-advanced to the 
distal landing zone as visible on tip of IVUS catheter and the position of the piezoelectric crystal 
recorded on two different angiographic projections (Figure 3A and B) to locate it within the 3 
dimensional space of the Navigant® (Figure 3C). These angiographic images were uploaded 
into the Navigant® and the position of this point identified as an additional overlay point on the 
live fluoroscopic navigational centerline derived from the CTCA (Figure 3D). The stent was then 
advanced to this new point on the live fluoroscopic overlay and deployed without using any 
contrast agent (Figure 3E) apart from a protocol driven safety check for placement accuracy. 
The accuracy of placement
Although the study was designed to test the feasibility of PCI without contrast agents a mea-
sure of safety was introduced in the protocol by the co-operator. As such, after positioning of 
the stent using the overlay a short angiographic film was taken to check the position. If this 
position was ideal no correction was undertaken and the stent deployed. If this was adjudged 
as being incorrectly positioned then the co-operator made the necessary readjustments prior 
to deployment. The film was also used for ACC/AHA lesion characterization.
Assessment of lesion lengths and reference diameters by IVUS and CTCA
The assessment of IVUS and CTCA measurements was performed off-line and independently by 
an IVUS trained technician and a radiologist experienced in interpreting CTCA data. The lesion 
length, the MLD, proximal diameter stenosis (DS) and the % DS were analyzed. The absolute dif-
ferences were calculated by the numerical summation of the over and underestimated values 
relative to both techniques. 
statistical analysis
Continuous variables are presented as mean ± standard deviation. Student T-test was used 
to determine if there were significant differences between the parameters assessed. Analyses 
were performed using SPSS 11.5 for Windows (SPSS, Chicago, IL). P value < 0.05 was considered 
statistically significant.
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results
Assessment of lesion with FFR and IVUS measurements
In all 15 patients the magnet wire was successfully navigated using a CTCA derived overlay. 
The average contrast media usage of 0.5ml, with an average crossing and fluoroscopic time 
of 105.3±35.5sec and 83.4±38.6sec respectively. Notably in 11 of the 15 patients no contrast 
agent was used in crossing the target vessel Table 1. The largest volume of contrast needed 
was 3mls in a patient who was enrolled in the initial phase. In this particular case the contrast 
agent was needed to reenter the main vessel following advancement of the magnetic wire 
in a small side branch almost parallel to the main branch. No contrast agent was needed in 5 
out of the 8 patients where FFR measurements were made. Moreover only in one patient was 
contrast agent used amongst the 10 patients in whom IVUS measurements were performed. 
In the first phase (patient 1-5) one patient with a negative FFR (0.87) had the entire procedure 
performed without an additional lumenogram with a control angiogram only done at the very 
end for safety control and documentation. The four other patients in this first series underwent 
stenting with conventional PCI techniques. 
In the second phase multivessel FFR was used to identify the culprit lesion/vessel since exercise 
ECG testing confirmed ischemia but no conclusive localization could be made (patients 6-8). 
Out of the six vessels assessed, three were found to have functionally significant disease and 
were subsequently treated. Furthermore, in three additional cases, lesions characterized by FFR 
had IVUS performed to accurately determine the stent size and length (patient 9-11) without 
needing further contrast agents. The average stent length in these patients was found to be 
17.6mm with an average diameter of 3.3mm. 
Complete PCI without additional contrast agents
In the last four patients the entire PCI procedure from lesion crossing to stent sizing, position-
ing and deployment was performed without additional contrast agents relying exclusively on 
CTCA datasets and IVUS measurements incorporated in the Navigant®. It should be noted that 
in only one of these cases following a check angiogram to determine the accuracy for place-
ment did the co-operator required performing a 2mm adjustment in stent repositioning. After 
stent deployment repeat IVUS measurements demonstrated satisfactory stent apposition and 
no post dilatation was performed. In one case IVUS did reveal a type A distal edge dissection 
not visible at control angiography. No additional stent placement was necessary. In keeping 
with the hospital’s angiographic recording policy the final results were documented using two 
different angiographic views. These control angiograms showed no additional abnormalities in 
all 15 patients.
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Analysis of IVUS and CTCA measurements
The off-line analysis of the IVUS and CTCA revealed that although longer lesion lengths were 
determined by CTCA measurements (19.2±13.3mm vs. 14.5±5.6mm) overall the difference was 
non-significant, p = 0.19 (Table 2). There was little differences observed in measuring the MLD 
and %DS. However, a significant difference was recorded with the proximal reference diameter 
measurements 3.6±0.6mm vs. 4.2±0.8mm p=0.05) which was overall smaller with CTCA. In 
terms of the absolute difference CTCA measurements would have resulted in one stent size 
smaller (absolute difference = 0.8mm) and longer (absolute difference = 6.6mm) than that 
determined through IVUS analysis.
Table 1 Vessels and lesions characterized by FFR and IVUS. Stent dimensions and deployment performed 
without contrast agents (patients 9-15); LAD, left anterior descending, LCx, Left circumflex, IM, intermediate 
and RCA, right coronary arteries
Patient Gender Age Vessel Procedure    Contrast/
ml
Crossing/sec 
Fluoro/time
Lesion
Type
1 Female 56 LAD IVUS 1 110/53 B1
2 Male 67 IM IVUS 0 123/121 A
3 Male 56 RCA IVUS 0 71/67 B1
4 Male 61 LCX FFR
No PCI
3 136/111 B1
5 Male 69 LCX FFR 0 89/87 B1
6 Male 72 LAD + RCA FFR both  +
PCI LAD
0 136/123 B1
7 Male 78 LAD + LCX FFR both +
PCI LAD
1 93/84 B1
8 Female 74 LAD + LCX FFR both +
PCI LCX
2 84/71 A
9 Male 61 LAD FFR+IVUS
chose stent 
0 64/63 A
10 Female 56 LAD FFR+IVUS
chose stent
0 130/100 A
11 Male 67 LCX FFR+IVUS
chose stent
0 92/84 B1
12 Male 58 LCX IVUS +
place stent
0† 104/98 B1
13 Male 73 LCX IVUS +
place stent
0 200/165 B1
14 Male 66 LAD IVUS +
place stent
0 105/87 A
15 Female 53 RCA IVUS +
place stent
0 42/42 A
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discussion
In this paper we described a new concept for non-contrast agent driven percutaneous 
coronary investigation and subsequent intervention. By integrating a diagnostic CTCA which 
is increasingly used as a screening tool for CAD 11 with the MNS it was possible at a later date 
to guide magnetically enable wires safely though a lesion without contrast agent. Moreover 
lesions were functionally characterized without contrast agents when the magnetic wire was 
exchanged with FFR wires. Although reduction of contrast agent usage is important because 
of its associated nephrotoxicity, this is the first reported study to demonstrate the extension of 
pre-procedural 3-D information to directly guide a PCI procedure. The MNS has recently been 
shown to incorporate 3D information to cross the target vessel12. But in this study the reduction 
in contrast agent was relatively small (2-7 ml) over conventional wire PCI approaches and does 
not affect significantly the total amount of contrast agents necessary to the complete proce-
dure. This is because large amounts of contrast agents are needed for the initial angiographic 
assessment of the lesion, stent/balloon sizing, stent positioning and deployment.
It is generally believed that CTCA is predicted to supersede diagnostic CAG in patients without 
a history of PCI or previous bypass surgery13. Presently radiation dose exposure is more than 
diagnostic CAG and it is hopeful that the faster CTCA systems in development with increased 
spatial resolution and single heart beat imaging will address this limitation14. Nevertheless with 
the satisfactory image quality obtained with the modern 64-slice scanners it seems illogical to 
start a PCI procedure with an additional lumenogram that exposes the patient to more radia-
tion and more contrast agents15. This is particularly so in light of the well recognized limitations 
of conventional angiography in lesion characterization (plaque eccentricity, vessel foreshort-
ening) and the trial and error approach in determining the best angiographic views for stent 
deployment16. It is not surprising therefore the potential advantages in using the CTCA dataset 
to guide a PCI procedure are attractive. But as a word of caution, CTCA is currently insufficient 
to guide the actual stent selection and placement due to its limited spatial resolution4. This was 
Table 2 Analysis of lesion dimensions with CTCA and IVUS
CTCA (n = 10)
Mean ± SD
IVUS (n = 10)
Mean ± SD
Absolute 
Difference
Student’s
t-Test
Lesion length/mm 19.2±13.3 14.5±5.6 6.6mm 0.19
Minimum Luminal 
Diameter/mm
1.5±0.8 1.4±0.3 0.6mm 0.87
Proximal. Reference
Diameter/mm
3.6±0.6 4.2±0.8 0.8mm 0.05
% Diameter
Stenosis
62.4±19 64.9±9.1 16.9% 0.71
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apparent in our study where stent selection based on CTCA alone would have recommended 
one stent length longer and having smaller diameters. Consequently, the incorporation of 
an intermediate step using IVUS was crucial in accurately determining the appropriate stent 
dimension 17. 
We choose to use an FFR guided strategy to characterize the lesion because evaluating coronary 
stenosis with CTCA alone does not provide additional relevant functional diagnostic informa-
tion18. Moreover, FFR guided therapy in multivessel disease has been proven to be a successful 
strategy in reducing the number of stents implanted so is cost effective19. In addition, in our 
patients where multivessel disease was identified on CTCA, 50% of the lesions were effectively 
ruled out by FFR measures without subjecting the patients to more contrast agents.
The novelty of stent placement without contrast is based on an identifiable positioning of refer-
ence point along a navigational centerline derived from CTCA. But currently there is a limitation 
with this methodology because the navigational pathway is derived for only one cardiac phase. 
In the future however, with increased computation power and algorithms to provide an electro-
cardiography (ECG) gated CTCA centerline superimposed on the live fluoroscopy image such 
a limitation might be overcome. But also needing consideration will be the patient voluntary 
movements and those linked with respiration, which may be more difficult to control. Already 
some compensation can be achieved through respiratory/movement sensors located on the 
sternum/diaphragm that adjust the centerline to the live radiographic image accordingly20. 
With newer technologies such as those based on a ‘GPS-like’ navigational system to accurately 
locate the catheter/wire position within the coronary tree many these movement artifacts may 
be eventually be eradicated21. When such a system is introduced within a magnetically enabled 
wire then more accurate positioning following the CTCA derived navigational centerline will 
be possible and this will pave the way for the truly remote non-contrast PCI procedure in the 
future.
Limitations
This was study to evaluate the concept of stenting without contrast agent so the patient popu-
lation was small. Selection was not based on particular patient demographics, but rather on 
the availability of the 64-slice CT scanner for the examination of cardiac patients. The study was 
not designed to directly compare the precision and accuracy of CTCA and IVUS, which has been 
validated by several groups, but purely to describe our finding with the parameters assessed4. 
Integration of the CTCA in the MNS was time consuming and can take up to 30mins prior to 
starting the PCI procedure. Apart from the check angiogram prior to stent deployment a final 
film was required for documentation. Therefore to be truly independent of contrast agents a 
validation study base solely on 3 D imaging techniques (such as 3D-IVUS) may be required.  
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conclusions
Although percutaneous coronary intervention has revolutionized the management of coro-
nary artery disease the general methodology has remained unchanged ever since the work 
of the early pioneers. In this concept paper we have shown that by merging modern imaging 
technologies in particular CTCA with the ability to use a magnetic field to precisely guide a 
wire within the coronaries, the potential exist to radically change this process. The integration 
of pre-procedural 3-D information and intravascular ultrasound in the magnetic navigation 
system allowed PCI without the use of contrast agents with optimal results.
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introduction
Magnetic Navigation System (MNS) is a rapidly growing technology with nearly 100 systems 
globally installed(1). It was first utilized in the field of neurosurgery and cardiac electrophysiol-
ogy (2)and is now being extended to percutaneous coronary interventions (PCI). In PCI, the 
Niobe®, MNS (Stereotaxis, St Louis, MO, USA) offers a novel approach to cross a lesion by precisely 
controlling of the tip of a magnetically enabled wire in vivo(3,4). The system comprises of four 
key components: i) two permanent adjustable magnets mounted on mechanical positioners 
situated at either side of the fluoroscopy table ii) a navigation software (Navigant®) that creates 
a virtual roadmap and vectors after inputting imaging data, iii) a real time fluoroscopy system to 
display a virtual roadmap on the live image and iv) a sterile touch screen monitor ideally placed 
at the operating table for the operator to control the system. The magnetic guide wire used 
together with this system has a nominal diameter of 0.014inch/0.36mm and a nominal length 
of 185cm or 300cm(5). The wire is configured with a 2 or 3mm embedded gold encapsulate 
neodynium iron boron magnet at the distal tip. The first generation wires called the Cronus™ 
was hydrophilically coated with a tapering end that led to a 2cm floppy or 3mm intermediate 
coiled segment to which the magnet was attached (Figure 1)(6). These tiny magnets when 
placed in the magnetic field generated by the MNS aligned themselves in the direction of the 
applied field(7). nce the tip direction is aligned in the desired direction then the wire can be 
manually advanced until another change of direction is required(8). This basic principle of 
wire guidance is retained in the newer generation wires and towards the development of a 
radiofrequency enabled magnetic wire aimed at coronary and peripheral occlusion.
The Current and Future Magnetic Navigation Wires
Figure 1 The basic design at the tip of a magnetically enabled wire
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The newest family of magnetic wires that is currently commercially available is the Titan™ range. 
Like the Cronus™ wires they are available in either angled or straight 2 or 3mm magnetic tips. 
Although the basic design of the wires is the same as the Cronus™ these wires are superior in 
their ability to deliver a device. Three point deflection testing performed by supporting the 
wires at two points and measuring the force required to deflect the mid-point to 4mm showed 
that they stiffen quicker in order to improve device delivery. It gives the Titan™ wires a profile 
more similar to that of a Balance Medium Weight (BMW, Abbott Vascular Devices, Redwood, CA, 
USA) moderate support wire. At present the Titan™ wires are used in the majority of magnetic 
assisted PCI and these can include chronic total occlusions (CTOs) provided that the occlusion 
is short and not very old. However, when a stiffer wire that has greater pushability is desirable 
then the Titan™ Assert wire can be used as the shaft and tip load has similar characteristics to 
a Miracle 3 gram (Asahi Intecc,. Nagoya, Japan). The tip load measures the force to buckle the 
guidewire with 1 cm of extension. The new Pegasus™ wires will soon supersede The Titan™ range. 
These wires are different as they are manufactured using nitinol in the distal shaft allowing a 
greater retention in the shape during the magnetic assisted PCI. The proximal shaft is stainless 
steel to provide pushability. As with other magnetic wires they are hydrophilically coated to 
facilitate a smooth wire transit. At the tip of the wire is attached the 2 or 3mm magnet. Various 
degrees of wire stiffness (moderate or intermediate) are possible by varying the diameter of 
the nitinol shaft under the coil. The three-point deflection test pattern shows that the Pegasus™ 
Moderate and Assert have similar support profiles. However, the very distal 2cm of the Assert 
is stiffer to transmit more force when crossing tight or total occlusions. There are a number of 
Figure 2: The lateral stiffness of magnetically enabled wire as determined by three point testing
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improvements scheduled in the near future to the magnetic wires beyond Pegasus™. These 
include having smaller, but more, magnets embedded in a polymer tipped wire so as to have 
smoother transitions and larger, sharper magnetic deflections.
 
Navigational Modes to Orientate the Magnetic Tip
The magnets when correctly positioned and iso-centered interact to produce a uniformly 
spherical 15cm magnetic field of 0.08 Tesla called the magnetic volume. Within this volume any 
applied magnetic field vector precisely directs the tiny magnet mounted on the tip of a wire. 
Preset vectors of major vessels can be selected by the operator and advanced via the touch 
screen monitor. In doing so the magnets rotate, tilt or translate to align the magnetic field to the 
orientation of the vector. The desired vector is displayed on the live fluoroscopy image and as 
the magnets move a second vector is displayed that eventually assumes the same orientation 
of the desired vector confirming the desired magnetic orientation is reached. In addition to 
the preset, vectors can also be created from two-dimensional maps of angiographic images or 
by using dedicated three-dimensional reconstruction software to generate a virtual road map 
of the vessel lumen. This virtual road map is displayed as a static centre white line on the live 
fluoroscopy image. The latter programme has the ability to create an endoluminal view of the 
Figure 3: The tip load comparison of magnetically enabled and conventional wires
Table 1: Characteristics of the Stereotaxis Guidewire Family
Stereotaxis Guidewire Family Comparison
Guidewire Distal Core Proximal Core Magnet Tip Length
Distal 
Hydrophilic 
Coating
Cronus Nitinol Nitinol 2 & 3 mm  25 cm
Titan Stainless Steel Stainless Steel 2 & 3 mm 10-34 cm
Pegasus Nitinol Stainless Steel 2 & 3 mm 40 cm
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coronary artery that can accentuate subtle changes in the direction of the vectors(9). In the 
initial experience to extend MNS to CTOs it was described that the ‘Bulls Eye View’ that allows 
navigation around a central axis was a particularly useful technique(6). In this approach the 
tip of the guidewire can be automatically or manually orientated to follow points that mimics 
a bulls eye used for target shooting. In doing so microchannels within the CTO can be locate 
through which the magnetic wire can enter (Figure 4).
The Theory of Radiofrequency (RF) Ablation in CTO
An attractive strategy for CTOs using the following concepts has been postulated by Ser-
ruys(10): first, using magnetic navigation to steer a guidewire towards the occlusion; second: 
a technology to look forward within the vessel, either through the use of an optical coherence 
tomography or an IVUS system or MSCT cross-sections to ensure ideal positioning of the wire 
in the true lumen; finally, some ablative power is needed at the tip of the wire to recanalize 
the CTO. Radiofrequency ablation has previously been reported with the Safe-Cross RF wire 
(Intraluminal Therapeutics, Carlsbad, CA., USA) uses optical reflectometry to verify the intralu-
minal position of the wire prior to radiofrequency ablation(11). In the treatment of CTOs using 
RF ablation the first step required is energy delivered through mono or bipolar electrodes in 
order to generate a current that travels between the active electrode and the ground electrode 
(or dispersive electrode). In addition, continuous RF energy of frequencies greater than 100 
kHz is desirable as this avoids neuromuscular stimulation without compromising the ablating 
potential. The distribution of this current is dictated by the size of the ablating active electrodes 
and the characteristics of the tissues surrounding the electrodes. The potential difference 
Figure 4: The Bulls Eye Navigational mode depicting the various interrogation patterns and tip angulations 
that can be utilized in searching for a micro channel in a CTO
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between the active electrode and the ground electrode determines the impedance and when 
low is the preferred pathway for current flow. When an RF voltage is applied to the electrodes, 
the polarity of the electrodes alternates at a given frequency. Polar molecules are alternatively 
attracted to the active electrode and then to the ground electrodes during each cycle of RF 
current, resulting in the generation of heat. The bioheat equation is used to describe how the 
temperature changes as a result of RF current delivery(12):
  
where  T= final temperature (K)
  ơ= electrical conductivity (S/m)
  p= tissue density (kg/m 3) 
  J= magnitude of the current density (A m2)
  t = duration of activation (s)
  T0 = initial temperature (K)
  c = specific heat (J/kg/K)
 
Furthermore, if the electric field between the tissue and electrode is large enough, arcing can 
occur. Electrical arcs are focused very high energy sparks that are thought to vaporized cells 
in front of the active electrode and in so doing disrupt the tissue layer for effective ablating/
cutting. Theoretical calculations show arcs can heat tissue from 37 °C to 100 °C in microseconds. 
Studies of electrical characteristics along with observation of the tip during cutting with the RF 
guidewire indicate two distinct phases in the cutting/ablation process(13):
 
Phase 1 - water around the active electrode heats up and vaporizes. A capacitive vapour layer 
(dielectric layer) separates the electrode and the tissue. 
Phase 2 – along the points on the electrode where the voltage potential is sufficient to break 
down the dielectric layer, an arc jumps from the electrode to the tissue.
Each arc quickly vaporizes water within the occlusion on contact, disrupting the tissue to allow 
easy passage of the electrode. If the vapour layer is maintained, then continuous arcing and 
steady cutting occurs. 
The Magnetically enabled RF wire 
At present this wire is still being developed by Stereotaxis with the final testing due to be com-
pleted later this year. The latest prototype (Figure 5) consists of an insulated core wire, 3 spaced 
magnets in a polymer jacket and a heat shield surrounded by a heat sleeve attaching the RF 
electrode. Its electrically conductive nitinol core wire is supportive on the proximal end whilst 
being flexible and durable on the distal end.  For safe delivery of the RF energy to the electrode 
tip of the wire, the length of the core is electrically insulated with a PTFE coating.  The degree 
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of insulation of the distal and the proximal section takes into account the wires function. In the 
distal section only very thin insulation is used so as to provide adequate dielectric strength 
without affecting the wire’s flexibility. In the proximal section the insulation has a higher 
dielectric strength than the distal section since it is to be handled by the operator. As PTFE is 
naturally lubricious it avoids the need for an additional coating. Different designed magnets 
(‘thru-hole magnets’) having hollow central cores are placed proximally along the distal tip of 
the wire and are specially treated to prevent corrosion.  A heat shield and sleeve protects them 
as since the intense heat generated can result in their demagnetization. The RF electrode is 
manufacture from the composite metal alloy and the entire wire is encased in a polyurethane 
polymer jacket for smooth transitions between the different components.  In house in vivo 
studies were performed in porcine models having artificially created occlusions of the femoral 
arteries.  The occlusions were typically 5-8cm in length and aged 6-8 weeks to form the tough 
end caps and induce collateral formation. The device proved capable of engaging and perforat-
ing the proximal cap and entering the occlusion.  It also proved capable of progressing within 
the occlusion, traversing the entire occlusion and exiting the distal cap into the distal patent 
section of artery.
Magnetic Navigation and MSCT Co-integration in CTOs
In a CTO the inability to image the artery with contrast media means that an alternative imaging 
modality is require to create the 3-D roadmap. Multislice Computer Tomography (MSCT) offers 
the ability to visualize the occluded coronary artery and can provide a full 3-D roadmap of 
the coronary tree in Navigant®(14). In the newest version (Navigant® 2.11) a segmented MSCT 
volume that only shows the coronary tree (Siemens Medical Solutions, Forchheim, Germany) 
can be imported into the software. In addition, the operator has access to the endoluminal 
view that simulates looking through the vessel lumen and simultaneously to the correspond-
ing Multi-Planar Reconstruction (MPR) slice, as well as an automated update of the magnetic 
vector as the wire is advanced. The latter means that the operator can fully concentrate on the 
wire advancement guided by the moving vectors on the live fluoroscopy image. Moreover, as 
the vector is sequentially updated so too are the MPR slices together with the endoluminal 
views so that the operator can always have prior knowledge of the lesion in front of the wire 
Figure 5: The magnetically enabled RF wire
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(Figure 6). Clinical evaluation of the magnetically enabled RF wire with MSCT co-integration of 
chronically occluded stents is in the final stages of preparation.
Limitations
One major limitation with current wire designs is that the magnet is stuck on to the tip of the 
wire and this can influence the wire’s ability to transit smoothly across a lesion. In the future 
generation wires the multi-magnet design as used in the RF wire will try to accommodate this 
limitation. Another limitation with the current technology in that the uploaded MSCT dataset 
for managing CTO creates a static roadmap of the vessel, while the heart is a beating dynamic 
organ. In the future a dynamic roadmap created from the MSCT will be needed so that the wire 
advancement can be appropriately gated to the image to maximize the probability that it will 
be within the true lumen.
conclusion
Magnetic Navigation is a promising technology in the management of CTOs. Over the past 
5 years the improvement in magnetic guide wire designs has led to wires with comparable 
characteristics to conventional wires. The development of the magnetically enabled RF ablat-
ing wire together with the recent upgrades in MSCT co-integration software has brought the 
MNS closer to realizing its full potential to the CTO field.
Figure 6: Navigation through MSCT co-integration demonstrating the MPR cross-section slice (left upper 
quadrant at the site of the navigational vector and the corresponding endoluminal view in the right panel.
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objective: 
Applying the Magnetic Navigation System (MNS) to manage Chronic Total Occlusions (CTOs)
Background: 
The MNS precisely directs a magnetised guidewire in vivo through two permanent external 
magnets.
Methods: 
Single center experience on the first 43 consecutive MNS treated CTOs was evaluated. Computed 
tomography coronary angiography (CTCA) co-integrated within the MNS provided a virtual 
road map through the occlusion. Failed MNS cases were intervened with bailout conventional 
CTO guidewires. Experienced CTO and MNS operators had unrestricted access to devices and 
equipments.
results: 
Crossing success rose from initially 40% to a maximum of 56% over 52 months. The overall 
MNS crossing success was 44.2% (19/43patients). Conventional wires were successful in 14 
out of the 24 failed MNS cases (58.3%). Overall procedural success was acceptable (76.6%) and 
complication rates low (4.6%). 1.8±0.9 stents (lengths 44.7±21.4mm and diameter 2.8±0.4mm) 
were implanted. Procedures were lengthy (125.0±35.3mins) with high dose area product (DAP) 
(11980.2±6457.9 Gy/cm2) and contrast media usage (388.8±170.2mls). Operators persevered 
less with magnetic wires (20.9±12.4min vs. 27.7±24.4mins) and used softer ones preferentially 
(1st choice, 53.5%). OTW balloons were used in 70% of the cases. Similarly weighted 3gram 
wires were terminated earlier in the MNS. CTCA co-integration did not influence procedural 
outcome but higher magnetic wire success was observed in low calcified lesions, those with a 
central stump and without bridging collaterals.
conclusion: 
In unselected CTOs the magnetic wires is safe, but the modest success rates and relatively high 
procedural bailouts means currently there is no additional advantage over the more sophisti-
cated conventional CTO wires. 
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introduction
Chronic total occlusions (CTO) are encountered in over 25% of patients undergoing percu-
taneous coronary interventions (PCI)1,2. Their importance stems from the fact that treatment 
relieves symptoms, increases exercise tolerance and improves left ventricular function3. More-
over, recanalization reduces the need for coronary artery bypass surgery and leads to better 
long-term survival 4. But despite a high proportion of CTOs having recanalized lumen, crossing 
the occlusion remains a challenge5. This is because factors such as calcification, the occlusion 
length, age, the nature of the stump, the presence of collaterals and the immediate anatomical 
environment of the CTO can all influence the outcome6. These vessel characteristics together 
with ability of the skilled operator in responding to tactile feedback prior to advancing sophis-
ticated conventional guidewires can be critical to the overall procedural success7.
The magnetic navigation system (MNS) has the ability to steer through a vessel by changing the 
tip of a magnetically enabled guidewire without the need to removing it from the patient8. It 
has been reported that this ability can aid the search for micro-channels to effectively negotiate 
through the occlusion9. Moreover, by co-integrating data obtained from computed tomog-
raphy coronary angiography (CTCA) into the MNS software a navigational pathway can be 
derived from the inherent radio-opacity of the occluded segment tissue that is non delineated 
by contrast media to be used in the guidewire navigation10. In this study we report on the 
feasibility and safety of this novel approach and our experience on the factors that influenced 
the procedural outcome with the MNS.
Material and methods
Study patients
In a 52month study period from February 2004 to May 2008, forty-three consecutive patients 
presenting with symptomatic coronary artery disease due to a chronic total occlusion were 
managed with the MNS. The selection criteria for a chronic occlusion was defined as either an 
occlusion on angiography with no antegrade filling of the distal vessel other than via collaterals 
or minimal antegrade flow (TIMI flow 0 or 1). All patients included had a native vessel occlu-
sion estimated to be at least one month’s duration, defined according to previously published 
studies and based on either a history of sudden chest pain, a previous acute myocardial infarc-
tion in the same target vessel territory, or the time between the diagnosis made on coronary 
angiography and PCI6,7. The type of CTO was either de novo or in-stent restenosis. The protocol 
was locally approved and all patients gave written informed consent. In total 5 cardiologist 
experienced in CTO had unrestricted access to the choice of either magnetic or conventional 
guidewires. Importantly the cardiologists were also trained with the MNS. In addition, one 
experienced MNS technician was required to operate the navigational software. Patients were 
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excluded if they were haemodynamically unstable or had contraindications for magnetic-
assisted intervention (MAI) such as having a pacemaker.
CTCA acquisition
CTCA was performed on 64-slice CT (Sensation 64, Siemens, Forchheim, Germany) using a 
bolus of 100 ml contrast fluid (iomeprol, Iomeron 400, Bracco, Milan, Italy) intravenously 
injected at a rate of 5ml/sec. ECG-gating dataset were reconstructed during the mid-to-end 
diastolic phase (–300 to –450 ms before the next R-wave or 60% to 70% of the R-R interval). The 
coronary artery was automatically extracted off-line using dedicated post processing software 
(Leonardo VB30A; Siemens) and incorporated directly in the MNS navigational software called 
the Navigant®. 
Figure 1: A) Clockface navigation mode vectors are orientated by through a touch sensitive monitor; B) 
CardiOpB® virtual 3DRC vessel showing fly-through endoluminal view for navigation; C) extracted CTCA 
virtual fly-through endoluminal view with MPR slice in the top left corner; the Bull’s eye navigational mode 
demonstrating the ability to reorient wire tip in a systematic manner.
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the Magnetic navigation system
The Niobe® II Magnetic Navigation System (MNS) (Stereotaxis, St. Louis, M. USA) has been 
previously described8. Briefly two permanent magnets generate a field (0.08Tesla) that can be 
focused to follow navigational vectors created in Navigant®. The vectors are derived through 
various navigational modes based on 2-Dimensional or 3-Dimensional information. In addition, 
they can be automatically updated or manually controlled via a touch sensitive monitor situ-
ated at arm’s length from the operating table. 
Navigational modes used in this study
i) The clockface navigation
In the clockface navigation mode vectors are orientated through a touch sensitive monitor that 
mimics the dial of a clock (Figure 1A). The vectors move in the X-Y axis and there is an option for 
a third dimension (Z axis). Full 360ºomni rotation of the magnetically enabled wire is therefore 
possible but to be effective a spatial understanding of coronary anatomy is required. 
ii) Three-dimensional (3-D) virtual reconstruction (3DRC)
The CardiOpB® (Paieon Medical Inc., Rosh Ha’ayin, Israel) uses 2 orthogonal Xray images that 
are at least 30° apart to create a virtual 3DRC vessel. A navigational path associated with vector 
created in Navigant® is then overlaid on the live fluoroscopic image after alignment with the tip 
of a guiding catheter. The system also incorporates a fly-through endoluminal view for naviga-
tion (Figure 1B).
iii) The co-integration of CTCA
Incorporating the extracted CTCA into Navigant® allows both the mapping and co-registration 
of the occluded segment. Superimposing the derived navigational pathway on the fluoroscopic 
images enables navigation to be performed in a similar manner to a 3DRC. But in addition to 
providing an endoluminal view the system can simultaneously display the multi-planer recon-
structed (MPR) slices through the occlusion thus allowing the operator to visualize upfront the 
morphology of the occlusion (Figure 1C).
iv) The Bull’s Eye view
Regardless of the 2D or 3D navigational mode, the Bull’s Eye can be additionally employed to 
search for micro-channels in a systematic way. To achieve this the wire tip can be automatically 
or manually re-orientated in a systematic fashion to mimic the contours of a dartboard or a 
bull’s eye (Figure 1D). 
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Special CTO Techniques
In this study over-the-wire balloons (OTW) provided additional back up for the guidewires. 
It also facilitated the rapid exchange of various guidewires though its lumen without losing 
the original wire position. Subsequent removal of the OTW required inflation of an indeflator 
containing saline to roughly 16 atmospheres connected to the lumen. 
Employing two guidewires to search for the true lumen was used in the parallel wire technique: 
-one that has entered the vessel subintimally and left in this position with another usually 
a stiffer wire used to find the true lumen from a different entry point. In a somewhat similar 
technique, the see-saw technique used two guidewires, but instead of leaving one of them in 
the false lumen, both are used sequentially to reenter in the true lumen11.
the guidewires
The first generation Cronus™ and second generation Titan™ Soft Support coronary guidewire 
(Stereotaxis, St. Louis, M. USA) are 180cm moderate support, hydrophilic coated 0.014in wires 
with a flexible 2cm distal coiled tip having a 2mm or 3mm long gold cup neodynium magnet 
attached. The Pegasus™ guidewire is similar to the Titan™ Soft Support coronary guidewire 
except the distal 30cm of the stainless steel distal shaft is replaced by nitinol. All 3 generations 
are available in the stiffer Assert™ wires ranges The conventional wires used in this study were 
PT Graphix™ Intermediate, Choice™ PT Floppy (Boston Scientific Corp. Miami Fl, USA); Pilot™ 
50, 150, Whisper™ and high torque BMW (Abbott Vascular Devices, Redwood CA, USA); Miracle 
bros™ 3G, 4.5G, 6G, 12G, Fielder and Confianza (ASAHI, INTEC, Co, Japan); Crosswire NT (Terumo 
Inc, Tokyo, Japan).
statistics
Continuous variables are presented as means and standard deviation. T-test and one-way 
ANOVA (Bonferoni) were used to determine if there were significant differences in the pro-
cedural time and fluoroscopic times. Analyses were performed using SPSS 11.5 for Windows 
(SPSS, Chicago, IL). P value < 0.05 was considered statistically significant.
results
Demographics and CTO characteristics
The baseline characteristics of the 43 patients enrolled in this single center registry on 
magnetically managed chronic total occlusion are given in Table 1. The mean age of patients 
were 67.1±9.8 years and the majority was male (76.7%). One fifth was diabetics and the most 
common cardiovascular risk factors were hypertension (60.5%) and hyperlipidaemia (76.7%). 
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Interestingly, a significant number of patients had a previous PCI (41.7%) or CABG (14.0%) at 
presentation. On diagnostic angiographic images there was roughly equal distribution of one, 
two and three vessel disease. The majority of patients (93.0%) underwent first attempt to revas-
cularize the CTO. Most CTOs were de novo lesions (95.3%) frequently involving the left anterior 
decending artery (LAD, 32.6%) and to a lesser extent the circumflex coronary artery (LCX, 25.5%) 
and the right coronary artery (RCA, 18.6%). The angiographic characteristics are also shown in 
Table 2. Of note the characteristic in stump morphology was equally distributed12. Over three-
quarters had significant contra-lateral collateralization and 30% had calcific vessels on coronary 
angiography. In addition to the occluded vessels nearly one third of patients had a second 
single vessel treated at the indexed procedure and in a smaller number (9.3%) two vessels.
The overall crossing success using the full armamentarium of all possible choices of magneti-
cally enabled wires and navigational modes was 44.2% (19/43patients). Bail-out conventional 
wires were successful in 14 of the failed 24 magnetic cases (58.3%) giving an overall procedural 
success of 76.6%. In the majority of cases the 2nd generation Titan™ wires were used (72.1%). 
table 1 Baseline characteristics n = 43
Age, years (mean+SD)  67.1 ± 9.8
Male (%)  76.7
Diabetes mellitus (%)   20.9 
Insulin Dependent (%) 14.0
Hypertension (%)  60.5
Family history of CHD (%)   27.9
Ex smoking (%)  48.8
Hypercholesterolaemia (%)  76.7
Previous PCI (%)  41.7
Previous CABG (%)  14.0
Vessel disease (%)
One vessel disease  34.9
Two vessel disease  39.5
Three vessel disease  25.6
Attempts to reopen the CTO (%)
First  93.0
Second  7.0
SD = standard deviation; CHD = cardiovascular heart disease;
CABG = coronary artery bypass graft;
PCI = percutaneous coronary intervention;
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table 2 cto characteristics
Type of CTO (%)  De novo 95.3
In-stent restenosis  4.7
Target vessel (%)
Left anterior descending   32.6
Left circumflex   25.5
Right coronary artery   18.6
Intermediate/Obtuse Marginal   14.0
Diagonal   9.3
Stump morphology (%)
Central   32.6
Eccentric   37.2
Blunt   30.2
Ostial involvement (%)   30.2
Side branch at entry (%)   81.3
Bridging collaterals (%)   37.2
Collateral filling [Rentrop Classification (%)]
0/1   20.9
2   41.9
3   37.2
Angiographic Calcification (%)
None/mild   69.8
Moderate   23.2
Severe   7.0
PCI in at least one additional (non-occluded) major vessel during the index procedure 
(%)
One arteries   32.6
Two arteries   9.3
Treated CTO  
Number of stents in treated occluded vessel   1.8±0.9
Average target vessel stent length (mm)   44.7±21.4
Average target vessel stent diameter (mm)   2.8±0.4
Contrast used (ml)   388.8±170.2
Procedure time (min)   125.0±35.3
Fluoroscopic time for entire procedure (min)   42.1±19.7
Radiation exposure, dose area product (DAP) Gy/cm2  11980.2±6457.9
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These wires had a greater overall crossing success over the 1st generation Cronus™ range (36.4% 
vs. 48.4%). A significant proportion (44.2%) of patients had CTCA co-integration into Navigant® 
to create vectors along a navigational path through the occlusion. Surprisingly, the overall suc-
cess in patients where the CTCA was co-integrated and navigated upon was nearly identical 
to those managed without CTCA co-integration (73.6% vs. 75% respectively). Moreover, CTCA 
co-integration only marginally improved the magnetic wire success (47.3%) when compared to 
the overall success achieved with this system (44.2%). 
In total 1.8±0.9 stents with an average length of 44.7±21.4mm and diameter of 2.8±0.4mm were 
implanted in the occluded vessels. The average procedural time was 125.0±35.3mins with an 
overall contrast media usage of 388.8±170.2mls. Additionally, patients were exposed to lengthy 
radiation times 42.1±19.7mins and periods of exposure 11980.2±6457.9 Gy/cm2. The overall 
procedural complication was low (4.6%) with two patients needing pericardial drainage inser-
tions resulting from bail out conventional wire exits and subsequent ballooning. One of these 
patients later proceeded to emergency surgery following an extra-vascular balloon dilatation.
Analysis of Magnetic Navigation System Performance in Crossing the Occlusion
Following the installment of the MNS in 2004 the feasibility of managing CTO was performed 
initially in 5 patients using the 1st generation wires (Cronus™) with a success rate of 40%. The 
low patient recruitment observed in the subsequent 2 years improved following the integration 
of the CTCA extracted coronary artery into the Navigant®. In year 3 there was a dramatic rise in 
Figure 2 Cumulative curve of CTO success with the MNS with respect to the total success and cases.
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the patient enrolment accounting for 53% of all the magnetically managed CTO (Figure 2) and 
with the availability of the 2nd generation wires (Titan™) the success rate to increased 56%. 
In terms of the wire performances, the average time for wiring the CTO whether successful or 
not regardless of the technique (magnetic or bail-out) was 34.5±28.4mins. Within this period 
the magnetic wire was used for average of 18.2±11.7mins. In the 19 successful magnetic cases 
the average crossing time was 14.8±9.8mins and in the 24 failed cases the average trial time 
was 20.9±12.4mins. Longer wiring times 27.7±24.4mins (p=0.22) was required in the 14 failed 
magnetic cases that were eventually successful using bailout conventional wire techniques. In 
the 10 cases (23.3%) were both wires failed, wiring was continued for over an hour (69.5±32.9). 
Analysis of these cases revealed that the majority (6 cases) was due to vessel dissections after 
several trials with the conventional wire. The inability to penetrate the cap or re-enter the true 
lumen distally each accounted for 2 failed cases. Analysis of the lesion characteristics revealed 
that the magnetic wires were more successful if the stump was central (76.6%) and if there were 
low levels (none/mild) of calcification (60.0%). Limited magnetic wire successes were observed 
in vessels having moderate/severe calcification (7.7%) or in cases where there was angiographi-
cally bridging collaterals (11.8%), Table 3.
Assessment of wire usage
In total twenty different types of guidewires (7 magnetic and 13 conventional) were used in this 
study (Table 4). 70% of the cases involved the use in of an OTW balloon. Overall operators were 
less inclined to use stiffer magnetic wires early in the procedure. They also gave up similarly 
weighted magnetic wire (the 3 gram Assert range) relatively earlier (4th choice) in favor to the 
3 gram Miracle wires, which was employed as far as a 9th choice. Amongst the 1st generation 
magnetic wires the Cronus™ Moderate was the 1st choice (20.9%) with stiffer Cronus™ 3 gram 
Assert guidewires used as a 2nd choice only in one case (Table 4). Surprisingly, softer 2nd genera-
tion wire (Titan™ Soft Support) where used as 1st choice in over fifty percent of cases. Only in 
a relatively small number of procedures (21%) were the stiffer Titan™ Moderate or Asset wires 
used as the 1st choice. In a somewhat similar fashion to the MNS, softer conventional wires (PT 
choice, Hi Torque Whisper, Hi Torque BMW) were preferentially used as the 1st choice (36.5%) 
in bailout MNS cases. More hydrophilic (PT Graphic Intermediate and Crosswire NT) and stiffer 
wires (Miracle 3gram and Confianza) were more often used as a 3rd choice (47.6% and 28.6% 
respectively). The prevalence of the stiffer conventional wires increased over time. 
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table 3 Wires, success, times and complications
Wires/cases (%)
Cronus    25.6
Titan  72.1
Pegasus  2.3
Special technique (%)
Over the wire balloon   69.8
Parallel wire   30.0
See Saw   4.7
MSCT co-integration 44.2
Success (%)
Overall success rate (33/43) 76.6
Magnetic wire success rate (19/43) 44.2
Standard wire success in failed Magnetic cases (14/24) 58.3
Cronus (4/11) 36.4
Titan (15/31) 48.4
Pegasus (0/1) 0
Magnetic success with MSCT co-integration (9/19) 47.3
Overall success with magnetic and bail-out standard wires in patients with MSCT 
co-integration (14/19)
73.6
Overall success with magnetic and bail-out standard wires in patients without 
MSCT co-integration (18/24)
75.0
Magnetic wire Success in Lesion Subset (%)
Moderate/Severe calcification (1/13) 7.7
None/Mild calcification (18/30) 60.0
Central stump (11/14) 76.6
Eccentric stump (4/16) 25.0
Blunt stump (4/13) 30.8
Bridging collaterals (2/17) 11.8
Crossing Times/min; (mean+SD)
Overall crossing time 34.5±28.4
Magnetic wire (successful and unsuccessful cases) 18.2±11.7
Magnetic wire (successful cases) 14.8±9.8
Magnetic wire (unsuccessful cases) 20.9±12.4
Standard wire times in magnetic unsuccessful cases 27.7±24.4
Magnetic and standard wire failures 69.5±32.9
Complications (%)
Pericardial Drains 4.6
Surgical repair 2.3
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discussion
The variability in success rates in crossing CTO provides the impetus for seeking alternative 
therapeutic options for managing this interesting but complex lesion subset10. Apart from 
Table 4: Choice of wires used in chronological order from 1st attempt with magnetically enabled wires to 9th 
choice with conventional wires.
1st 2nd 3rd 4th 5th 6th 7th 8th 9th
Number and
% patients
n=43
100.0
n=24
55.8
n=21
48.8
n=16
37.2
n= 8
18.6
n=7
16.3
n=2
4.7
n=2
4.7
n=1
2.3
Magnetic 
wires %
Cronus 
Soft
2.3 
Cronus 
Moderate 
20.9
Cronus Assert 2.3 4.2
Titan 
Soft
51.2 12.5 4.8
Titan Moderate 14.0
Titan 
Assert
7.0 4.2 6.3
Pegasus 
Intermediate
2.3
Standard
Wires %
Choice 
PT 
8.3
PT Graphix 
Intermediate 
29.2 28.6 18.7 12.5
Crosswire NT 4.2 19.0 18.7 14.3
Hi-torque 
Whisper 
4.2
Hi-torque pilot 
50 
25.0 19.0 12.5 12.5 14.3
Hi-torque pilot 
150
50.0
Hi-torque 
BMW wire 
4.2
ASAHI Fielder 12.5 14.3
ASAHI 
Miracle 3g
4.2 23.8 37.5 25.0 28.6 100.0 50.0 100.0
ASAHI 
Miracle 4.5g
12.5
ASAHI 
Miracle 6g
12.5
ASAHI 
Miracle 12g
14.3
ASAHI 
Confianza
4.8 6.3 12.5 14.3
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being gratifying for the operator the successful treatment is prognostically significant to the 
patient. As such the wealth of tools and devices bears testament to the determination amongst 
the interventional cardiology community in succeeding. But in this quest, several key elements 
are occasionally overlooked. Patients are subjected to lengthy procedures, high volumes of 
contrast media impacting on renal function, and high levels of radiation exposure13,14. More-
over, the high procedural cost can have repercussions on budgets and resources15. 
It is not surprising therefore that the application of the magnetic navigation system to managing 
CTOs has been warmly received10. The technology has been shown to be effective in crossing 
complex vascular anatomies in patent vessels16. Moreover, it can reduce contrast media usage 
and successfully manage selected cases that failed to cross conventionally17. In occluded vessels 
however, there is limited data from only two recent registries and no randomized studies. In one 
having 30 patients, 3 out of the 5 magnetically failed cases was due to subtotal chronic occlusion 
and this included 1 patient who required surgical intervention18. In the other registry containing 
439 lesions in 350 consecutive PCI patients, 25 out of the 35 failed crossing where CTOs19. 
In this paper we report in detail our experience as a leading center in the MAI treatment of 
chronic total occlusions starting form the initial installation of the system in 2004 9. The data 
demonstrated that the MNS has limited success but can be safely used in unselected occlu-
sions. Over this period a learning curve was demonstrable as with the initial low success rates 
improved over time. Several coronary and non-coronary groups using the MNS have previously 
reported similar learning curves19-21. The overall success rate with the MNS was lower than that 
historically reported from our center6. Following bailout conventional wire strategy a good 
overall success rate achieved. Moreover, complication rates were low and restricted to the 
bailout group. These findings are not surprising if one considers the wiring times and choice 
in wire usage in the MNS. In general, operators were more inclined to use the softer magnetic 
wires and gave up much earlier in preference to the traditionally dedicated CTO standard wires. 
These dedicated CTO were more often stiffer, used for longer periods and were exchanged for 
increasingly stiffer ones in the more difficulty cases. The reason for this could be explained in 
part to the initial novelty and lack of familiarity with the magnetic wires to this lesion subset. 
But more so, in our experience we felt that even though the ability to steer using a 2-3mm 
long attached magnetic tip has been proved to be effective for patent vessels, this tip profile 
may not be ideally suited for total occlusions. The notion of searching for micro-channels using 
the bull’s eye is limited by the blunt and straight nature of the wire tip restricting the wire 
from engaging small-angulated channels within the occluded segment22. Furthermore the 
transition of the magnetic tip to the shaft lends itself to “buckling” when “push force” is applied 
to the wire. Operators were therefore more likely to resort to the conventional wires that had 
smoother transition of the tip to the shaft without compromising the applied force. Using the 
magnetic wire in an OTW balloon does not solve this crucial limitation. This is because although 
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like conventional wires the shaft is equally support, the advancement of the balloon to support 
the tip incapacitates the steering ability and furthermore changes the profile of the wire to such 
an extent that the tactile responsiveness of the tip is completely lost. 
These results provide further evidence that for the magnetic system to be effective in the all CTOs 
and not restricted to those with central stumps, low calcium or collateralization a completely 
different wire with a different procedural strategy is required. Non-steerable radiofrequency and 
laser-guided wires have been previously used to manage CTOs with limited success10. Enabling 
such devices to steer can potentially improve the outcome in managing CTOs. But in order 
to be safe and effective precision mapping of the occluded segment and real time feedback 
positioning of the device within a fraction of a millimeter is required. This report demonstrates 
that real time knowledge of the navigational path through the occlusion did not influence 
the success in patients who had a CTCA overlaid on the fluoroscopy images and those treated 
without. This suggest that for the co-integration of a CTCA roadmap to be clinically effective 
it needs to be used with dedicated CTO devices such as the magnetically enabled RF ablating 
wire (Stereotaxis Corp) in development8. It is also necessary to simultaneously update the CTCA 
roadmap to the changing vessel anatomy of the cardiac cycle (dynamic road mapping) since 
currently the static overlay based only on one diastolic image will not guarantee that the device 
will be optimally positioned when the energy is delivered.  Additional factors such as patient 
and respiratory movement will need to be adequately compensated and overcome.
Limitations
The level experiences with the two strategies may have influence the period of time operators 
were willing to persevere with each system. There was no written or universal approach to deal 
with the various complexities encountered. The study was not powered to assess the influence 
of guiding catheters, which could have influence procedural outcome. Contrast media usage and 
fluoroscopic times were assessed for the whole procedure so included treatment of other vessels. 
The age of the occlusion could not be precisely determined, relying primarily on the patient’s 
clinical history and previous angiographic films. This was a single-center’s experience in a Univer-
sity specialist tertiary referral unit and the case mix might be different to that seen elsewhere.
conclusions
In unselected chronically occluded vessel the magnetic navigation system is safe. The modest 
success and relatively high procedural bailouts does not currently confer an advantage with the 
MNS over the more sophisticated conventional CTO wires. The limited success is related to the 
operator’s reluctance to persevere because of the inherent limitations with the current mag-
netic wire technology. At present CTCA co-integration did not influence procedural outcome.
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Chapter 7
Magnetic navigation For non-
coronary interventions
Magnetically guided left ventricular lead 
implantation base on virtual 3d reconstructed 
image of the coronary sinus
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abstract
Background:
Left ventricular lead (LV) implantation is feasible using remote magnetic navigation of a 
guidewire (Stereotaxis, St. Louis, MO, USA). A novel software that performs a 3-D reconstruction 
of vessels based on 2 or more angiographic views has recently been developed (CardiOp-B 
system™, Paeion Inc, Haifa, Israel).
objectives:
To evaluate 1) the performance of the 3D reconstruction software to reproduce de anatomy of 
the coronary sinus (CS) and 2) the efficacy of remotely navigating a magnetic guidewire within 
the CS based on this reconstruction.
Methods:
In patients undergoing CRT implantation a 3D reconstruction of the CS was performed using 
CardiOp-B™ system. Accuracy of the reconstruction was evaluated as compared to the CS 
angiogram. This reconstruction was imported into the Stereotaxis system. Based on the recon-
struction magnetic vectors to navigate within the CS were automatically selected and manually 
adjusted if needed. Feasibility of deploying the guidewire and LV lead into the selected side 
branch, fluoroscopy time (FT) required for cannulation of the target side branch (SB) and total 
FT were also evaluated.
results:
Sixteen patients were included. In one case the software could not reconstruct the CS. The 
quality of the reconstruction was graded as good in 13 and poor in 2. In 10 cases manual adjust-
ments to the traced edges of the CS was required to perform the 3-D reconstruction and in 5 no 
adjustments were needed.  In 13 patients the target SB was engaged based on the automati-
cally selected vectors.  In 2 cases manual modification of the vector was required.  Mean total FT 
was 23 ± 14 min and FT required to cannulate the target SB was 1.7 ± 1.3 min.
conclusion:
A 3D reconstruction of the CS can be accurately performed using 2 angiographic views.  This 
reconstruction allows precise magnetic navigation of a guidewire within the CS.
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introduction
Despite the technological progress aimed at improving success and reducing complication 
rates during cardiac resynchronization therapy (CRT) device implantation, in a proportion of 
cases delivery of a left ventricular (LV) pacing lead through the coronary sinus (CS) still fails.  As 
recently demonstrated transvenous implantation of a LV pacing lead is safe and feasible using 
remote magnetic navigation of a guidewire (1,2). However, we encountered certain limitations 
in order to reach the ultimate goal of reproducibly implanting the LV lead remotely.  Among 
these limitations was the lack of having a real-time three-dimensional (3D) CS model to facili-
tate more accurate navigation of the guidewire.  A novel imaging system (CardiOp-B system, 
Paeion Inc, Haifa, Israel) is becoming an established technique for the 3D reconstruction of 
vessels using data obtained from standard vascular angiography (3).  The reconstructed vessel 
can subsequently be imported to the Niobe™ (Stereotaxis, St. Louis, USA) magnetic navigation 
system and magnetic vectors can be selected based on this virtual model of the vessel.  
Our purpose was to test the feasibility of reconstructing the anatomy of the CS using this 
software and evaluate the accuracy of navigating within the CS based on this 3D model.
Material and Methods
Patient Population
Sixteen consecutive patients who underwent CRT device implantation were included in this 
study. These patients met the standard criteria for CRT comprising of advanced heart failure 
refractory to medical therapy, low ejection fraction (EF) (<35 %), and a broad QRS (≥120 msec) 
on the electrocardiogram (ECG) with a left bundle branch block (LBBB)-like morphology. All 
patients gave informed consent.
Implantation Procedure: 
All procedures were performed in the room equipped for magnetic navigation (Niobe™ II, 
Stereotaxis, St. Louis, MO, USA). In all patients the left cephalic vein was dissected. An RV shock 
lead (model 1580 Riata, St. Jude Medical, Sylman,CA, USA or model 6947 Sprint Quattro Secure, 
Medtronic Inc., Minneapolis, MN, USA) was introduced and actively fixed to the right ventricular 
apical wall. After a double left subclavian venous puncture, a right atrial active fixation lead 
(model 5076, Medtronic, Inc.) was introduced and positioned in the right atrial appendage. 
Pacing and sensing properties of these leads was assessed.
CS angiography and 3D reconstruction
 A 9 F long guiding sheath (model Attain 6216, Medtronic, Inc.) was introduced, in order to 
cannulate the CS.  Angiograms of the CS were performed using 30˚ LAO, AP and 30˚ RAO projec-
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tions (projections allowed when the magnets are in navigate position).  These angiograms were 
imported to the CardiOp-B System™ (Paeion Inc.). 
An automatic algorithm detects the vessel edges in each of the projections used for the recon-
struction.  In case edge detection was inaccurate (not exactly superimposed to the angiographic 
edge), manual adjustments could be made so as to obtain the best reconstruction possible. 
Based on the traced edges, and using a minimum of two complementary angiographic views, 
a 3D reconstruction of the vessel was performed.  The system allows reconstructing the body 
of the vessel and one bifurcation or side branch at a time. The reconstructed 3D model of the 
CS and its side branch can then be imported to the Niobe™ (Stereotaxis, St. Louis, MO, USA) 
where, after alignment to the real time fluoroscopic views, flythrough images of the model can 
be used to navigate (Figure 1). The quality of the reconstruction was assessed by two opera-
tors performing the procedure and graded as i) not possible to be reconstructed, ii) poor or iii) 
good, after superimposing and aligning it to the real-time angiography in the LAO, AP and RAO 
projections (Figure 2).  The need of manual adjustment of the traced edges in order to improve 
the quality of the reconstruction was also evaluated. 
Figure 1. Top: at the left, 3D reconstruction of the coronary sinus with one side branch in an antero-
posterior view. Note the marked angulation of the lateral side-branch. At the right, a flythrough image of the 
reconstruction. Bottom: Reconstructed model aligned to the fluoroscopic view in LAO projection (left panel) 
and AP projection (right panel).  In green, the automatically selected vector.
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Magnetic navigation based on the virtual 3D image of the CS
Magnetic navigation is performed by positioning two external magnets (Stereotaxis) at each 
side of the table in order to generate a 0.08 Tesla magnetic field within the patient. The orienta-
tion of the magnetic field is established by the interaction the two external magnets exert with 
each other and can be automatically determined or specified by an operator working remotely 
in the viewing room.  A single 2 mm neodymium iron boron magnet attached at the tip of a 
0.014 guidewire (Cronus™ Soft support Endovascular Guide wire, Stereotaxis) aligns itself to 
the direction of the magnetic vector.  In this way, by changing the orientation of the magnets, 
the resultant magnetic vector changes and the tip of the guidewire aligns itself in the direc-
tion of the newly applied vector.  A dedicated software package, the Navigant™ (Stereotaxis) 
allows the full integration of the Niobe™ system and the imported CardioOp® 3D reconstruction 
(Paeion).  In this way the vectors needed to navigate within the reconstructed vessels and to 
access the desired portion of the vessel, can be automatically determined by the system (Figure 
Figure 2. Four panels, as seen in real time, showing the different automatically selected vectors (green arrows) 
chosen to navigate within the reconstructed coronary sinus (CS) model. In each panel, at the top left: 3D 
reconstruction of the CS; top right: endovascular view; bottom left: RAO projection and not aligned 3D model to 
facilitate visualization of the side branch; bottom right: LAO projection with aligned 3D model.  Note how the 
vector changes according to the portion of the vessel it is aiming at.
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2). In case the vectors suggested by the system are not accurate enough to allow access to 
the desired side branch, manual adjustments can be performed.  In this study the guidewire 
was manually advanced after each modification of the magnetic field (every 3 to 5 mm steps) 
in order to access the ideal side branch (as previously defined by the operators).  Once the 
target side branch was engaged an over-the-wire LV pacing lead, (Medtronic Attain, Medtronic, 
Inc. or QuickSite, St. Jude Medical, Sylmar, CA, USA) was introduced and lodged in the vessel. 
Feasibility of i) deploying the guidewire and LV lead into the selected side branch (SB) using 
the automatically determined vectors, ii) need of manual adjustments of these vectors, iii) 
fluoroscopy time (FT) required for cannulation of the target SB, iv) total FT and v) procedure 
time were assessed.  
results
The procedural outcome of the 16 consecutive patients included in the study is detailed in Table 
1.  All had a LBBB-like broad QRS complex on the ECG, a severely depressed LV ejection fraction 
and advanced symptoms of heart failure (NHYA functional class 3 ± 1).  The mean procedure 
time was 99 ± 26 min, the mean FT was 23 ± 14 min and the mean FT required to position the 
LV lead into the target CS side branch was 1.7 ± 1.3 min.  
3D reconstruction of the coronary sinus
In 15 patients (93 %) the 3D reconstruction of the CS was successfully performed.  In case num-
ber 4 the software was unable to reconstruct the CS and consequently the LV lead implantation 
was conventionally performed.  In 10 cases minor manual adjustments to the traced edges of 
the CS was required in order to obtain a 3-D reconstruction of good (in 8 cases) or poor (2 cases) 
quality.  In the remaining 5 patients no manual adjustments were required in order to obtain a 
good reconstruction (Figure 1).  Overall, the quality of the reconstruction was considered to be 
good in 13 cases (81 %) and poor in 2 (12 %). 
LV lead implantation
In all 15 patients in whom magnetic navigation based on the reconstructed CS was performed 
the target side branch was successfully engaged with the magnetically steered guidewire. 
In 13 patients (87%) this was possible based only on the automatically selected vectors; in 2 
cases (13%) manual modification of the automatically selected vectors was required in order to 
navigate distally in the target vessel.  In one case the lead had to be definitively deployed in an 
anterior side branch due to lack of acceptable pacing thresholds in other locations.  However, 
navigation all through the CS was feasible in this patient using the automatically selected vec-
tors.  In 2 other cases the LV lead had to be deployed in a different side branch than that initially 
targeted because they could not be engaged with the selected leads.  It is interesting to note 
that in patient 1 after CS angiography no further fluoroscopy was required to engage the target 
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Table 1 – Procedure characteristics and left ventricular lead position 
Patient
number
Procedure 
Time
(min)
Fluoroscopy
Time
(min)
LVL 
Fluoroscopy
(min)
Target SB 
accessed w/
guidewire
Final LVL 
Location
Pacing 
Threshold
(mV)
1 150 18,4 0,2 Yes PL 1
2 85 36,7 3 Yes AL 0,4
3 75 23,3 2,36 Yes PL 0,5
4 - - - Yes PL 1.1
5 95 23,2 1,64 Yes PL 0,7
6 140 46 0,13 Yes Ant 1,6
7 96 14,48 4,5 Yes L 1
8 101 19,2 0,33 Yes L 1,2
9 75 18,4 0,26 Yes PL 0,7
10 70 7,5 2,26 Yes L 0,8
11 85 27,35 1,05 Yes L 0,9
12 110 9,41 0,18 Yes Ant 4,8
13 98 16,21 2 Yes PL 2
14 60 8,7 3,05 Yes L 1,5
15 110 21,42 2,4 Yes PL 1,1
16 130 58 2,2 Yes L 0,4
Mean (SD) 98.6 (25) 23.2 (14) 1.7 (1.3) 1.2 (1)
AL=anterolateral, Ant= anterior, LVL= left ventricular lead, L=lateral, PL= postero-lateral side, SB= coronary 
sinus side branch, SD= standard deviation.
Table 2 – Quality of reconstruction and Navigation
Patient
number
Quality of 3D 
reconstruction
Edge adjustment 
needed
Type of navigation
1 Good Yes Automatic
2 Good Yes Automatic
3 Good Yes Automatic
4 Not done - -
5 Good Yes Automatic
6 Good Yes Automatic
7 Good Yes Automatic
8 Good No Automatic
9 Good Yes Automatic + Manual
10 Good No Automatic
11 Poor Yes Automatic
12 Good No Automatic
13 Poor Yes Automatic + Manual
14 Good No Automatic
15 Good Yes Automatic
16 Good No Automatic
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side branch and position the lead.  One patient suffered from diaphragmatic stimulation at high 
pacing output (10 V) but the lead required no repositioning because of lack of diaphragmatic 
capture with lower output (7.5 V).  No other complications were observed during or after the 
procedure.
discussion
To the best of our knowledge, this is the first reported use of 3D reconstruction software to cre-
ate an accurate real-time virtual map of the CS. We demonstrate that this virtual 3D model can 
be integrated with the magnetic navigation system in order to allow reliable navigation within 
the CS.  Based on the reconstructed image, the system allows automatic vector selection to 
guide a magnetically enabled wire to its desired position within the CS in order to later advance 
the LV pacing lead. 
 3D reconstruction of the coronary sinus
Transvenous LV lead implantation is sometimes time consuming, it may require prolonged 
fluoroscopy times and can eventually fail.  Local complications generated by the delivery 
system and the occlusive angiogram of the CS (dissection of the vessel, spasm or even rupture) 
may lead to implantation failure.  However, the main reason of implantation failure remains 
the sometimes challenging anatomical properties of the CS.  Valvular structures, stenosis, lack 
of side branches, highly angulated side branches and tortuous vessels are common findings 
during CRT implantation.  Despite continuous innovations and technological improvement of 
the delivery systems, guidewires and LV leads, approximately 10% of implantations attempts 
still fail (4).  
Implantation procedures are conventionally guided by the use of fluoroscopy which offers a 
two dimensional view of the vessel of interest. In this way, tortuous side branches can appear 
foreshortened or overlapped (5) resulting in inaccurate interpretations of the anatomy and 
making decisions regarding selection of the appropriate material and manoeuvres needed to 
reach certain vessels more difficult.   Magnetic navigation of guidewires was meant to help 
overcome these difficulties and allow access to places that using conventional technology is 
very challenging (6,7).  The possibility of performing an accurate 3D reconstruction of a vessel 
that is integrated to the magnetic navigation system allows more reliable and effective naviga-
tion as compared to that guided only by fluoroscopy.  The advantage of this reconstruction is 
that it is performed with the patient in the same position and under the same circumstances 
(heart rate, rhythm, hemodynamic status, etc.) than that during the implantation.  This should 
allow more precise navigation than using imported pre-operative 3D images obtained under 
different circumstances than during implantation.
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In our experience it was not possible to obtain a 3D model of the CS, in only one case prob-
ably due to the fact that the diameter of this particular vessel was larger than conventionally 
encountered.   It should be borne in mind that this software was developed to reproduce 
the anatomy of coronary arteries which are narrower and less tortuous than the CS and its 
side-branches.   In 2 other cases the final result was a poor reconstruction.  Here, the sizes of 
the vessels were no different than those that were more accurately reconstructed.  Probably 
the particular anatomy of these vessels required other fluoroscopic projections than the ones 
used (LAO 30˚, AP and RAO 30˚) to create the model.  Nevertheless, these reconstructions 
were good enough to allow navigation and deployment of the guidewire into the desired side 
branch.  In the remaining 13 cases a good quality reconstruction was obtained.  In 10 cases 
the automatically traced contour of the vessel had to be manually modified in order to correct 
for inaccuracies in the interpretation of the vessel’s edge.  However, in most of them the end 
result of the reconstruction was satisfactory.  Performing the 3D reconstruction, importing it 
to the magnetic navigation system and aligning it to the fluoroscopic views required only a 
few minutes and did not significantly delay the procedure.  The reconstruction of the CS was 
performed while the implanting physician was selecting the appropriate lead, preparing it and 
introducing it into the guiding sheath.  
This software, and its integration to the magnetic navigation system, offers a reliable 3D view of 
the CS and its side branches allowing precise navigation within the vessel.  In all patients were 
reconstruction of the CS was feasible the target side branch was successfully engaged by the 
guidewire.  In 87% of these cases this was achieved only using the automatically selected vectors 
and in 2 cases manual modifications were required.  Using the 3D reconstruction as a model for 
navigation provides much more information than the fluoroscopic views and allows the system 
(and the operator) to more precisely interpret the side-branch location, direction, angulation 
and length.  It is this model that is used to guide the implant, consequently potentially reducing 
the use of fluoroscopy and limiting the amount of projections (and contrast injections) needed 
to interpret the angiograms.  In all the patients in whom the CS was successfully reconstructed, 
navigation within the CS was only based on the reconstruction irrespective of whether vectors 
were automatically selected or manually adjusted.  
Limitations
One limitation of this technique is that the 3D model of the vessel is obtained from static images 
from a beating heart.  Even though the fluoroscopic images used to perform the reconstruction 
were ECG gated, it remains a static model that is being used to guide an implantation performed 
in a beating heart.  Also respirator movements are also not compensated for by this system. 
Consequently, inaccuracies of magnetic navigation based on this 3D reconstructed model may 
also be due to a lack of compensation for respiratory movements and cardiac cycle.  Whether 
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developments as rotational angiography will serve as better models for magnetic navigation is 
another step to investigate (8).  Nonetheless, these same limitations would be applicable also 
for this technique.  However, nowadays it is not possible to integrate rotational angiography to 
the magnetic navigation system. 
Another limitation of the present version of the software is that it allows reconstruction of the 
body of the vessel and only one side branch or bifurcation.  In this way, in order to navigate to 
a different side branch than the initially selected, a new reconstruction using the second side 
branch was needed. 
In our view, once the guiding sheath and the guidewire can be remotely advanced using 
an advancer system similar to the one used for radiofrequency ablation catheters (9-12), this 
software will allow remote LV lead implantations with minimal fluoroscopic exposure.  One 
example is the patient in whom navigation using the reconstructed CS image was enough to 
engage the desired side branch without the use of fluoroscopy. 
conclusion
A reliable 3D reconstruction of the coronary sinus can be performed using at least two comple-
mentary angiographic views.  This reconstruction, when integrated into the magnetic naviga-
tion system, allows accurate navigation within the vessel of a magnetically steered guidewire 
to perform left ventricular lead implantations.
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introduction
Cardiac failure secondary to ischaemic heart disease is a leading cause of morbidity and mortal-
ity1.  Infarction leads to cell loss by oxidative stress and reperfusion injury.  Chronic ischaemia 
and myocyte loss produces progressive expansion of the infarct area, fibrous replacement of 
the myocardium and predisposes to dilation of the left ventricle2, a major factor in survival3. 
Progenitor/stem cell therapy has potential for promoting structural and functional repair of the 
myocardium.
Progenitor/stem cells may stimulate either angiogenesis4,5 by the release of growth factors 
and anti-apoptotic factors (including Akt, VEGF and FGF), and/or vasodilation (by VEGF) with 
an increase in iNOS bioavailability that may help maintain cell viability and encourage blood 
flow.  More controversially, progenitor/stem cells from the bone marrow, circulating blood or 
embryonically-derived, may lead to myocardial cell regeneration6,7.  However to date, improve-
ments in cardiac function and structure have been modest8,9.
Current delivery techniques include 2-D angiographically-guided endocardial injection and 
catheter-based intracoronary release.  However, these techniques have general limitations that 
include imprecise on-table identification of the best areas to target, poor ability in targeting a 
specific area, and mediocre identification of the treated area at follow-up.  In addition, intrac-
oronary release has specific drawbacks such as induction of ischaemia, or the ‘shedding’ of cells 
into the general circulation.  Two particular clinical settings that appear particularly appropriate 
for progenitor/stem cell therapy are those of recent anterior myocardial infarction that results 
in reduced LV function and of chronic, ischaemic, and dilated cardiomyopathy.
The development and integration of electromechanical mapping technology, NOGA® XP (Bio-
logics Delivery Systems™, Cordis Corporation, Diamond Bar, California, USA) with the develop-
ment of a magnetically navigable injection catheter, the MyoStar™ Injection Catheter (Biologics 
Delivery Systems™), could transform cell delivery.  
This article will review the principles of magnetic navigation with the forthcoming technology; 
consider how localisation, delivery and follow-up might potentially be improved compared 
with current techniques; discuss the relevance to two of the clinical settings that might derive 
the most benefit; and mention the possibilities of improved percutaneous revascularisation 
that might be used to optimise the local milieu for progenitor/stem cell survival.  The purpose 
of this article is to suggest and speculate upon how this technology might allow integration of 
the real-time visualisation of target tissue with site-directed deliverability in order to reduce 
procedure times and irradiation, and to simultaneously improve efficacy and follow-up.
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Magnetic navigation system
The magnetic navigation system (Niobe®, Stereotaxis, St Louis, MO, USA) consists of two adjust-
able permanent magnets on either side of the fluoroscopy table (Figure 1). In essence the 
system does three things.  Firstly, the system operates using a 3-D reconstruction that is either 
produced from angiographic images (as in the case of coronary arteries) or, alternatively, an 
imported 3-D reconstruction from an external system e.g. NOGA® XP.  Secondly, the spatial ori-
entation and location of this reconstruction is matched to the real-life patient’s internal cardiac 
anatomy i.e. coronary artery or cardiac chamber.  Thirdly, the model gives the real-time, on-line 
vectors to direct an external magnetic field to orientate a magnet on an intravascular device to 
match the direction required for navigation through the 3-D reconstruction.  The result is the 
ability to use 3-D information in real-time in patient therapy.
The magnetic navigation system has been described in detail previously10,11.  Briefly, the 
interacting magnetic field produces a 15 cm uniform magnetic field of 0.08 Tesla that can be 
increased to 0.1 Tesla.  Computer-controlled movements of the magnets allow re-direction of 
this externally applied magnetic field vector in 360o in all planes.  For cardiac chambers a 3-D 
volume-rendered reconstruction is imported and aligned for navigation.  For coronary artery 
use, the 2-D locations of points on X-ray images are known in relation to the image intensifier, 
angiography system and table and this allows production of a 3-D reconstruction from 2 views 
separated by at least 30o.  The result is real-time, on-table localization of the reconstruction 
within the chest of a patient during a procedure to allow direction of therapy.  Adjustment 
Figure 1. Magnetic navigation system is shown with the magnets in position on either side of the patient.
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of the magnetic vectors from the model synchronized to the X-ray system adjusts tip-magnet 
direction in the patient to produce deflection of the wire.  This gives reproducibly precise steer-
ing of the tip of the intravascular device and this steering is independent of the factors that can 
restrict conventional procedures such as poor transmission of manipulation.
new technology for progenitor/stem cell delivery
Previous methods for endocardial stem cell delivery had several drawbacks in identification, 
cell delivery and therapy.  Identification of the sites for injections was poor and depended on 
strategies such as marking acetate sheets overlaid on the X-ray screen, delivery was time-con-
suming with poor targeting, and follow-up was hampered by imprecise knowledge of where 
the injections had been and therefore depended on generalised LV measurements rather then 
the region of interest.
The magnetic navigation system can integrate other 3-D volume rendered information such as 
MSCT, MRI or the NOGA® XP mapping system, (Figure 2) to give precise steering /direction of 
injections. Infarct localisation is possible by current techniques such as MSCT, which is capable 
of identifying infarcted areas of myocardium12, and integration can provide a 3-D volume ren-
dered map of the damaged myocardium.  However this information is not real-time and was of 
limited use in treating the patient on the table.  New technology is under current development. 
The NOGA® XP mapping system gives information on the functional and electrical properties 
Figure 2. Graphic showing reconstruction of LV mapping
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of the myocardium simultaneously with real-time, precise localisation by producing a map of 
the left ventricle, Figure 2.  This may allow differentiation between the extent of the infarct and 
peri-infarct regions as well as giving valuable information for follow-up.  This, together with 
the MyoStar™ Injection Catheter to allow magnetically enabled cell delivery, Figure 3, may not 
only allow areas to be identified by electrical and mechanical mapping measurements but also 
deliver injections of cell therapy. 
Potentially, this could give several major advantages.  Firstly, integration of real-time electrome-
chanical mapping would give a real-time, on-table 3-D LV map for exact localisation.  Secondly, 
electromechanical mapping may discriminate between viable and non-viable infarcted areas 
e.g. identifying electrically active but non-contractile areas such as stunned myocardium. 
Therefore this combination of detection methods could enable new strategies that tailor deliv-
ery of cell therapy to particular areas.  Thirdly, a magnetically navigable injection catheter could 
precisely direct cell injection and simultaneously integrate spatial and electrical information. 
Fourthly, an electromechanical map could aid follow-up both to identify the region on the map 
that was previously treated, and also to give quantifiable information for specific locations on 
the map.  Definable delivery of stem cells would allow investigation of specific locations or 
patterns of cell delivery.  As different parts of an infarcted area may have discordant electrical 
and mechanical properties, the effect of injection of penumbral regions with intact electrical 
but poor mechanical activity that might indicate stunned myocardium may be easier to clarify. 
Additionally, current estimates of the resolution of the new system suggest that this could 
localise positions to within 1mmthat would represent a major improvement.  An idea of the 
type of the information that may be available with this system for diagnosis and follow-up is 
seen in Figure 4.
Figure 3. MYOSTAR™ Injection Catheter to have electromechanical guidance provided by the NOGA® XP.
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Limitations of current cell delivery techniques
The strategy of endocardial injection has suffered from a number of limitations.  The current 
technique of LV angiography gives mediocre localisation as the entire LV volume is seen only 
in 2-D pictures from different views.  This technique gives little idea of the location of the 
watershed or penumbral area that might contain stunned rather then necrotic cells.  Injection 
sites, and particularly areas that might be particularly susceptible to improvement with cell 
therapy, are poorly identifiable in real-time, and are difficult to access with current equipment. 
Intracoronary injection has been the other widely used technique and has its’ own limitations. 
Release of cells depends on haematogenous spread and this may be poor in areas that are 
poorly revascularised or are still occluded, therefore reducing the effectiveness in these areas. 
This inhomogeneous delivery may prevent delivery to salvageable areas that have competitive 
flow from a neighbouring territory that is, however, insufficient for long-term survival.  As intra-
coronary injection often uses occlusion of the proximal vessel this results in further ischaemic 
insult with further, possibly irreversible, damage and cell loss and reduced perfusion pressure 
leading to collapse of pinched microvasculature.  Additionally, loss of cells that do pass through 
Figure 4. NOGA™ electrical (UNIV, at top) and mechanical (LLS, at bottom) maps from a human patient in the 
stem cell treatment group. The maps on the left are those performed at the time of injection and maps at right 
are those at 4-month follow-up. An area of viability, showing normal electrical activity, can be noted on the 
upper-right map. The maps on the right show improvement in both electrical and mechanical function. LLS = 
linear local shortening; UNIV = unipolar voltage.
Ch
ap
te
r 7
222
the microvasculature into the general circulation, also known as ‘shedding’, may lead to the 
drawback of these progenitor cells reaching areas where conditions favourable for angiogen-
esis are present but clinically unwanted, e.g. neoplastic neovascularisation or ischaemic areas 
such as retinopathy.
implications for the clinical situation of cell delivery
Two particular situations may be particularly appropriate for treatment of cell therapy; these 
are recent anterior infarction with significant LV impairment and non-revascularisable chronic 
ischaemic cardiomyopathy.  While these situations have some similarity such as extensive 
cell loss, unattractiveness for cardiothoracic surgery, there are specific reasons why precisely 
directed endocardial injection may hold particular advantages. These have advantages over 
and above the general advantages of improved diagnosis with two modalities, precise site-
directed delivery and follow-up discussed above. The purpose of using cell therapy in the 
treatment of recent acute MI is to prevent maladaptation or remodelling and so preserve LV 
contractile function and thus exercises tolerance.  This group may be the most effective group 
to treat with cell therapy in order to maximise myocardial cell salvage.  As discussed above 
endocardial injection may be advantageous over intracoronary delivery as it delivers cells to 
areas that have a restricted or absent blood supply.  This direct delivery via the endocardium 
overcomes the problem of tissue swelling related to ischaemic damage that may cause pinch-
ing of the microvasculature to reduce haematogenous delivery to peripheral sections of the 
infarct territory i.e. to the penumbral areas that may be particularly suitable for salvage.  In 
addition, endocardial injection decreases shedding of cells into the circulation since cells are 
injected within the tissue thus placing decreased numbers of cells into the bloodstream
.  
In the treatment of chronic heart failure there has already been tissue loss and often, this is 
combined with severe ischaemic coronary disease.  Cell therapy aims to reverse the chronic 
changes by improving the vascular bed and salvaging as much myocardium as possible.  This 
situation would particularly benefit from addition of new myocardial cells, although the ability 
to produce new myocytes remains controversial.  Precise delivery to electrically and mechani-
cally definable areas could allow uniform coverage or other distributions to target specific areas. 
In addition the risk of perforation of a thin myocardium may be minimised by use of electrical 
signals via the adjustable and retractable needle providing exact depth control together with 
monitoring of the ECG for reverse potentials.
revascularisation
A further option enabled by the magnetic navigation system is the ability to treat complex 
coronary disease.  As the predominant cause of LV dysfunction is ischaemic heart disease, the 
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partial or complete recovery of the native coronary circulation may encourage both recovery of 
native myocytes and provide a milieu for better uptake and differentiation of stem cells.
The ability of the system to support PCI has been demonstrated in a number of scenarios from 
simple to complex lesions13 and evidence suggests that this system may be particularly advan-
tageous in more difficult anatomy14 and is capable of successfully treating CTOs15.  The integra-
tion of MSCT data, Figure 5, allows the missing segment of the vessel to be judged, Figure 6, and 
the superimposition of this data by co-registration gives an indication of the pathway.
Figure 5. The panel on the left shows the raw data from angiography and the panel on the right shows the 
reconstructed MSCT.
Figure 6.  The panel on the left shows the co-registered points applied to the MSCT image that was imported 
into Navigant and the panel on the right shows the computer reconstructed pathway that is derived from CT 
and projected onto the reconstruction in Navigant.
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conclusion
Magnetic navigation may aid the performance of cardiac stem cell transplantation by allow-
ing integration of spatially-localised, 3-D volume-rendered information with real-time tissue 
visualisation in multiple modalities to give site-directed deliverability to reduce procedure 
times and irradiation, and improve efficacy simultaneously. The development of the NOGA® 
XP system and the magnetically navigable MyoStar™ Injection Catheter may lead to improved 
detection of non-functional myocardium, better delivery and more precise follow-up.
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introduction
Magnetically supported PCI is starting to deliver on its potential to improve and extend several 
aspects of percutaneous cardiac treatment. In particular, the ability to control tip direction more 
accurately and independently of bends or friction has allowed increased utilization. We present 
a patient in whom both surgery and previous conventional PCI failed to produce a satisfactory 
long-term result. The use of magnetic navigation allowed for successful revascularization of an 
extremely tortuous conduit, restoring blood supply to a large territory of myocardium.
the system 
The Niobe® II magnetic navigation system (MNS: Stereotaxis, St Louis, Missouri) has two external 
magnets that produce a 15-cm uniform magnetic field. Through computer-controlled magnet 
movements, the magnetic field can be directed 360˚ in all planes. When the field is changed, the 
deflection of the magnet at the wire tip also changes, resulting in reproducibly precise steering. 
The system has an adjustable touch screen at the lab table that is the interface between the 
operator and the MNS (Figure 1). The current system has three main advantages with regards to 
tortuosity. First, it produces a 3-D, volume-rendered reconstruction from angiographic images, 
providing better morphological information about the artery. Second, the spatial coordinates, 
or location, of the reconstruction within the patient are known. Third, the model gives real-
Figure 1. System in position for PCI. M indicates magnets in tilt position for better lateral movement of the 
image intensifier. T indicates touch screen interface to give real-time instruction to the MNS. S indicates in-lab 
main screen monitor.
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time, on-line vectors, which direct the external magnetic field to navigate the wire through the 
3-D reconstruction. As a result, operators have the ability to utilize 3-D information in real-time 
patient therapy. 
System costs. The current list price for the Stereotaxis Magnetic Navigation System is $1.9 million. 
The size of a typical modern Stereotaxis cath lab room is 770 square feet (72 square meters). The 
cost of magnetic shielding generally ranges from $50,000–$100,000 and consists of minimal 
common steel shielding in the walls, ceiling and floor. 
There is a range of magnetically enabled Stereotaxis 0.014” guidewires that are priced at a mar-
ginal premium over conventional wires. All other PCI equipment is standard and compatible 
with the Stereotaxis guidewires and MNS. No additional consumable items are required. All 
third-party billing occurs as part of a standard PCI intervention; therefore, all current reimburse-
ment applies and there is no effect on current billing practices 
case report 
This report describes a 60-year-old man with multiple medical pathologies and a burdened 
cardiac history. Past medical history included severe airways disease (FEV1 of 1 litre), ulcerative 
colitis with chronic iron deficiency anemia despite iron therapy, previous GI bleeding, gout, 
hypertension and hypecholesterolaemia, and a family history of ischemic heart disease and 
peripheral vessel disease. 
The patient had undergone an aortic valve replacement 8 months earlier for significant calcific 
aortic stenosis. At that time, he received a jump saphenous vein graft (SVG) that anastomosed 
to the obtuse marginal branch (OM) and then the right posterior descending coronary artery 
(RDP). At the time of the operation, the cardiothoracic surgeon had noted that although the 
RCA had been grafted, it was heavily calcified, of poor quality and not suitable for further surgi-
cal treatment. The patient had a difficult recovery after the coronary artery bypass graft (CABG) 
operation with persistent hypotension, in part due to episodes of arrhythmia such as sinus 
bradycardia that was externally paced, and also atrial fibrillation (AF), for which he was later 
cardioverted. He had some generalized oedema and, once extubated, dyspnoea that resolved 
slowly. 
Unfortunately, 2 months after surgery, the patient again began to suffer with chest pains 
(despite a satisfactory Hb) that could not be fully controlled with medication. Angiography 
showed the proximal end of the graft was occluded but a section of graft between the OM 
and the RDP was still patent. However, this remaining section of the SVG was compromised by 
severe lesions at both anastomoses with an adversely acute angle in the stenosis just before the 
OM anastomosis (Figure 2). .
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Further surgery was refused and conventional PCI using biplane angiography was attempted, 
with a view to reopening the RCA or if unsuccessful, intervening on the tortuous Cx-OM-SVG-
RDP (Cx: circumflex artery). The RCA was heavily calcified. Despite the use of stiff occlusion wires 
and a variety of balloons for support, a wire could not be passed and the attempt was stopped 
due to the presence of dissection. An attempt to pass the wire into the SVG via the left coronary 
artery (LCA) was unsuccessful due to tortuosity and despite the use of multiple catheters and 
wires. For the attempts on both vessels, a total of 5 guiding catheters and 7 angioplasty guide 
wires, including Asahi Miracle 3, Asahi Miracle 6 (Abbott Vascular Devices, Redwood City, CA) 
and Crosswire NT (Terumo Medical Corporation, Somerset, NJ), were used. 
the Magnetic Procedure 
Reconstruction. A decision was made to attempt a further procedure with the MNS. A 3-D recon-
struction (Figures 3–4) showed that the sum of all the angles from the LMS to the RCA was over 
1180˚ (equivalent to over 3 complete turns of a corkscrew). Currently, an analysis of the reasons 
for prolonged procedures (with respect to wire passage across a lesion) is ongoing. Both the 
Figure 2. The top left panel shows the occluded RCA that could not be opened anterogradely. The other three 
panels are different views showing Cx tortuousity and severe lesions at proximal and distal anastomoses of the 
SVG. C indicates the Cx. P indicates the proximal anastomosis. D indicates the distal anastomosis
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number of bends and the degree of angulation seem to be strongly related to a prolonged 
crossing time. Each bend adds friction to conventional wire rotation and therefore steering, 
and this friction becomes greater as the angulation increases (as the wire is more deformed and 
Figure 3. Panels showing different fluoroscopy views with vessel edges marked by edge detection software 
(CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel) before reconstruction. P indicates proximal point. D 
indicates distal point
Figure 4. Three-dimensional reconstruction of target pathway. C indicates the tortuous Cx. P indicates the 
proximal anastomosis. D indicates the distal anastomosis
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may also be pushed more forcefully against the vessel wall). Thus, the cumulative angulation 
may be extremely relevant to procedural duration and success.
Navigation. One of the prime benefits of the MNS 3-D reconstruction is that it provides an 
endoluminal view with a computed 3-D center line (Figure 5). This view offers a tailored direc-
tion for the magnetic field vector at every point in the vessel. There is also a white-line overlay 
that is a roadmap on the fluoroscopy screen. Tip advancement is shown on the white-line 
overlay in tandem with operator advancement of the wire. The 3-D vector changes simultane-
ously to keep the wire pointing down the chosen path. The Titan™ Soft Support 2 mm angled 
tip wire (Cordis Corp., Miami, FL) was navigated through the tortuous LMS, Cx and OM using 
the vectors as far as the stenosis before the first anastomosis (with the adverse angle). At this 
stage, finer navigation was required to reach the SVG. Careful interrogation, by changing the 
angulation using the endoluminal view (the vector can be changed in the endoluminal view by 
double-tapping the screen at any point), and increasing the magnetic field strength to 0.1 Tesla, 
managed to get the wire tip to angulate enough to pass into the body of the graft. At this point, 
a 1.5 mm Maverick over-the-wire balloon (Boston Scientific Corp., Natick, MA) was passed to the 
graft body and used for support. The wire was then advanced through the graft using vector 
control and then into the RDP. In order to maximize support, the balloon was advanced to the 
RDP and an Iron Man support wire (Abbott Vascular) exchanged. 
Figure 5. Screen of Stereotaxis Navigant program during procedure, showing top left panel with endoluminal 
view. The top right panel shows the reconstruction. The bottom 2 panels are static-captured fluoroscopy 
images with the reconstruction for that angle superimposed.
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Intervention. Both anastomoses were predilated. However, on the first attempt to pass a stent, 
there was excess resistance in the Cx that nearly caused wire retraction. The Cx was predilated, 
and both the anastomoses and the Cx were then stented (Figure 6). There was a good result, 
with TIMI-3 flow at the conclusion of the procedure (Figure 7). 
discussion 
The potential advantages of magnetic navigation are especially relevant to excessively tortu-
ous vessels. It is in these cases where the advantages of magnetic steering are most obvious 
over conventional procedures: 
1) A conventional procedure has to use the same tip shape throughout. While appropriate for 
some angles, it is not ideal for multiple bends of varying angulation. 
2) Once inside the patient, the tip shape of a conventional wire cannot be changed without 
retrieving the wire and losing position or exchanging through a support catheter. 
Figure 6. Interventions. The top left panel shows predilation of Cx. The top right panel shows stent placement 
in distal anastomosis. The bottom left panel shows stent deployment at the proximal anastomosis. The bottom 
right panel shows one of the stents being deployed in the Cx. C indicates the Cx. P indicates the proximal 
anastomosis. D indicates the distal anastomosis.
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3) After a conventional wire has been passed distally, there may be resistance when trying to 
rotate the wire tip for manipulation. 
In contrast, the tip of a magnetically-enabled wire can be directed at will in any direction. There-
fore, the tip shape is variable at will, is adjustable in situ for a particular bend and is independent 
of rotation of the wire (and thus friction from the bends in the vessel). Such abilities may be of 
significant benefit in challenging cases. 
 While the system is relatively intuitive and usable after minimal experience, we are finding that 
further improvement continues steadily as the range of additional features is explored. The 
experience at our institutions is a little over 350 cases and rising. A variety of randomization 
studies and registries are currently ongoing or under analysis. 
Future directions 
The MNS has other potentially valuable capabilities. For PCI, the integration of other 3-D, 
volume-rendered imaging such as multislice computed tomography (MSCT) as well as the 
possibility of other useful functions such as magnetically-navigable ablation or remote control 
Figure 7. Results of stenting form different views. C indicates the Cx. P indicates the proximal anastomosis. D 
indicates the distal anastomosis.
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navigation, may prove advantageous. In addition, the integration of data such as the electro-
mechanical maps from the Carto RMT™ system (Cordis) may enhance procedures such as stem 
cell therapy. 
Limitations 
Software. While 3-D imaging represents improved appreciation of coronary anatomy compared 
to the 2-D black-and-white x-ray images that have been the standard manner of visualizing 
coronary arteries, the current reconstructions are static. Dynamic road-mapping is an area 
under development. 
Hardware. The internal guide wire magnets are currently rigid 3 mm wire tips, with a 2 mm 
option. While the rigidity can potentially restrict the movement of the magnet tip in a lesion 
of less than 3 mm diameter, to date, there has been only a mild clinical impact, mainly when 
attempting to enter side branches that may come off at right angles within a tight lesion. A 
flexible tip (with several magnets) is under development for enhanced navigation. 
Strategies. The range of options within the system translate into a number of possible strategies 
that may develop in an evolutionary fashion. One example of a hybrid strategy is the manipula-
tion of an angled wire without a magnetic field, bringing in the magnets as necessary. The use 
of presets and the 2-D clockface allow for relatively speedy use of the system, and may better 
suit procedures in simple lesions or where time plays a role, such as primary PCI. Performing a 
3-D reconstruction may give a better idea of the anatomy and provide more individually tai-
lored pre-calculated vectors for navigation. Bringing together reconstructions from diagnostic 
images and using navigation with the white-line overlay and minimal contrast may be helpful 
when it is necessary to reduce contrast volume. Additionally, 3-D reconstruction may be espe-
cially useful in extremely long and tortuous segments. 
conclusions 
MNS has been shown to aid PCI of complex and tortuous vessels. System capabilities, together 
with other current and forthcoming options, indicate that MNS could have a major impact on 
the performance of PCI. In our opinion, the finer wire tip control, the extended anatomical 
information, the potential for integration in using other 3-D sources such as MSCT in real-time, 
together with forthcoming developments such as flexible wire-tips, ablative wire-tips and 
navigable injection catheters, may produce a formidable system. 
seLected cases
Primary Percutaneous coronary intervention 
using Magnetic navigation
Eurointervention 2007, 12,
Riezebos RK, Patterson MS, Braat JH, ramcharitar s, Serruys PW, Kiemeneij F
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abstract
Primary percutaneous coronary intervention is a situation that can benefit from the advantages 
of magnetic navigation. This case describes the use of this novel system to rapidly perform a 
complex primary PCI. Magnetic navigation has distinct advantages including the guidance of 
wire orientation on 3D information such as preset vectors, precise deflection that obviates the 
need for wire rotation. In addition magnet navigation offers the possibility to reconstruct a 
tailored 3D model that can be used to facilitate complex procedures.
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introduction
The rapid restoration of full TIMI 3 flow is crucial in primary percutaneous coronary interven-
tion (PCI) (1). However, angiographic success is not always obtained (2-6). Magnetic navigation 
might facilitated primary PCI by allowing more accurate manipulation. However, there has 
been concern that the use of this procedure could delay reperfusion. The magnetic navigation 
system (MNS: Stereotaxis, St Louis, Missouri, USA) can be used immediately by using the preset 
vector control or freestyle navigation with the 2D clockface view, Figure 1. The system allows 
for precise navigation without the need for excessive wire rotation. In case of more complex 
anatomy, a 3D reconstruction can be used (Software: CardiOp-B: Paieon Medical Inc., Rosh 
Ha’ayin, Israel) for individualized navigation (7). This report describes the feasibility of the MNS 
to quickly and successfully complete a complex primary PCI that involved aspiration thrombec-
tomy and a bifurcation procedure.
case report
A 48 year old man presented to the Emergency Department with an evolving STEMI requiring 
immediate reperfusion. Angiography showed a proximal occlusion of the Left Circumflexus 
(LCx) with an obvious filling defect and TIMI 0 distal flow, see Figure 2. A Titan™ 3mm angled 
Soft Support wire was chosen. While the wire and an aspiration catheter were brought and 
prepared, the patient was put in the magnetic isocenter position by visualizing the catheter tip 
and cardiac silhouette on X-ray in 2 orthogonal views. Navigation was performed using preset 
Figure 1. The screen of the Navigant workstation, the panel (P) shows virtual coronary tree of the preset 
navigation with the list of preset vectors (V) seen above.  The panel (C) shows the 2D clockface.
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vectors through the Left Main Stem (LMS) and proximal LCx to reach the lesion. The lesion was 
eccentric and more irregular on the superior aspect, see figure 2. An inferior vector was selected 
on the 2D clock freestyle navigation to cross this section in order to reduce contact and possible 
dislodgement of material. The crossing time from the tip of the catheter was 28 seconds and 2 
ml of contrast was given. Contrast injection confirmed TIMI 1 flow and an aspiration catheter 
removed a large portion of the thrombus to produce TIMI 3 flow in 2 branches but with obvi-
ous residual stenoses, see Figure 2. A 3.0 x 25mm Skylor™ produced a good result in the main 
branch, but there was pinching of the ostium of the sidebranch, see Figure 3. 
It was decided to fenestrate the stent into the sidebranch. The passage of a second Titan™ 3mm 
angled Soft Support wire into the sidebranch took 8 seconds with no contrast used. Kissing 
balloons produced a good result with TIMI 3 flow in both vessels, see Figure 4.  
discussion
There is strong evidence that swift restoration of flow in the obstructed infarct artery after 
the onset of symptoms of a STEMI is key determinant of short – and long term outcome. (3-7) 
Therefore, current guidelines advocate rapid evaluation for reperfusion therapy and the prompt 
implementation of a reperfusion therapy at presentation. (1) PCI is a very effective method for 
re-establishing coronary perfusion and is suitable for approximately 90% of patients. (2-6) In 
cases with more complex anatomy the magnetic navigation system may provide extra benefits 
such as 3D reconstruction. (7) The magnetic navigation system uses two permanent magnets, 
mounted on mechanical positioners, on either side of the fluoroscopy table. (7) These magnets 
create an interacting magnetic field to produce an approximately spherical 15 cm uniform 
Figure 2. The left panal shows the occluded OM branch with an eccentric lesion, more irregular on the superior 
aspect, before the occlusion, the right panel shows the restoration of flow to 2 distal branches after aspiration 
thrombectomy.
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magnetic field of 0.08 T. The movement of the magnets allows the direction of the applied 
magnetic field vector to be orientated in 360° on all planes. The result is control of direction of 
the wire tip, in vivo, without the need for a preshaped wire tip angle. 
The current case demonstrates that the procedure can be performed rapidly during primary 
PCI with the use of 2D controls such as the use of preset vectors or the 2D clockface. However, 
should more complex anatomy be uncovered, then an interactive 3D coronary model can be 
Figure 3. The left panal shows the result of the stent with pinching of the ostium (arrowed) to the inferior 
branch, the right panel shows the deployment of kissing balloons
Figure 4. The final result showing TIMI 3 flow in both distal branches
Ch
ap
te
r 8
242
created from two views allowing accurate individualized navigation, see Figure 5. Theoretically, 
the MNS may have two particular benefits in primary PCI. First, precise control of the magnetic 
tip needs less movement when compared with conventional wires that must be rotated to steer. 
This improves not only the navigation to, but also past an eccentric thrombus-laden lesion. 
Possibly this may help to reduce thrombus dislodgement and subsequent distal embolization. 
(8) Second, the lack of rotation of a second wire reduces the risk of wire entwinement that could 
both impair steering and smooth balloon delivery. 
conclusion
Primary PCI is not only feasible with the MNS but may give procedural advantages. Furthermore, 
the option of 3D reconstruction is available when complex anatomy is uncovered. This case 
demonstrates the feasibility of the MNS to rapidly perform primary PCI and support complex 
procedures that sometimes occur in this emergent situation.
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suMMary
Interventional cardiology has embraced many novel technologies to push the frontiers in man-
aging more complex lesions. As such, the evolution of the drug stents with the ability to limit 
restenosis has radically changed the way we approach a lesion, enabling the latent creativity 
entwined in our minds to be effectively realized. But one area that has resisted change thus far 
has been technologies aimed specifically at lesion crossing and in particular the co-integration 
of 3 dimensional imaging modalities to guide a procedure. The magnetic navigation system 
(MNS) addresses both these issues by its ability to redirect wires without externally reshaping 
the tip and by creating a 3 dimensional road map that also can be view endoluminally. The aim 
of this Thesis was to critically evaluate the current technology within the field of interventional 
cardiology.
 
Following an introduction, Chapter 2 evaluated both the current hardware and the software. 
We were able to show that the MNS significantly reduces both the crossing and fluoroscopy 
times in tortuous coronary phantom models achieving excellent success rates with dramatic 
reductions in guidewire usage. Operators with prior MNS experience had an advantage over 
the inexperienced thus effectively demonstrating the need for a learning curve. In evaluating 
the software we found that an alternative 3 dimensional reconstruction software, the CAAS 5 
3D QCA system had a greater degree of accuracy and precision in both the luminal and area 
measurements than the Navigant® CardiOp-B 3D QCA system. We identified weakness in the 
system such as the catheter based calibration methodology. 
Concentric phantoms used for the validation are however not representative of the eccentricity 
of the plaque or the natural complexity in a dynamically beating heart. So in Chapter 3 we 
identified the types of patients most likely to benefit from the magnetic navigation system. 
Multivariable logistic regression and linear shrinkage with bootstrapping were used to develop 
a clinical prediction rule that dichotomised cases into easy or difficult (prolonged crossing 
time). A relationship was demonstrable between complexity that took into account both the 
vessel and lesion characteristics (so called Naviscore) and prolongation of crossing times with 
conventional wires. When investigated in routine cases the MNS had overall longer crossing 
and fluoroscopy times than conventional wires (72.9 ± 50.3sec vs. 58.1 ± 47.2sec, p<0.001 
and 66.2 ± 44.1sec vs. 55.2 ± 44.4sec p=0.03 respectively. But, there was a trend to support 
a potential advantage in more complex vessels as identified by the Naviscore. Interestingly, 
by simultaneously employing a virtual roadmap there was a small but significant reduction in 
contrast usage.
We proceeded in Chapter 4 to evaluate selective complex lesions. We found that in routine 
bifurcation the MNS had greater crossing success despite being slower and was useful in 
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managing failed standard wire cases. It was more effective in crossing double rather than single 
layers of stent struts by retracting and changing the tip direction at the proximity of the carina 
to engage an alternative set of cells. As a prelude to investigating chronically occluded vessels 
in Chapter 5 we showed that it was possible to directly co-integrate a CTCA scan and create a 
road map for the angiographically “missing segment”.  This led to a concept paper demonstrat-
ing the possibility of using a pre-procedural CTCA scan to directly perform an intervention 
without contrast agents. It opened the possibility to effectively move away from the use of 
2-dimensional radiographic imaging which has inherent limitations in both lesion and vessel 
characterizations.
In assessing the Thoraxcenter’s overall experience in using magnetically enabled wires to man-
age CTOs we reported in Chapter 6 that crossing success rose from initially 40% to a maximum 
of 56% over 52 months. But there were relatively high procedural bailouts with conventional 
PCI techniques, which meant that currently there was no additional advantage of the MNS over 
the more sophisticated conventional CTO wires. Importantly we were able to show that CTCA 
co-integration did not influence procedural outcome but found that higher magnetic wire suc-
cesses were observed in low calcified lesions, those with a central stump and without bridging 
collaterals. In Chapter 7, the system was shown to be effective in guiding left ventricular lead 
implantation based on the virtually 3D reconstructed image of the coronary sinus. The chapter 
also examined the methodology and equipment required for a magnetically enabled injection 
needle to facilitate precise stem cell implantation within the myocardium. 
concLusions 
The magnetic navigation system can be safely applied to non-selective percutaneous coronary 
and non-coronary interventions. But technical limitations with the current system curtail its 
potential advantage over conventional wires approaches in a PCI setting. The rigid 2-3mm long 
magnetic tip wires restricts the degree of flexibility achieved with the smoother transition of 
the tip and the shaft apparent in the more sophisticated standard conventional wires. More-
over the ‘ocular-hand coordination’ of the ‘seasoned’ conventional PCI operator seems currently 
unbeatable since time is loss in moving the large external magnets to realign with the desired 
vectors. It is also an expensive technology that has a learning curve for both the operator and 
the technical staff. But its novel approach of redirecting a device in the body together with the 
ability to effectively co-integrate 3-dimensional information within its software has the poten-
tial to revolutionise the manner in which percutaneous intervention is currently performed. 
saMenvatting en concLusie
Magnetische navigatie in Percutane coronaire 
en niet-coronaire interventies
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saMenvatting 
Interventie cardiologie heeft vele nieuwe technologieën omhelst om de grenzen te verkennen 
van complexe lesies. Het gebruik van drug eluting stents heeft niet alleen geresulteerd  in een 
afname van in-stent stenose, maar ook de wijze waarop wij lesies benaderen. Echter, de wijze 
waarop stenoses gepasseerd worden tijdens een procedure zijn tot op heden aan innovatieve 
ontwikkelingen ontsnapt, in het bijzonder het integreren van 3 dimensionale beeldweergave 
tijdens de procedure. Het magnetische navigatiesysteem (MNS) heeft de potentie om beide 
problemen op te lossen daar de  voerdraden opnieuw te richten zijn zonder deze handmatig 
te vervormen alsmede de mogelijkheid om gebruik te maken van een 3D weergave van de 
coronairarteriën samen met een virtueel lumen. Het doel van dit proefschrift is de huidige 
technologie binnen de interventie cardiologie kritisch te evalueren. 
Na een inleiding, wordt in Hoofdstuk 2 ingegaan op de gebruikte (MNS) hardware en software. 
Wij konden aantonen dat MNS fluoroscopie tijden, de tijd die nodig is om een lesie te passeren 
en het gebruik van voerdraden drastisch te reduceren in fantoom modellen. Interventie car-
diologen die ervaring met MNS hadden, bleken een voordeel over onervaren cardiologen te 
hebben, hetgeen duidelijk aangeeft dat er sprake is van een leercurve. Bij de evaluatie van de 
software vonden wij dat één van de 3D software systemen, het CAAS 5 3D QCA systeem een 
grotere graad van nauwkeurigheid en precisie heeft dan het 3D QCA systeem van Navigant® 
CardiOp-B met betrekking tot het lumen/ area van het. Wij identificeerden beperkingen in het 
systeem met betrekking tot de kalibratie methode.
De concentrische fantomen die voor de validatie worden gebruikt zijn tot op heden niet repre-
sentatief voor de excentriciteit van de plaque of de natuurlijke complexiteit in een dynamisch 
kloppend hart. In Hoofdstuk 3 identificeerden wij patiënten die mogelijk het meest van het 
magnetische navigatiesysteem zullen profiteren. Multivariable logistische regressie en de lin-
eaire shrinkage met bootstrapping werden gebruikt om te voorspellen welke lesies eenvoudig 
of moeilijk te passeren zijn. Een correlatie werd aangetoond tussen de kenmerken van de lesie 
en het vat (zogenaamde Naviscore) en vertraging bij het passeren van de stenose ten opzicht 
van conventionele voerdraden. Routinematig gebruik bij niet geselecteerde patiënten toonde 
een langere passagetijd en fluoroscopie tijd aan bij het gebruik van conventionele draden (72.9 
± 50.3sec versus 58.1 ± 47.2sec, p< 0.001 en 66.2 ± 44.1sec versus 55.2 ± 44.4sec respectievelijk 
p=0.03). Er bleek echter wel een trend in het voordeel van complexe procedures (geïdentificeerd 
door Naviscore). Opmerkelijk was de significante reductie in het gebruik van contrastvloeistof 
bij het gelijktijdig gebruik van een virtuele 3D reconstructie van de coronairarteriën.
In Hoofdstuk 4 ligt het accent op het evalueren van geselecteerde complexe lesies. Wij vonden 
dat in bifurcatielesies MNS een beter passerend vermogen had ondanks de tragere passagetijd. 
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MNS bleek efficiënter in de passage van overlappende (dubbel gelaagde) stent struts ter hoogte 
van het ostium van een zijtak dan een enkele laag stent struts door vermogen om de voerdraad 
terug te trekken en van richting te laten veranderen door gebruik te maken van de magneet. 
Als voorloper van de onderzoeken bij chronisch afgesloten coronairarteriën in Hoofdstuk 5 
toonden wij aan dat het integreren van CTscan van de coronairarteriën  (CTCA), waarmee het 
mogelijk is een 3D reconstructie van de volledig afgesloten coronairarterie (CTO) te maken. Dit 
leidde tot het concept waarbij de mogelijkheid om een pre-procedurele CTCA te gebruiken om 
een interventie uit te voeren zonder contrastvloeistof. Dit opende vervolgens de mogelijkheid 
om alternatieve beeldvormende technieken te gebruiken dan de standaard 2-D röntgen met 
bijbehorende technische beperkingen.
Bij de evaluatie van onze ervaringen bij het gebruik van magneet navigatie voerdraden om 
CTOs te passeren rapporteren wij in Hoofdstuk 6 het toegenomen succes van aanvankelijk 40% 
tot een maximum van 56% over een periode van 52 maanden. Een belangrijke observatie was 
echter het hoge percentage bailout PCI procedures met conventionele technieken, hetgeen het 
extra voordeel van MNS techniek ten opzichte van verfijnde conventionele CTO draden teniet 
deed. Belangrijk was ook dat het mede-integreren van CTCA het resultaat niet beïnvloedde, 
hoewel dit succespercentage hoger was in stenoses met weinig kalk, centrale stomp en zonder 
het overbruggen van collateralen. In Hoofdstuk 7, laten we zien dat het plaatsen van een 
linker ventrikel lead met behulp van MNS effectief is, wanneer gebruik gemaakt wordt van 3D 
reconstructie. In dit hoofdstuk wordt ook aandacht geschonken aan de methodologie en het 
materiaal dat voor een toegelaten magnetisch injectienaald wordt vereist en de nauwkeurige 
implantatie van de stamcellen binnen het myocardium te vergemakkelijken.
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concLusies 
Het magnetische navigatiesysteem kan veilig op niet-selectieve percutane coronaire en niet-
coronaire interventies worden toegepast. Het is belangrijk hierbij op te merken dat dit systeem 
nog technische beperkingen heeft. De stijve 2-3mm lange magnetische tip van de voerdraden 
beperkt gewenste flexibiliteit in vergijking met verfijndere standaard conventionele voerdraden 
met een geleidelijke overgang tussen de schacht en tip van de voerdraad. Bovendien schijnt de 
`oog-handcoördinatie’ van de ervaren interventie cardioloog bij conventionele PCI momenteel 
onverslaanbaar, daar veel tijd verloren gaat bij het bewegen van de grote externe magneten in 
de gewenste vectoren. Verder dient te worden opgemerkt dat er sprake van een dure technolo-
gie, waarbij sprake is van een leercurve. Deze nieuwe techniek om voerdraden gericht te sturen, 
alsook de mogelijkheid om effectief gebruik te maken van 3D beeldvormende technieken 
hebben de potentie om de huidige praktijk van percutane interventie technieken drastisch te 
veranderen.
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I could never get through many of the presentation or publications. A genius in Photoshop only 
surpassed by the great Jan Tuin and his protégé Rakesh. Their great sense of humour and calm-
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Figure 1 The Niobe® Magnetic Navigation System.
(a) A typical magnetic navigation system set-up showing the magnets, C-arm and the control room. 
(b) The Titan® magnetic navigation wire showing the 2 or 3 mm magnet located at its tip.
Figure 2  The clockface navigational mode
By touching the perimeter the vector moves in that direction; controls for anterior and posterior movements are 
at the edges.
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Figure 3  True-vessel navigation using an accurate three-dimensional representation of the coronary artery 
(a) A constellation road map created from two-dimensional X-ray images; chosen points are depicted by 
squares along the navigational path. (B) Navigation using a three-dimensional reconstruction created 
with the CardiOp®-B software. (c) Navigation by means of the endoluminal view. Abbreviation: OM, 
obtuse marginal branch.
Figure 4 Three-dimensional representation of the coronary artery.
(A) A three-dimensional reconstruction of the artery using the CardiOp®-B software. (B) The same arteries 
extracted from a multislice CT data set (C and D), displayed as navigational centerlines with a directional 
vector on the live fluoroscopic images.
FULL COLOUR SECTION 267
Figure 5 Using the Navigant® system the multislice CT data set can be used to create: (A) a road map of a 
chronic total occlusion not seen angiographically and (B) cross-sections along the map.
Figure 6 A diagrammatic representation of the magnetically enabled radiofrequency ablating wire for chronic 
total occlusions.
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Figure 7 A diagrammatic representation of magnetically enabled cell injection catheter following an 
automatic map in the myocardium.
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Figure 1 The “clockface” navigation system
chapter 2
Figure 2 The phantom A-E with diagramatic representation of the level of difficulty. The angles and “vessel” 
caliber are as follows: (A) 3 mm, 120° turn into a 3 mm, 90° turn; (B) 3 mm, 120° turn into a 3 mm, 90° turn; (C) 
3 mm, 60° turn into a 3 mm, 120 turn and then into a 60° turn to a 2 mm vessel; (D) 3 mm, 90° into a 2 mm 
followed by a 90° turn; (E) 3 mm, 90° into a 2 mm followed by a 120° turn. The “arrow” indicates the starting 
point and the asterisk (*) show the end of each phantom run.
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Figure 3 (A) The average crossing times/sec obtained using SG and MG for all operators with phantoms A-E. 
(SG, standard guidewire; MG, magnetic guidewire). (B) The average fluoroscopy times/sec obtained using SG 
and MG for all operators with phantoms A-E. (SG, standard guidewire; MG, magnetic guidewire).
Figure 4 The average crossing times/sec obtained using SG and MG for groups 1-3, operators with phantoms 
A-E. (SG. standard guidewire; MG, magnetic guidewire).
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Figure 5 (A) The overall procedural success using SG and MG for phantoms A-E. (SG, standard guidewire; MG, 
magnetic guidewire). (B) The SG and MG usage in operators 1-6 for phantoms A-E. (SG, standard guidewire; 
MG, magnetic guidewire).
Figure 1 The magnified tip of one of the Fogarty catheters view along its long (A) and short axis (B) with a 
transparent radiolucent cylinder (phantom) having a channel of 1.9 mm diameter (white arrow) and the 
catheter lumen used for insertion of removable metallic stylet (black arrow) to aid positioning.
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Figure 2 The 3D reconstruction of a phantom derived from two orthogonal views (frontal and lateral) using the 
CASS 5 system. The 3D color varies according to the severity of stenosis ranging from white (healthy vessel) to 
dark red (99% cross-sectional area stenosis). The yellow squares denote proximal reference point (P*), most 
stenotic point (S), and distal reference point (D) of the target lesion, respectively. The region of interest (ROI) 
for calculation of mean luminal diameter can be manually defined by moving the proximal (P*) and distal (D) 
points (Definition of ROI for mean LD; Graph view). 
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Figure 1 Magnetic navigation system is shown with the magnets in the tilt position on either side of the 
patient. Inserted at the bottom left hand panel is the touch screen monitor used to direct the navigation along 
the chosen vessel
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Figure 2. The Magnetic Guidewire with the 2-3mm embedded gold encapsulate neodynium iron boron 
magnet at the distal tip
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Figure 3 The chosen vector is displayed as a dotted arrow on navigational path-line on the live fluoroscopy 
image. The bottom left panel shows what the operator sees on the touch screen monitor.
Figure 4 Top panels showing the tip of the catheters in fluoroscopy image co-registered with the extracted 
coronaries derived from the MSCT dataset.  These give the specific 3-D coordinates that allow integration of the 
2 modalities. Bottom panels showing the extracted coronaries with the centerline together with multiplaner 
reconstructed cross-section displayed in the Navigant® and the endoluminal views for MSCT based navigation.
FULL COLOUR SECTION 275
Figure 5 The magnetically enabled RF wire 
Figure 2 The left 2 panels show separate angiographic angulations with edges detected and the right panel 
shows a 2D image of the 3D reconstruction.
Figure 3 Identification of the bends in a vessel and measurement of each angle (possible in the Navigant 
program) The total angulation of the 5 worst bends, (Vta), (Figure 3)
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Figure 4 The measurement of the length from the vessel ostium to the lesion in CardiOp-B (green square 
indicates proximal marking point and blue square indicates distal marking point)
Figure 6 The top panels show the measurement of the lesion length (green square indicates proximal marking 
point and blue square indicates distal marking point). The lower panel shows the segment greater than 80% 
measured in CardiOp-B (green square indicates proximal marking point and blue square indicates distal 
marking point).
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Figure 1 The clockface navigational mode showing a vector depicted by an arrow that can be repositioned by 
selecting points around the perimeter of the clock; B) a 3-dimensional reconstruction of a coronary bypass graft 
to the native left anterior decending artery and C) the registration with the fluoroscopic image; D) navigating 
at the bifurcation of the virtual reconstructed graft showing a navigational pathway through the lumen
Figure 2 The 3D reconstruction (A) and the endoluminal view of the LAD/diagonal bifurcation (B). The 
magnetically guided TitanTM Soft Support wire (arrowed) successfully crosses the stent strut into the true 
lumen and the Graphix Intermediate wire preferentially chose the false lumen of the dissection (C).
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Figure 1 A) A virtually reconstructed bifurcation using the Paeion software displaying a directional vector 
created in the Navigant; B) The endoluminal view of the virtual carina at the bifurcation showing the 
navigational path in one of the branches; C) Co-registration of the virtual vessel to the angiographic image; D) 
The navigational vectors and centrelines displayed on the live fluoroscopic image.
Figure 4 Anomalous origin of the right coronary artery (RCA). (a) An aortogram was performed to localize the 
origin of the RCA, whose contours are faintly visible (arrowheads). (b) Non-selective injection confirms its origin 
(arrowheads) out of the left coronary cusp. (c, d, e) CT coronary angiogram clearly showing the anomalous 
origin (arrowheads) and course of the RCA
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Figure 7 (a) Invasive coronary angiogram showing a significant bifurcation lesion (large arrow) of the 
left anterior descending coronary artery with the first diagonal branch (D1). Also note the limited contrast 
enhancement (small arrows) in what looks like a small side branch. (b) Three-dimensional reconstruction of 
the heart with CT showing the bifurcation lesion. The dense spot within the lesion (arrowhead) corresponds 
to calcification. The branch that was faintly visible angiographically, can now be clearly recognized without 
interference of overlapping vessels as the intermediate branch (arrows). (c) 3-mm thick maximum intensity 
projection clearly showing the calcified (arrowhead) and non-calcified plaque components causing the lumen 
narrowing. (d) After wiring the intermediate branch its true dimension can be well appreciated (arrows).
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Figure 9 Patient with recurrent angina after previous coronary bypass graft surgery, including a venous graft 
to the right coronary artery (RCA) and left internal mammary artery (LIMA) to the left anterior descending 
coronary artery. At initial invasive catheterization the origin of the left coronary artery appeared occluded. 
(a) Cardiac CT scan, coronal view, indeed showing a short occlusion (arrowheads) of the left main stem. (b) 
Three-dimensional reconstruction of the heart showing the patent LIMA (arrow) and venous graft to the 
RCA (arrowheads). (c) Contrast injection after wiring of the LIMA (arrow) results in opacification of the native 
coronary artery up to the distal part of the left main stem. (d) Six-month angiographic result after successful 
PCI (inset) of the left main stem.
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Figure 11 (a) Invasive coronary angiogram, showing a chronic total occlusion (arrow) of the circumflex artery 
(CX). Only the very distal part of the vessel is visible through collaterals (arrowheads) (b) Corresponding CT 
image (curved multiplanar reconstruction): compared to the angiographic information the occlusion appears 
much shorter and consists of non calcified tissue. (c) The CT dataset has been uploaded in the navigation 
software; the course of the CX, including the path of the occlusion, is marked by a green line overlay. (d) The 
course of the CX has been marked as a yellow line. The rectangular which is present in panel c and d marks the 
location of the wire tip in the vessel. The inset in panel d represents the perpendicular cross-sectional view of 
the vessel to allow the steering of the guidewire in the desired direction.
Figure 1 Volume-rendered MSCT image with coronary segmentation is displayed in blue with vessel 
calcification shown in bottom right image
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Figure 2 Coronary tree with the automatically computed pathway and the tangent magnetic vector
Figure 3 Navigation and tools for the operator
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Figure 4 Automated vessel sequencing MPR slices upper left quadrant
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Figure 2 A) Extracted coronaries arteries from the CTCA dataset to be introduced directly into the MNS; B) slice 
through a navigational pathway (depicted by yellow line) simultaneously showing the corresponding MPR 
cross-section at that position; C and D) Co-registration of the navigational pathway to the guiding catheter in 
two orthogonal planes; E) the navigational pathway with a directional vector and F) it being displayed on the 
live fluoroscopic image 
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Figure 3 A and B) Radiographic recordings of two orthogonal images IVUS probe positioned in the middle of 
the lesion and C and D) these two points co-registered as a new reference point (green circle) in the 3D space 
of Navigant®; E) the overlay of the location of this point  (open white circle) on the live fluoroscopic was used 
to position the stent on the middle of the lesion; F) The stent being deployed following a single “safety check” 
angiogram.
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Figure 1 The basic design at the tip of a magnetically enabled wire
Figure 2 The lateral stiffness of magnetically enabled wire as determined by three point testing
chapter 6
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Figure 3 The tip load comparison of magnetically enabled and conventional wires
Figure 4 The Bulls Eye Navigational mode depicting the various interrogation patterns and tip angulations 
that can be utilized in searching for a micro channel in a CTO
Figure 5 The magnetically enabled RF wire
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Figure 6 Navigation through MSCT co-integration demonstrating the MPR cross-section slice (left upper 
quadrant at the site of the navigational vector and the corresponding endoluminal view in the right panel.
Figure 1 A) Clockface navigation mode vectors are orientated by through a touch sensitive monitor; B) 
CardiOpB® virtual 3DRC vessel showing fly-through endoluminal view for navigation; C) extracted CTCA 
virtual fly-through endoluminal view with MPR slice in the top left corner; the Bull’s eye navigational mode 
demonstrating the ability to reorient wire tip in a systematic manner.
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Figure 2 Cumulative curve of CTO success with the MNS with respect to the total success and cases.
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Figure 1. Top: at the left, 3D reconstruction of the coronary sinus with one side branch in an antero-
posterior view. Note the marked angulation of the lateral side-branch. At the right, a flythrough image of the 
reconstruction. Bottom: Reconstructed model aligned to the fluoroscopic view in LAO projection (left panel) 
and AP projection (right panel).  In green, the automatically selected vector.
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Figure 2. Four panels, as seen in real time, showing the different automatically selected vectors (green arrows) 
chosen to navigate within the reconstructed coronary sinus (CS) model. In each panel, at the top left: 3D 
reconstruction of the CS; top right: endovascular view; bottom left: RAO projection and not aligned 3D model to 
facilitate visualization of the side branch; bottom right: LAO projection with aligned 3D model.  Note how the 
vector changes according to the portion of the vessel it is aiming at.
Figure 1. Magnetic navigation system is shown with the magnets in position on either side of the patient.
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Figure 2 Graphic showing reconstruction of LV mapping
Figure 3 MYOSTAR™ Injection Catheter to have electromechanical guidance provided by the NOGA® XP.
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Figure 4 NOGA™ electrical (UNIV, at top) and mechanical (LLS, at bottom) maps from a human patient in the 
stem cell treatment group. The maps on the left are those performed at the time of injection and maps at right 
are those at 4-month follow-up. An area of viability, showing normal electrical activity, can be noted on the 
upper-right map. The maps on the right show improvement in both electrical and mechanical function. LLS = 
linear local shortening; UNIV = unipolar voltage.
Figure 5 The panel on the left shows the raw data from angiography and the panel on the right shows the 
reconstructed MSCT.
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Figure 6 The panel on the left shows the co-registered points applied to the MSCT image that was imported 
into Navigant and the panel on the right shows the computer reconstructed pathway that is derived from CT 
and projected onto the reconstruction in Navigant.
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Figure 1 System in position for PCI. M indicates magnets in tilt position for better lateral movement of the 
image intensifier. T indicates touch screen interface to give real-time instruction to the MNS. S indicates in-lab 
main screen monitor.
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Figure 2 The top left panel shows the occluded RCA that could not be opened anterogradely. The other three 
panels are different views showing Cx tortuousity and severe lesions at proximal and distal anastomoses of the 
SVG. C indicates the Cx. P indicates the proximal anastomosis. D indicates the distal anastomosis
Figure 3 Panels showing different fluoroscopy views with vessel edges marked by edge detection software 
(CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel) before reconstruction. P indicates proximal point. D 
indicates distal point
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Figure 4 Three-dimensional reconstruction of target pathway. C indicates the tortuous Cx. P indicates the 
proximal anastomosis. D indicates the distal anastomosis
Figure 5 Screen of Stereotaxis Navigant program during procedure, showing top left panel with endoluminal 
view. The top right panel shows the reconstruction. The bottom 2 panels are static-captured fluoroscopy 
images with the reconstruction for that angle superimposed.
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Figure 6 Interventions. The top left panel shows predilation of Cx. The top right panel shows stent placement 
in distal anastomosis. The bottom left panel shows stent deployment at the proximal anastomosis. The bottom 
right panel shows one of the stents being deployed in the Cx. C indicates the Cx. P indicates the proximal 
anastomosis. D indicates the distal anastomosis.
Figure 7 Results of stenting form different views. C indicates the Cx. P indicates the proximal anastomosis. D 
indicates the distal anastomosis.
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Figure 1 The screen of the Navigant workstation, the panel (P) shows virtual coronary tree of the preset 
navigation with the list of preset vectors (V) seen above.  The panel (C) shows the 2D clockface.
Figure 5 The left panel shows the edges detected on the fluoroscopy image (2 views required), the right panel 
shows the 3 dimensional reconstruction of the infarct related coronary artery.
